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Abstract
Electromagnetic Hypersensitivity (EHS), more formally known as Idiopathic
Environmental Intolerance attributed to Electromagnetic Fields (IEI-EMF), is a
controversial condition characterised by the experience of a broad range of non-specific
symptoms which a person attributes to the electromagnetic fields (EMF) emitted by
everyday electronic and wireless technologies. In contrast to growing anecdotal reports
of sensitivity to EMF, much of the existing literature has not found evidence that
exposure to EMF can result in the symptoms reported by IEI-EMF sufferers. Instead,
the condition is thought to be the result of a nocebo effect, where conscious or
subconscious symptom expectation leads to the development and detection of
symptoms. Yet, despite decades of research, IEI-EMF sufferers and a minority of
scientists argue that the symptoms are caused by exposure to EMF, via some as-yet
unrecognised bioelectromagnetic mechanism.
In an effort to resolve the aetiological debate, this thesis aimed to clarify whether
toxicogenic or psychogenic processes can explain the symptoms reported by IEI-EMF
sufferers. Specifically, a number of methodological issues were addressed to more
clearly determine whether individuals can be sensitive to EMF exposure, or whether
psychogenic processes play a role in the presentation of symptoms attributed to EMF
exposure.
First, as a means of establishing whether radiofrequency EMF (RF-EMF) exposure
below the established safety guidelines could elicit adverse effects in humans and in an
attempt to determine the most sensitive objective endpoints to test IEI-EMF
participants, Study 1 investigated whether exposure to RF-EMF influences human
cognitive performance in a dose-dependent manner. While the results showed that
v

exposure to RF-EMF can improve reaction time on a working memory task, given that
methodological improvements employed in this study have not yet been replicated, and
given that the effect was not found to be dose-dependent and that an improvement in
performance does not reflect an adverse health effect, Study 1 did not provide
convincing evidence that exposure to RF-EMF can adversely affect cognitive
functioning. Furthermore, the study did not identify any sensitive cognitive performance
measures with which to test IEI-EMF sufferers. This line of research was thus
discontinued.
Study 2 aimed to determine whether the symptoms reported by IEI-EMF sufferers can
be explained by toxicogenic or psychogenic processes, and incorporated several
methodological improvements to overcome the limitations of previous research. The
study was designed as a series of individual case studies to test whether exposure to RFEMF results in an increase in IEI-EMF participants’ self-nominated symptoms
compared to sham, and , to determine whether IEI-EMF individuals could accurately
detect the presence of RF-EMF emissions under double-blind conditions. Despite
accounting for a number of potential limitations, the results of the case studies failed to
demonstrate that the symptomatic response of self-reported IEI-EMF sufferers is
affected by RF-EMF exposure, nor that IEI-EMF sufferers can detect the presence of
RF-EMF emissions at greater than chance levels. While all participants displayed an
increased symptom severity and were confident that they could detect the presence of
RF-EMF in the open-label RF-ON but not RF-OFF trial, no significant differences in
symptom severity or exposure detection were found between the double-blind RF-ON
and RF-OFF (sham) conditions. Notably, a significant relationship between a
participant’s belief that they were being exposed (irrespective of the actual exposure
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condition) and their symptomatic response was observed, giving a strong indication the
symptoms experienced were due to a nocebo response, and therefore, that IEI-EMF can
be explained by psychogenic processes.
Study 3 extended upon Study 2 by investigating whether a nocebo response is specific
only to IEI-EMF sufferers, and by examining the potential role of psychological
processes in the presentation of symptoms attributed to EMF exposure. Healthy
participants were randomly assigned to watch either an alarmist video emphasising
‘adverse effects of EMF exposure’ or a control video completely unrelated to EMF and
health, before completing a series of open-label and double-blind provocation trials.
Consistent with Study 2, results showed that healthy participants reported higher
symptoms in the open-label RF-ON compared to the RF-OFF trial. However, in the
subsequent double-blind trials, no difference in either belief of exposure or symptoms
was found between the RF-ON and sham conditions. Belief of exposure was also
positively associated with higher symptom scores in the double-blind trials, further
indicating that a nocebo effect, rather than EMF exposure itself, was responsible for the
increase in symptoms. Additionally, participants who viewed the alarmist video
reported higher symptom scores in the open-label trials, as well as a greater increase in
state anxiety and risk perception from baseline, than those who viewed the control
video. This indicates that viewing sensationalist media reports about perceived
environmental hazards raises concerns and negative beliefs about EMF exposure, and
may exacerbate a nocebo response, suggesting that the degree to which people
experience symptoms that they believe are associated with EMF exposure may be
influenced by media reporting.
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Taken together, the findings from this thesis do not support the notion that toxicogenic
processes can explain the symptoms attributed to EMF exposure. Instead the studies
presented provide strong support for the view that psychological factors play an
important role in triggering, maintaining, or exacerbating symptoms in response to
perceived exposure to EMF.
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1.

CHAPTER 1: GENERAL INTRODUCTION

The research presented in this doctoral thesis was designed to investigate the
determinants of Idiopathic Environmental Intolerance attributed to Electromagnetic
Fields (IEI-EMF), a controversial condition more commonly referred to as
Electromagnetic Hypersensitivity (EHS). While continuing technological advances have
generally benefited greater society, the unprecedented rise in the number and diversity
of electromagnetic field (EMF) sources has raised public concerns about potential
adverse health risks posed by our increasing exposure to EMF. Amongst these concerns
are the reports of a proportion of the population who claim to experience a variety of
health problems which they attribute to exposure to EMF. As the associated symptoms
are debilitating for many, it is crucial to understand the determinants of this condition.
Two alternate theories have been proposed to explain the origin of the symptoms
reported by individuals who suffer from IEI-EMF; namely the toxicogenic theory and
the psychogenic theory. While much of the extant literature indicates that the reported
symptoms are of a psychogenic origin, a number of methodological issues need to be
overcome before this can be conclusively determined, and much remains to be clarified.
In an effort to resolve the aetiological debate, the empirical studies presented in this
thesis specifically sought to address a number of methodological issues to more clearly
determine whether individuals can be sensitive to EMF exposure, and to examine the
potential role of psychogenic processes in the presentation of symptoms attributed to
EMF exposure. The following chapter outlines the general background and rationale for
this research, the research aims, and the significance and originality of this research.

1

1.1

Background

The use of wireless technology has rapidly increased over the past two decades with the
continuing development of mobile phone, laptop, tablet and smart devices. Globally, the
United Nations estimates that there are approximately 7 billion active mobile phone
subscriptions (International Telecommunications Union, 2017), a figure almost
equivalent to the total human population. In Australia, one of the country’s largest
telecommunications companies has introduced over 2 million public wireless fidelity
(Wi-Fi) hotspots since 2015 to cope with the increasing demand for access to high
speed wireless internet (Telstra, 2014), while state utility companies across the nation
are beginning to introduce smart metres, which communicate wirelessly, to track
household electricity use (Energy Australia, 2014). By 2020, the roll out of 5G
technology will further drive society globally into the ‘internet of things’, where various
numbers of smart devices will communicate wirelessly with each other in an effort to
improve the lives of the people who use them. There is probably no other technology
that has been so quickly and widely adopted by the general public in recent times
(Stewart, 2008).
Yet, despite the benefits associated with the introduction and widespread use of wireless
technologies, concerns have been raised about whether there may be adverse health
effects associated with our increasing exposure to the non-ionising EMF utilised by
these devices. These concerns have been partially driven by reports from a proportion of
the population who claim to have detected a clear association between their experience
of distressing and sometimes debilitating symptoms and their exposure to the EMF
emitted by various everyday technologies and infrastructure (as described in Vignette
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1). These individuals suffer from a condition commonly described as Electromagnetic
Hypersensitivity (EHS).
Vignette 1:
Steve (aged 45 years), is an IT professional who has been using computers his
entire adult life. He has always considered himself an early adopter of new
technologies. In 2001, after purchasing one of the most powerful Wi-Fi routers
at the time, Steve began to experience symptoms including pressure in the chest,
pressure in the head, mood changes, and tingling sensations in the hands and
face within minutes using the Wi-Fi router. After turning off the Wi-Fi router, he
experienced a headache that persisted for several hours. Steve soon believed that
there was a consistent pattern between the symptoms that he was experiencing
and the use of his Wi-Fi router. With the subsequent rollout and advancement of
other wireless technologies including mobile phones, smart metres, digital
cordless telephones and inflight Wi-Fi, Steve’s health worsened to a point where
he began to experience sleeping difficulties, constant headaches and extreme
lethargy. These symptoms then resulted in a complete loss of motivation to do
activities with his family and forced him to only use the rear parts of his home,
which he shielded with metallic paint and “RF blocking” curtains. He can no
longer drive through suburbs where smart metres have been installed without
developing a serious headache that can last for several days. Steve is deeply
concerned about the lack of support, care and understanding he has experienced
from medical professionals, power utilities and various government departments
and is adamant that his symptoms can be attributed to EMF exposure (Weller,
2014).

3

The aetiology of this condition, however, is extremely controversial. While some
researchers and many of those who suffer from the condition believe that it is caused by
exposure to EMF, to date, there has been insufficient scientific evidence to support this
claim. Instead, much of the evidence suggests that that the condition is likely the result
of a nocebo response (Röösli, Frei, Mohler, & Hug, 2010; Rubin, Das Munshi, &
Wessely, 2005; Rubin, Nieto-Hernandez, & Wessely, 2010), where conscious or
subconscious symptom expectation following a perceived exposure to EMF leads to the
formation or detection of symptoms. Due to the lack of evidence for a relationship
between the reported symptoms and exposure to EMF, the World Health Organisation
(WHO) proposed the term ‘Idiopathic Environmental Intolerance attributed to
Electromagnetic Fields’ (IEI-EMF) to be used in place of ‘Electromagnetic
Hypersensitivity’ (EHS), in order to avoid implying a causal role of EMF in producing
the reported symptoms (World Health Organisation, 2004) 1.
Idiopathic Environmental Intolerance (IEI) is an umbrella term used to describe a group
of health conditions that are characterised by the experience of a wide range of somatic,
non-specific symptoms which are claimed to arise in response to environmental
triggers, but for which there is no established evidence of a relationship between the
claimed environmental triggers and adverse symptoms (Van den Bergh, Brown,
Petersen, & Witthöft, 2017). As well as being used to describe the symptoms which
people attribute to EMF, the IEI term has also been used to describe a number of other
conditions such as Multiple Chemical Sensitivity (MCS), which refers to the attribution
of symptoms to a wide range of everyday chemical sources (which may include
1

Consistent with this recommendation, the present thesis uses ‘IEI-EMF’ as a neutral term to refer to

EHS.

4

cleaning products, air pollution and pesticides); and Infrasound Hypersensitivity (IHS),
more commonly known as Wind Turbine Syndrome, which refers to the attribution of
symptoms to the low frequency noise emitted by wind turbines. The aetiologies of the
IEI conditions are controversial for a number of reasons. First, there is often no
established relationship between the environmental exposure claimed to trigger
symptoms and organ pathology or dysfunction. Second, the reported symptoms are
extremely heterogeneous, and are often alleged to be triggered by environmental
exposures at strengths well below the thresholds currently known to cause adverse
health effects. In addition to this, there is generally no evidence to suggest that the
symptoms claimed by IEI sufferers are associated with the claimed exposures. For
instance, MCS and IEI-EMF sufferers who participate in well-designed laboratory
studies which use double-blind protocols and utilise the particular environmental
exposures purported to be responsible for symptoms generally fail to have their
symptom claims verified in active compared to sham exposures, and instead
behavioural and psychological processes have been consistently found to play a role in
the presentation of symptoms (Das-Munshi, Rubin, & Wessely, 2006; Rubin et al.,
2005; Rubin et al., 2010). Likewise, there is no evidence of a direct causal link between
living in close proximity to wind turbines, the noise they emit and the physiological
health effects claimed to be attributable to wind turbines by IHS sufferers (Knopper &
Ollson, 2011). Finally, there is a large symptom overlap between IEI’s and other
somatoform disorders and functional syndromes such as chronic fatigue syndrome and
fibromyalgia (Van den Bergh et al., 2017).
Like the other IEI conditions, the discrepancy between the scientific evidence and the
reports of sensitivity to EMF has instigated a highly contentious debate concerning the
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aetiology of IEI-EMF. On one side, advocates of the toxicogenic explanation argue that
the adverse symptoms reported by IEI-EMF sufferers are the result of an intolerance or
susceptibility to exposure to low levels of EMF, which affects the human body via some
as-yet unrecognised toxicogenic or ‘bioelectromagnetic’ mechanism (Rubin et al., 2010;
Staudenmayer, Binkley, Leznoff, & Phillips, 2003a). Alternatively, proponents of a
psychogenic explanation contend that the condition can be explained by an individual’s
overvalued belief of toxicity, a belief which is shaped by a range of psychological,
psychosocial and psychophysiological processes (Staudenmayer, Binkley, Leznoff, &
Phillips, 2003b) and which ultimately culminates in the presentation of adverse
symptoms via a nocebo response.
Given the debilitating nature of IEI-EMF (as described in Vignette 1), resolving the
aetiological debate is extremely important, not least because the two opposing theories
have very different implications in terms of identifying and developing the most
appropriate treatments and support for those who experience the condition (Rubin, Das
Munshi, & Wessely, 2006; Rubin et al., 2010). For instance, if EMF exposure is indeed
responsible for the development of these symptoms, then exposure reduction and
avoidance may be the most suitable strategy to alleviate symptoms. Conversely, if the
symptoms are the result of a nocebo effect, then a psychologically complex scenario
needs to be dealt with. Investigating the determinants of this condition forms the focus
of this thesis.
1.2

Electromagnetic Fields and Health

Electromagnetic fields (EMF) are waves of energy which radiate through space. These
waves are generated by both natural and man-made sources, and are comprised of two
components, an electrical field (E-field) and a magnetic field (H-field) (Wood & Roy,
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2017). E-fields are measured in volts per-metre (V/m) and are present whenever
positive or negative electrical charges exert force on other charged particles in the field.
E-fields are strongest closer to the device (for e.g. a mobile phone) and diminish rapidly
with greater distance from the source (Wood & Roy, 2017; World Health Organisation,
2018). H-fields are measured in amperes per metre (A/m) and are produced by the
physical movement of electrical charges. Like E-fields, H-fields are strongest closer to
the source and diminish with greater distance from the source (Wood & Roy, 2017;
World Health Organisation, 2018). EMFs are defined by the frequency or corresponding
wavelength of the electromagnetic wave. Frequency is used to describe the number of
oscillations or cycles per second (typically measured in Hertz (Hz)), while wavelength
is used to describe the distance between one peak (or trough) of the electromagnetic
wave and the next peak (or trough) (World Health Organisation, 2018). Frequency and
wavelength have an inverse relationship, the higher the frequency, the shorter the
wavelength.
EMF can be classified into different ranges based on frequency and/or wavelength.
When arranged on a continuum they form what is known as the electromagnetic
spectrum. Based on frequency, the spectrum is divided into two distinct categories;
ionising and non-ionising radiation. Figure 1.1 illustrates the distinction between
ionising and non-ionising EMF and delineates the frequency bands typically used to
refer to types of EMF, and the typical sources that utilise each frequency.
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Figure 1.1: The electromagnetic spectrum and associated sources (adapted from the National
Cancer Institute
https://www.cancer.gov/PublishedContent/Images/images/infographics/electromagneticspectrum-enlarge.__v10067782.png)

Ionising radiation is at the high frequency (and thus high-energy) end of the spectrum
and includes X-rays and gamma rays. Ionising radiation carries enough energy to free
electrons from atoms or molecules, thereby creating free radicals, which are highly
reactive. These free radicals can effectively break chemical bonds and damage
biological tissue. While the destructive and detrimental effects of ionising radiation are
well-known (for example when used in atomic weapons or during and following a
nuclear reactor meltdown), ionising radiation is also used in a beneficial way in
medicine, for example in radiography and cancer treatments. Non-ionising radiation, on
the other hand, is at the lower-energy end of the spectrum and refers to the
electromagnetic radiation that does not carry sufficient energy to remove electrons from
atoms or molecules. Extremely Low Frequency (ELF) radiation, Radiofrequency (RF)
radiation, infrared radiation, visible light, and Ultra Violet (UV) radiation are all forms
of non-ionising EMF. Generally, electronic and wireless technologies utilise EMF in the
ELF (from 3 to 30 Hz) and RF (from 3 kHz to 300 GHz) bands of the non-ionising
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radiation domain (ARPANSA, 2012). A number of biological and health effects from
exposures to high intensities of non-ionising EMF have been well documented. These
effects generally relate to the localised heating or stimulation of excitable tissue that is
associated with the amount of energy absorbed by the body (Repacholi, 1998). The rate
and distribution of energy absorption in the body depends strongly on the frequency,
strength and orientation of the incident EMF 2 as well as the body’s size and its electrical
properties (Health Canada, 2015).
The absorption of RF-EMF by the human body is commonly described in terms of the
specific absorption rate (SAR), which is a measure of the rate of energy deposition per
unit mass of body tissue and is usually expressed in units of watts per kilogram (W/kg).
It is important to note that the high exposure levels known to adversely affect human
health via thermal mechanisms do not exist in daily life, as the technologies which
utilise RF-EMF are heavily regulated by governments and health agencies (for example
ARPANSA, 2002) using internationally recognised safety guidelines (for example
ICNIRP, 1998). For instance, the ICNIRP (1998) RF-EMF guidelines are based on SAR
limits at many orders of magnitude lower than the thresholds known to cause
temperature increases that would affect human health. For the general public, these
guidelines recommend limiting the SAR to 2 W/kg; while for people undergoing
occupational exposure, the guidelines recommend a limit of 10 W/kg (averaged over 10
grams of tissue) (ICNIRP, 1998). Likewise, internationally recognised safety guidelines
have been developed to protect humans against the potential adverse effects of ELFEMF exposures (ICNIRP, 2010). Exposure to high intensity ELF-EMF may cause welldefined biological responses, including perception and annoyance, alterations in some
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From herein, the present thesis refers to ‘non-ionising EMF’ as ‘EMF’ for readability
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aspects of brain and nervous system function, and the induction of retinal phosphenes
(the perception of faint flickering light in the absence of visual input). The physical
quantity used to specify the exposure limits for ELF-EMF is the internal electric field
strength (Ei), as it is the electric field that affects nerve cells and other electrically
sensitive cells. However, as this value is often difficult to derive, reference levels based
on measurements (or computations) of electric field strength, magnetic field strength,
magnetic flux density and currents flowing through the limbs can be used to ensure
compliance with the relevant exposure limit (ICNIRP, 2010). With the exception of
some medical exposures to patients and some specialised occupational exposures,
exposure to the high levels of ELF-EMF that are known to cause adverse health effects
in humans are extremely rare, and are unlikely to occur in daily life.
Despite a number of authoritative reviews of the scientific literature generally
concluding that there are no established health risks associated with exposure to EMF
within the established guidelines, nor any established mechanism by which this could
occur (Health Canada, 2015; Health Council of the Netherlands, 2009; SCENIHR
(Scientific Committee on Emerging and Newly Identified Health Risks), 2009; World
Health Organisation, 2014), the rapid development and increasing use of wireless
technologies has generated considerable public concern about potential adverse health
effects of exposure to EMF below the established exposure guidelines (World Health
Organisation, 2018).
Evidence that EMF exposure below the established guidelines can have biological or
physiological effects is often used by IEI-EMF sufferers and advocates as arguments to
suggest that EMF exposure can adversely affect health (for example. BioInitiative
Working Group, 2012). It is important in these instances, however, to distinguish
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between biological/physiological effects and health effects. Biological/physiological
effects are measurable responses to a stimulus or to a change in the environment, but
they are not necessarily harmful for human health (World Health Organisation, 2018).
These often occur in daily life, for example when eating food, playing sport or listening
to music. Conversely, an adverse health effect is something which results in a detectable
impairment in the health of the exposed individual (World Health Organisation, 2018).
One of the most consistently reported effects of RF-EMF exposure, similar to that
emitted by mobile phones, are alterations in the brain’s electrical activity, specifically in
the spontaneous resting alpha (8 – 12 Hz) (Croft et al., 2008; Croft et al., 2010; Curcio
et al., 2005; Leung et al., 2011) and the sleep spindle frequency range (approximately
11 – 15 Hz) (Huber et al., 2000; Huber et al., 2002; Loughran et al., 2005; Regel et al.,
2007; Schmid et al., 2012) of the electroencephalograph (EEG). These effects have been
found to occur in a dose-dependent manner. Although dose dependency is a
fundamental principle of toxicology, and refers to the change in effect caused by
differing levels of exposure (Staudenmayer et al., 2003a), the change in EEG as a result
of exposure to RF-EMF may not necessarily reflect an adverse health effect.
While the EEG is closely related to cognitive and mental processes and states
(Andreassi, 2007), studies investigating the effect of RF-EMF on gross measures of
cognitive performance, such as response times and accuracy, have produced
contradictory, but mostly null results. For instance, one meta analyses reported that
human attention and working memory is affected by exposure to EMF (Barth et al.,
2008), while other meta analyses have found no influence of exposure on gross
measures of performance (Barth, Ponocny, Gnambs, & Winker, 2012; Valentini,
Ferrara, Presaghi, De Gennaro, & Curcio, 2010). The inconsistent results, however, may
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be due to a number of methodological issues, including variation in methods between
research groups (making it difficult to compare or verify previous results), poor
exposure protocols and experimental designs, inadequate sample sizes and a lack of
reliable cognitive performance measures (Regel & Achermann, 2011). In addition,
individual differences in cognitive performance have not been adequately accounted for
in previous studies, nor has the potential influence of thermal variability, which may be
particularly important given that exposure to RF-EMF imparts a thermal load on the
body (Adair & Black, 2003). Given these issues, the associated functional
consequence(s) of the change in EEG, if any, remains to be clearly determined, and as
such, there is some uncertainty as to whether exposure to RF-EMF can impair cognitive
performance.
The World Health Organisation (WHO) defines health as “a state of complete physical,
mental and social well-being and not merely the absence of disease or infirmity” (World
Health Organisation, 1946).While, to date, there is no evidence of any adverse health
effects of EMF exposure below the established safety guidelines (Health Canada, 2015;
Health Council of the Netherlands, 2009; SCENIHR (Scientific Committee on
Emerging and Newly Identified Health Risks), 2009; World Health Organisation, 2014),
the prevalence of adverse symptoms attributed to EMF exposure, while currently
lacking evidence of a direct causal relationship (Röösli et al., 2010; Rubin et al., 2005;
Rubin et al., 2010), may be viewed by many in the community as a major health effect,
warranting the need for further investigation.
1.3

Perceived sensitivity to EMF

Anecdotal reports of sensitivity to devices which emit EMF began to emerge in the late
1970’s, when reports of facial skin symptoms related to workers using visual display
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units (VDU) began to arise in Great Britain and Norway, and were followed by similar
reports in Sweden, the United States and Japan (Lindén & Rolfsen, 1981; Nilsen, 1982;
World Health Organisation, 2004). As technology progressed, so too did the reports of
sensitivity to devices which emit EMF, with emitters such as mobile phones and Wi-Fi
now claimed to adversely affect individuals. While there is currently no established
diagnostic criterion to identify individuals suffering from IEI-EMF (World Health
Organisation, 2004), generally, the condition is characterised by a person experiencing a
broad range of dermatological, neurasthenic, vegetative or mood symptoms (see table
1.1) which they attribute to the EMF emitted by various electronic and wireless devices
or infrastructure.
The difficulty in establishing a clear aetiology for the symptoms reported by IEI-EMF
sufferers is compounded by the heterogeneous nature of the condition. No consistent
pattern in either the types of symptoms, the time it takes for symptoms to develop and
subside or the sources of EMF that are claimed to trigger symptoms has been detected.
For instance, cross-sectional survey studies and qualitative case studies have shown that
IEI-EMF symptoms have been reported by sufferers in response to a wide range of
EMF emitting devices and infrastructure including mobile and cordless phones, mobile
phone base stations, personal computers, ELF-EMF sources (i.e., power lines, electrical
appliances and railroads), Wireless Local Area Networks (W-LAN or ‘Wi-Fi”),
Magnetic Resonance Imaging (MRIs) and Ultra Violet (UV) radiation from sunlight. In
addition, the sources that people report sensitivity to have been found to be either very
specific (e.g., they report responding to one source only) or are more general (e.g., they
report responding to a range of, or ‘all’ EMF sources) (Hagström, Auranen, & Ekman,
2013; Hocking, 1998, 2014; Kato & Johansson, 2012; Röösli, Moser, Baldinini, Meier,
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& Braun-Fahrländer, 2004; Schüz et al., 2006). Furthermore, some sufferers report
experiencing short lasting ‘acute’ symptoms which they allege are in relation to using or
being in the vicinity of EMF-emitting devices, while others report experiencing more
prolonged and debilitating symptoms which are claimed to be the result of a build-up of
exposure from a variety of sources over time (Hocking, 1998, 2014; Röösli et al., 2004).
As well as experiencing considerable physical impairment, individuals suffering from
IEI-EMF report a significant degree of social, mental, functional, and financial strain.
This is often associated with increased levels of distress, increased health service use,
the desire to move away from cities to areas perceived as ‘safer’ or ‘low-EMF’ and
being either partly or completely unable to work due to their health issues (Hagström et
al., 2013; Johansson, Nordin, Heiden, & Sandström, 2010; Kato & Johansson, 2012;
Röösli et al., 2004; Rubin et al., 2010).
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Table 1.1: Common symptoms reported by IEI-EMF sufferers
Neurasthenic

Vegetative/Mood

Dermatological

Headaches

Abnormal fatigue

Dizziness

Depression

Burning/warmth skin
sensations

Heavy/pressure sensations
in the head

Mood changes

Concentration problems

General sensation of illness

Memory problems

Nervousness/anxiety

Stress

Stinging sensation of the
skin
Hot sensations of the head
region

Increased sensitivity to
noise
Ear aches
Tinnitus
Arrhythmia
Sore joints
Back aches
Nausea
Sleeping disorders
Muscle tension
Muscle weakness
Limb pain

Table 1.2 displays the estimated prevalence of IEI-EMF in various countries around the
world. These figures demonstrate that the prevalence of the condition is also relatively
heterogeneous globally. It is important to note, however, that not all individuals
attributing health complaints to EMF exposure identify themselves as ‘being EHS’
(Kato & Johansson, 2012; Schüz et al., 2006). It is also possible that the difference in
prevalence rates are reflective of the differences in the type of questions asked and the
time of the survey being administered, rather than an actual difference in prevalence
rate. For instance, Hillert, Berglind, Arnetz, and Bellander (2002) asked surveyed
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participants to mark factors for which they believed they were hypersensitive or allergic
to from a range of 13 environmental stimuli (for example pollen, noise, electromagnetic
fields) at a time when concern about EMF in Sweden was mainly focused on the EMF
emitted by VDU and powerlines. Conversely, Blettner et al. (2009) conducted a survey
which focused specifically on symptoms attributed to RF-EMF and asked participants
whether they were worried about health effects of mobile phone base stations in general,
and whether they believed that their health was adversely affected by mobile phone base
stations. Clearly, these two methodologies differ substantially in terms of their focus
and the time at which they were conducted. As such, the figures presented in Table 1.2
should be noted with caution, as they may represent an over- or under-estimate of the
prevalence of the condition.
Table 1.2: Estimated prevalence of IEI-EMF
Country

Prevalence (%)

Source

Sweden

1.5

(Hillert et al., 2002)

California

3.2

(Levallois, Neutra, Lee, & Hristova,
2002)

Austria

3.5

(Schröttner & Leitgeb, 2008)

Netherlands

3.5

(Baliatsas et al., 2015)

United Kingdom

4.0

(Eltiti, Wallace, Zougkou, et al., 2007)

Switzerland

5.0

(Schreier, Huss, & Röösli, 2006)

Germany

~10

(Blettner et al., 2009)

Taiwan

13.3

(Tseng, Lin, & Cheng, 2011)

The distressing and debilitating symptoms experienced by those who suffer from IEIEMF often lead to significant impairments in physical, mental and social wellbeing
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(Johansson, Sandström, Heiden, & Nordin, 2010). Clearly, those who experience IEIEMF are impaired according to the WHO definition of health, and further investigation
is required to elucidate the aetiology of their symptoms. Although the characterisation
of IEI-EMF through qualitative case studies and survey data generates considerable
insight into how the condition affects people’s lives, such studies cannot objectively
comment on the existence of a causal relationship between EMF and the reported
symptoms (Hocking, 1998). Generally, this is because these types of studies do not
involve an empirical test of whether exposure to EMF can generate the symptoms, but
instead rely heavily on retrospective self-report, which is known to suffer from recall
bias (Baliatsas et al., 2015; Vrijheid et al., 2009). Anecdotal reports are also unable to
account for the possibility that a psychological phenomenon, such as a nocebo effect,
rather than the EMF exposure itself, is responsible for triggering the reported
symptoms. As such, these studies cannot provide definitive support for the toxicogenic
theory of IEI-EMF.
1.4

The Nocebo Effect

Medical practitioners have long been aware of a seemingly mysterious phenomenon
known as a placebo effect. This effect is characterised by a genuine physiological or
psychological response to a stimulus that has no inherent powers to produce the
observed effect (Stewart-Williams, 2004; Stewart-Williams & Podd, 2004). The classic
example of a placebo effect occurs when a patient is prescribed a sugar pill and the
patient, unaware that the pill is merely a placebo (and is thus pharmacologically
irrelevant to their complaint), makes a full recovery (Stewart-Williams, 2004). Of
interest to this thesis, however, is the negative counterpart of the placebo effect, the
nocebo effect. The term ‘nocebo effect’ was first introduced in the 1960’s to describe
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the genuine adverse physiological and psychological effects of stimuli which have no
inherent powers to produce observed effects (Barsky, Saintfort, Rogers, & Borus, 2002;
Hahn, 1997; Kennedy, 1961). Importantly, in both placebo and nocebo effects, the
exposure or substance administered to a person is not a necessary or sufficient cause of
the associated outcome (Hahn, 1997).
In comparison to the placebo effect, much less is known about the factors which
contribute to a nocebo response. Generally, this is because inducing a nocebo response
is a stressful and anxiety provoking procedure which may lead to a real deterioration in
health, thus limiting its potential to be ethically investigated in humans (Enck,
Benedetti, & Schedlowski, 2008). The extensive study of placebo effects has, however,
revealed the complex interaction between psychological processes, such as expectation
and anticipation, and particular neuronal systems that are capable of altering the course
of a symptom or disease (Benedetti, Lanotte, Lopiano, & Colloca, 2007). This has led to
the formation of a number of theories about the possible factors and neurobiological
mechanisms that may contribute to a nocebo effect, though determining which
mechanism sufficiently explains the nocebo effect has not yet been adequately clarified.
So far, three theories have been proposed to explain the nocebo effect; namely
misattribution, learning and expectation (Webster, Weinman, & Rubin, 2016).
The misattribution theory posits that pre-existing symptoms are misattributed to the
effects of a new exposure (Webster et al., 2016). While it is common to experience
symptoms in everyday life (Kroenke & Price, 1993; Petrie, Faasse, Crichton, & Grey,
2014; Reid, Wessely, Crayford, & Hotopf, 2001), when these symptoms are perceived
to occur consistently with an environmental exposure, the potential to mistakenly
attribute the symptoms to the exposure source are increased. In respect to IEI-EMF, one
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recent qualitative study suggested that people who claim to suffer from IEI-EMF are
actually individuals who have pre-existing medically unexplained symptoms (MUS)
who are using the notion of sensitivity to EMF as a narrative to help explain their
symptoms (and thereby misattribute their symptoms to EMF) in an effort to make their
condition more practically and emotionally manageable (Dieudonné, 2016). Some
researchers, however, argue that misattributing symptoms to an exposure does not
technically constitute a nocebo effect, and that expectations and/or learning are the
predominant factors underpinning a nocebo response (Barsky et al., 2002; Colloca &
Franklin, 2011). This may be because misattribution can be viewed as one step in the
nocebo process, rather than a nocebo effect itself. Indeed, Dieudonné (2016) did not
consider the misattribution of MUS to EMF as a nocebo response per se, but rather
suggested that the misattribution of symptoms occurs independently, and that a nocebo
response based on negative expectations or learning may occur at a later stage to further
reinforce the original symptom misattribution. In a recent systematic review, however,
Webster et al. (2016) showed that a number of studies investigating the nocebo response
had found that participants who suffered from conditions with symptoms similar to
those being induced by an inert substance predicted increased symptom reporting,
demonstrating that the misattribution mechanism of the nocebo effect may be plausible
in some instances. While misattribution may be an underlying factor in the presentation
of some IEI-EMF cases, it is a difficult factor to quantify through empirical research, as
the original symptom misattribution could only be understood through qualitative
interviews or epidemiological survey studies, which are often conducted retrospectively
and may be influenced by recall bias. Yet, irrespective of the debate surrounding
whether misattribution technically constitutes a nocebo effect, it is clear that the concept
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of conscious or subconscious symptom misattribution is an important element in the
remaining two nocebo effect theories.
The learning theory suggests that nocebo effects are elicited through classical
conditioning (Barsky et al., 2002; Webster et al., 2016). For example, a person may
experience side effects to a prescribed medication, but not because of a pharmacological
reaction, but rather because they have experienced side effects to drugs with, for
instance, a similar shape, colour, smell or taste, in the past (Barsky et al., 2002). In this
way, the physical properties of the medication have acquired the capacity to elicit a
physiological change as a result of classical conditioning, through either a conscious or
subconscious mechanism (Webster et al., 2016). In regards to IEI-EMF, it is possible
that the coincidental experience of a common symptom when a person comes into
contact with a certain EMF emitting source on a number of occasions forms an
association in the brain such that when that (or a similar) device is seen, it automatically
triggers the associated response (i.e. a symptom). In this way, an individual will have
become conditioned to experience a symptom when they come into contact with that
specific or similar looking EMF emitting sources or if they come to believe that they are
in an environment where they are being exposed to EMF. Misattribution may then play
a role when a person attributes the cause of their symptoms (without any objective
evidence) to the EMF emitting source as a way of labelling what the conditioning has
demonstrated.
The expectation theory proposes that negative expectations of adverse symptoms or
reactions and the associated emotional states associated with such expectations elicit the
adverse symptoms or reactions in the expectant person (Hahn, 1997). The possible
psychological mechanisms thought to underlie the formation of the negative
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expectations that may drive nocebo responses are anticipation and information about
negative outcomes, prior experience of negative therapeutic outcomes and the
observation of other patient’s negative outcomes (Colloca & Franklin, 2011). For
instance, if a person is given information that an interaction with a (neutral) stimulus
may have negative side effects (for example a headache), the negative expectation
generated by this information may make an individual increasingly likely to notice or
attend to either existing or new symptoms, and then attribute these symptoms to the
stimulus (Barsky et al., 2002). In addition to this, the emotional states associated with
negative expectations may also induce that particular negative emotional state. For
example, the expectation of anxiety is in itself anxiety provoking, and therefore directly
elicits the negative effect that was expected (Webster et al., 2016). In many instances,
explicit suggestions about the effects of an exposure have been shown to be a key
contributing factor in the generation of negative expectations that result in nocebo
effects (Barsky et al., 2002; Benedetti et al., 2007; Webster et al., 2016). In terms of
IEI-EMF, an example of this may be that the communication of information about
potential adverse health effects, either through news media stories or through the
precautionary information communicated by governments and health agencies,
constitutes an explicit suggestion which could then be responsible for the formation of
negative expectations and a subsequent nocebo effect. Yet while many studies have
shown that explicit suggestions about the effects of EMF can negatively influence
people’s beliefs about EMF exposure (Barnett, Timotijevic, Shepherd, & Senior, 2007;
Köteles, Tarján, & Berkes, 2016; Nielsen et al., 2010; Wiedemann, Boerner, &
Repacholi, 2014; Wiedemann et al., 2013; Wiedemann & Schütz, 2005; Wiedemann,
Thalmann, Grutsch, & Schütz, 2006; Witthöft et al., 2017), whether the negative beliefs
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induced by such information can result in a symptomatic nocebo response following a
perceived exposure to EMF has not been sufficiently established.
Recent studies investigating the potential factors and neurobiological mechanisms
underlying placebo and nocebo effects mostly stem from the investigation of pain
processing in healthy participants. Despite the ongoing debate about which theory can
better explain placebo and nocebo effects, these studies have confirmed that mental
processes, mediated by expectations and learning, have the ability to modify the
experience of pain. Further, these changes in pain processing have been able to be
objectively measured and associated with certain brain regions and
psychopharmacological processes using neuroimaging methods (Colloca & Franklin,
2011). In particular, experimental studies have shown that negative verbal suggestions
following the administration of inert substances can induce anticipatory anxiety about
the impending pain increase which, in turn, triggers the activation of two different and
independent biochemical pathways (Benedetti, Amanzio, Vighetti, & Asteggiano,
2006). One pathway involves the activation of cholecystokinin (CCK), a neuropeptide
that has been found to play a crucial role in a number of psychological and
physiological functions (Hebb, Poulin, Roach, Zacharko, & Drolet, 2005), including as
a neuromodulator in the facilitation of the experience of pain (Benedetti et al., 2007).
The other pathway involves the activation of the hypothalamic-pituitary-adrenal axis
(HPA), a pathway implicated in the release of cortisol and the experience of anxiety
(Benedetti et al., 2006; Benedetti et al., 2007). In addition to this, Landgrebe, Barta, et
al. (2008) found that a sham EMF exposure administered to people with IEI-EMF
resulted in symptom experiences that correlated with alterations in neural activity in the
anterior cingulate cortex and the insula; brain regions that have been associated with
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processing experimentally induced pain. The observation that sham exposures can elicit
symptoms in IEI-EMF participants is often used to suggest that the symptoms
experienced are the result of a nocebo effect (Rubin et al., 2010), and the findings of
Landgrebe, Barta, et al. (2008) provides strong evidence of the neurobiological
mechanism potentially underlying this response.
Although there appears to be relatively strong evidence for the ability of psychological
and neurobiological processes to influence symptom perception via nocebo effects,
whether this is the case for the symptoms experienced by IEI-EMF sufferer’s remains
highly contentious. Although Dieudonné (2016) concluded that IEI-EMF does not
originate from a nocebo response, it is important to note that Dieudonné (2016) did not
test the cause of the participant’s symptoms, but rather, retrospectively asked
participants about their beliefs regarding the cause of their symptoms using qualitative
methods. Retrospective self-reports, especially in relation to the aetiology of symptoms
associated with EMF exposure, are known to suffer from recall bias (Baliatsas et al.,
2015; Vrijheid et al., 2009), and as such, the conclusions reached by Dieudonné (2016)
cannot be used to comment on the possibility that IEI-EMF is associated with a nocebo
effect. As such, only empirical studies, which test for a quantifiable relationship
between symptoms and exposure, can be used to establish whether IEI-EMF can be
better explained by a toxicogenic or psychogenic theory.
1.5

Empirical Studies Investigating Reported Sensitivity to EMF

Observational epidemiology studies and experimental laboratory studies are the two
main scientific approaches that have been used to investigate whether humans are
sensitive to EMF exposure within the established public safety guidelines (for e.g.
ICNIRP, 1998). Epidemiological studies attempt to find an association between
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symptom reports and exposure, by estimating the amount of exposure individuals (who
may or may not believe they are sensitive to EMF exposure) are receiving in their daily
lives in relation to the type, frequency and severity of non-specific symptoms that they
experience. Laboratory studies, on the other hand, attempt to deliberately trigger
symptom responses to specific types and strengths of EMF exposure in a controlled
setting, and generally focus specifically on individuals who report experiencing IEIEMF. Both of these approaches have a number of strengths and limitations, all of which
must be taken into account when assessing our current understanding of IEI-EMF.
Although some researchers and IEI-EMF advocacy groups have suggested that studies
utilising ‘subjective’ measures of symptoms are scientifically unreliable (Leszcynski,
2018), there is also no reliable evidence showing that IEI-EMF sufferers experience any
consistent physiological responses as a result of exposure to EMF (Rubin, Hillert,
Nieto-Hernandez, van Rongen, & Oftedal, 2011). As no consistent pattern of
objectively measurable changes resulting from EMF exposure can be used to
characterise or diagnose IEI-EMF, epidemiological and laboratory studies must rely on
participant self-report. The use of self-report measures in IEI-EMF studies is, however,
appropriate because IEI-EMF sufferers report subjective changes which they associate
with perceived exposure to EMF, they do not rely on objective data of disease from
situations where exposure is and is not present and then conclude that one causes the
other.
While sensitivity to a whole range of devices which emit different types of EMF has
been reported (as discussed in section 1.3), much of the recent literature has been
focused on investigating the potential adverse effects of exposure to RF-EMF emitted
by wireless communication technologies and infrastructure, as these have become
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increasingly ubiquitous and have been the cause of most concern in recent times. In line
with this, and in an effort to provide focus for the present doctoral research, the
remainder of this thesis will focus on the possible relationship between RF-EMF
exposure and IEI-EMF.
1.5.1

Epidemiological studies

Epidemiology is the study of the distribution and causes of human disease in free living
populations; that is, the study of disease in populations that are not under the constraints
of a laboratory environment. Epidemiological studies either measure the frequency of
diseases or other health related characteristics in populations in order to observe
whether such frequencies vary with other characteristics, or they assess whether
associations exist between possible causative factors and health outcomes (Elwood,
2017). As epidemiological studies require large sample sizes to account for error
variance, studies investigating the possible causal association between RF-EMF
emissions and symptoms have mostly recruited participants from the general population
(and may or may not have included IEI-EMF participants). These epidemiological
studies typically examine whether there is an association between mobile phone base
stations and symptoms. Although the lack of focus on IEI-EMF participants may be
viewed as a major limitation for establishing whether symptoms attributed to EMF are
associated with exposure, one of the major benefits of these studies (over laboratory
studies) is that they allow for the investigation of longer exposure periods and symptom
outcomes in large samples under normal living conditions, and thus may be useful for
providing evidence (if any) of a potential association between EMF exposure and
symptoms more generally.
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Over the past two decades, a number of epidemiological studies have been conducted,
with varying methods and results. Notably, two studies reported significant associations
between symptoms and exposure to EMF. Hutter, Moshammer, Wallner, and Kundi
(2006) investigated the relation between RF-EMF exposure and several measures of
cognitive performance, well-being and sleep quality, in individuals living near 10
selected base stations. Spot measurements in the bedrooms of participants and a
calculation of distance to the mobile phone base station were used to estimate exposure
rates. Although it was found that exposure rates in the participant’s homes were far
below the recommended standards, the results showed a significant relationship
between exposure level and headache score. Symptom ratings were also found to be
higher in participants expressing concerns about health effects from the base station.
Similarly, Abdel-Rassoul et al. (2007), using a cross-sectional study, reported a
significantly higher prevalence of reported neuropsychiatric complaints, including
headache, in people living or working near a base station than in matched controls.
However, the measurement of RF-EMF exposure was made 4 years before the study
was conducted and only in one area where some of the experimental participants were
located, and no attempt was made to measure exposure in the control group. Therefore,
the results of this study are unable to comment on the relationship between exposure
and symptoms.
While there has been some limited evidence of an association between symptom reports
and exposure, the majority of epidemiology studies assessing the potential association
between symptom reports and exposure have failed to find such an association (Röösli
et al., 2010). For instance, Thomas et al. (2008) did not find any significant association
between exposure and chronic or acute symptoms in a sample of adults who were

26

required to wear personal dosimeters for a 24 hour period. In addition to this, in a large
cross-sectional study which used dosimeters to measure RF-EMF in the bedrooms of
participants, Berg-Beckhoff et al. (2009) found no association between RF-EMF
exposure and a range of health outcomes including sleep quality, headache,
psychosomatic complaints, mental and physical health or chronic stress. Moreover,
Baliatsas et al. (2015) did not find an association between everyday life RF-EMF
exposure, and non-specific symptoms or sleep quality.
Although epidemiological studies attempt to bridge the gap between the anecdotal
reports of symptoms in response to EMF exposure and the controlled laboratory studies
investigating the causal role of EMF exposure in producing symptoms, these studies
face serious methodological limitations, especially in regards to exposure
characterisation. Many studies rely on the historical reconstruction of exposure history
or the individual’s perceived distance to an exposure source to estimate how much
exposure a person has received, but this is prone to recall bias and often does not take
into account the variety of near and far field sources to which people are exposed
(Baliatsas et al., 2015). In a systematic review of this field, Röösli et al. (2010) found
that epidemiological studies with crude exposure assessments show health effects, while
studies with more sophisticated exposure measurements rarely indicate an association.
The more sophisticated methods of exposure characterisation include the use of spot
measurements or personal exposure meters. But these again are limited, in that spot
measurements can only provide information about exposure at specific locations and at
specific times, while personal exposure meters can be influenced by a number of
factors; including calibration, body shielding and bias associated with the alteration of
behaviour if exposure levels become known to the participant (Baliatsas et al., 2015).
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Consequently, while epidemiological studies vary substantially in both quality and
outcomes, the limitations associated with such studies make it difficult to determine
whether exposure to EMF is associated with non-specific symptoms or IEI-EMF itself.
In support of this, the World Health Organisation has recommended that the aetiology
of IEI conditions be determined via the results of double-blind, sham-controlled,
provocation studies, where the ability to discriminate between active and sham
environmental exposures suggests a toxicogenic mechanism, and inability to
discriminate suggests a psychogenic mechanism (International Programme on Chemical
Safety/World Health Organization (IPCS/WHO), 1996).
1.5.2

Laboratory studies

Human laboratory studies, often termed ‘provocation studies’, offer a powerful method
for testing whether the presence of EMF is sufficient to trigger symptoms in humans.
Provocation studies typically involve volunteers being exposed to active and sham EMF
under controlled conditions, preferably in a double-blind testing protocol. Typically,
these studies test whether people who report suffering from IEI-EMF are better at
detecting EMF than people without the condition (or at greater than chance levels), and
whether sufferers of IEI-EMF respond to the presence of EMF with increased
symptoms compared to sham exposures. Over the past two decades, a number of
provocation studies using varying methodologies simulating either mobile phone base
station like exposures or mobile phone handset like exposure have been conducted.
Provocation studies utilising mobile phone base station like exposures attempt to
simulate the whole body exposures typically experienced in the vicinity of mobile
phone base stations, whilst studies utilising mobile phone handset like exposures try to
simulate the near field acute exposures typically experienced when using a mobile
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phone handset in an active talking mode. Generally, provocation studies have failed to
provide evidence to support the notion that IEI-EMF is a condition directly associated
with the presence of EMF (Rubin et al., 2005; Rubin et al., 2010).
One of the first studies conducted investigating the effect of a base station-like exposure
on well-being in a controlled laboratory setting reported that EMF exposure reduced
well-being scores in both IEI-EMF and control participants (Zwamborn, Vossen, van
Leersum, Ouwens, & Makel, 2003). However, in a follow up study using an improved
methodology and a larger sample size, Regel et al. (2006) failed to find an effect of
exposure on symptom scores or well-being in either IEI-EMF participants or healthy
controls, and did not find evidence to suggest that participants could discriminate
between the active and sham conditions. Interestingly, Eltiti, Wallace, Ridgewell, et al.
(2007) found that IEI-EMF participants reported an increase in symptoms in an initial
non-blind active trial, but that when the study was blinded, the increase in symptoms in
the active trial was not present. The results did show a significant increase in reports of
arousal during exposure compared to sham, however further analysis revealed that this
was likely due to a lack of appropriate randomisation and counterbalancing. No other
effect of exposure in either the IEI-EMF or healthy control group was found. Similarly,
Wallace et al. (2012) found that IEI-EMF participants reported an increase in symptoms
in an active base station exposure condition compared to sham in an initial non-blinded
trial, but found no differences in well-being, symptom levels or discrimination in later
double-blind trials. In addition to this, Furubayashi et al. (2009) did not find any effect
of either long or intermittent exposures on measures of mood, discomfort or the ability
to discriminate between active and sham conditions during a double-blind protocol, in
either IEI-EMF participants or healthy controls.
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Studies investigating mobile phone handset-like exposures and IEI-EMF have also
generally failed to find any relationship. For example, Wilén, Johansson, Sandström,
Kalezic, and Lyskov (2006) found no significant effect of RF-EMF exposure on a range
of physiological or cognitive parameters in either participants who reported mobile
phone exposure-related symptoms or matched healthy controls. Similarly, Rubin, Hahn,
Everitt, Cleare, and Wessely (2006) found that while IEI-EMF participants reported
greater symptom severity than matched controls, IEI-EMF individuals were unable to
reliably discriminate between the exposure conditions, and the increase in symptoms
was not dependent on the exposure condition, with the sham condition being sufficient
to trigger symptoms. Corresponding to this, Oftedal, Straume, Johnsson and Stovner
(2007) found that the sham condition also triggered symptoms in IEI-EMF participants,
but did not find any evidence to suggest that either the IEI-EMF or matched control
groups could accurately detect when they were being actively exposed. In addition,
Nam et al. (2009) did not find any effect of exposure on subjective symptoms or a range
of physiological parameters, and IEI-EMF participants were no better at detecting the
presence of RF-EMF than controls. Moreover, after a subset of participants took part in
a sleep component of a provocation study, no effect of exposure on self-reported
sleepiness, fatigue or arousal following sleep was found (Lowden et al., 2011). Finally,
in a recent study assessing whether IEI-EMF participants were able to correctly identify
whether they were being exposed to an individually relevant signal (exposures which
each individual participant reported reacting to) or sham condition, van Moorselaar et
al. (2017) found that while participants were able verify that they were being exposed in
an initial non-blinded exposure, subsequent double-blind testing revealed that they were
not able to detect the active from sham exposure at better than chance levels.
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Of the few studies that have found significant effects in the IEI-EMF group,
methodological problems have often confounded the results, including the failure to
account for multiple significance tests, inadequate counterbalancing or the possible deblinding of participants or researchers (Rubin et al., 2010). These confounds appear to
explain the failure to replicate such results in larger samples. For instance, although
Hillert et al. (2008) found that neither the IEI-EMF or control group could detect RFEMF exposure better than chance, a significant number of participants reported
headache symptoms more commonly after RF-EMF exposure than sham. However, the
effect was due to a rise in headache reporting in the control group and the statistical
analyses were not corrected for multiple tests. In addition to this, one study reported that
two IEI-EMF participants were able to accurately detect an active exposure condition at
highly significant rates (Kwon, Koivisto, Laine, & Hamalainen, 2008), however on a
subsequent retest six months later, the same two participants were unable to replicate
their results, suggesting that their initial performance was not related to a
bioelectromagnetic phenomenon (given that the exposures were the same in both
situations). Moreover, Nieto-Hernandez et al. (2011) reported increased ratings of
headache and difficulty in concentration in IEI-EMF participants and increased levels of
headache and fatigue in non-IEI-EMF participants following exposure to a continuous
wave signal. Concentration difficulties were again reported for the IEI-EMF participants
after exposure to a pulsed signal. However, after appropriate adjustment for multiple
comparisons, these results were not significant. Furthermore, McCarty et al. (2011)
reported that an IEI-EMF participant’s symptoms were associated with exposure
(specifically, they were related to the field transitions created when switching from
active to sham conditions), but this did not account for chance through statistics (and
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thus could not be said to be less likely than chance), and the results were not replicated
(Rubin, Cleare, & Wessely, 2011).
Like epidemiological studies, provocation studies are challenged by several
methodological limitations, some of which could potentially explain the inability of
these studies to find an effect of exposure. One of these limitations relates to
recruitment. Little is known about whether subsets of the condition exist and so it is
conceivable that the samples tested may have included a combination of both
individuals who are sensitive to EMF or to types of EMF not used in the testing
protocol, and others who may suffer from unrelated conditions. This could result in a
large amount of noise being added to the data, which would reduce statistical power and
mask any real effects. Another issue is determining whether the environment that
provocation studies are conducted in reflects the environment in which IEI-EMF
individuals report symptoms. Often, studies are conducted in laboratories with
specialised chambers which block out background electromagnetic fields. While it is
generally thought that this should increase the chances of detecting an effect, it may
potentially remove important synergistic elements present in the environment. Anxiety,
which may be heightened due to participating in a laboratory experiment, may also
mask any significant effects. Participants may have also encountered other EMF
exposures on the way to the experimental session which inadvertently trigger symptoms
(Rubin, Hahn, et al., 2006; Rubin et al., 2010). This again, would mask any potential
significant effects from being discovered. Criticism has also been raised concerning the
relevance of simulated RF-EMF signals used in many of these studies to participant’s
reported symptoms (Panagopoulos, Johansson, & Carlo, 2015). Yet, the evidence so far
suggests that symptoms are triggered during provocation studies, regardless of
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similarity of the exposure (and irrespective of the exposure status), which suggests that
this is not an important confound. Likewise, although it has been suggested that
symptom onset and offsets have not been matched in experimental studies, there is no
evidence that this has confounded previous research either. Finally, while a number of
studies have consistently demonstrated that the symptoms experienced by IEI-EMF
sufferers are likely the result of a nocebo effect, few studies have investigated the
underlying mechanisms which may contribute to such a response. It is important to
note, however, that although these methodological issues are often used by IEI-EMF
advocacy groups to argue that it is premature to rule out the role of EMF in the
presentation of IEI-EMF, there is no evidence to demonstrate that these issues have
influenced the results of previous studies.
1.6

Thesis Rationale and Aim

Clearly, IEI-EMF is a complex condition which is not adequately understood by current
scientific models. In stark contrast to the anecdotal reports of sensitivity to EMF (see
section 1.3), a considerable number of epidemiological and laboratory studies have
failed to find evidence for a relationship between EMF exposure and IEI-EMF (see
section 1.5 for review). While the majority of IEI-EMF sufferers believe that the
condition is caused by exposure to EMF, much of the existing empirical literature
indicates that the condition is more closely associated with a nocebo effect, where
conscious or subconscious symptom expectation following a perceived exposure to
EMF leads to the formation or the presentation of symptoms (Hillert et al., 2008;
Landgrebe, Frick, et al., 2008; Oftedal et al., 2007; Rubin et al., 2010). While the
discrepancy between the anecdotal reports of sensitivity to EMF and the scientific
literature has instigated a highly contentious aetiological debate, sufferers have been left
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to experience distressing and debilitating symptoms with no reliable, evidence-based
treatment options or support. Considering that those who suffer from IEI-EMF could
not be considered healthy according to the WHO definition of health (World Health
Organisation, 1946), further research is required to clearly determine the aetiology of
their symptoms.
The fundamental issue at the centre of the aetiological debate is whether the associated
symptoms can be explained by a toxicogenic or psychogenic theory. The toxicogenic
theory of IEI-EMF proposes that the presentation of adverse symptoms is the result of
an intolerance or susceptibility to exposure to low levels of EMF, which then affect the
body via an as-yet-unrecognised bioelectromagnetic pathway (Rubin et al., 2010;
Staudenmayer et al., 2003a). Alternatively, the psychogenic theory of IEI-EMF suggests
that the condition can be explained by an individual’s overvalued belief of harm, a
belief which is shaped by psychological, psychosocial and psychophysiological
processes (Staudenmayer et al., 2003b) and which culminates in the presentation of
adverse symptoms via a nocebo response. However, due to a number of potential
methodological limitations, and a general lack of understanding of the possible
mechanisms underlying toxicogenic and psychogenic explanations of IEI-EMF, it is
difficult to conclusively determine the aetiology of IEI-EMF on the basis of the
currently available evidence.
The overall aim of the present doctoral research is to clarify the determinants of IEIEMF by investigating whether toxicogenic or psychogenic processes can explain the
symptoms reported by IEI-EMF sufferers. Specifically, the research contained in this
thesis encompasses three human provocation studies designed with methodological
improvements to investigate the possible adverse health effects associated with
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exposure to EMF and to examine the potential psychological mechanisms which may
underlie IEI-EMF sufferers’ perception that they are sensitive to EMF exposure.
This thesis is presented as a collection of manuscripts prepared for publication in accord
with the requirements of the University of Wollongong (Thesis by Compilation). Each
chapter represents a manuscript written for a specific journal with a defined audience.
Each chapter begins with a Chapter Foreword which outlines the rationale, aims and
significance of each manuscript, and establishes a link between each manuscript and the
thesis aims more generally. The structure of the abstract and headings within each paper
is consistent with the style used by the journal for which it is written. Chapter 2 has
been published in the International Journal for Radiation Biology, Chapter 3 has been
published in Bioelectromagnetics and Chapter 4 has been published in Environmental
Research. While each journal requires a specific referencing style, for consistency all
chapters in this thesis are referenced in the current style of the American Psychological
Association (APA 6th edition).
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2.

CHAPTER 2: PULSE MODULATED RADIOFREQUENCY
EXPOSURE INFLUENCES COGNITIVE PERFORMANCE
2.1

Chapter Foreword

Despite decades of research, IEI-EMF provocation studies have generally failed to
provide evidence that the symptoms reported by IEI-EMF sufferers are associated with
EMF exposure. While many IEI-EMF sufferers and advocacy groups have raised
concerns that subjective measures of belief of exposure and self-reported symptoms in
provocation studies are ‘scientifically unreliable’, objective tests of sensitivity to EMF
are currently lacking, as there have been no consistent reports of adverse effects of EMF
exposure on endpoints that are relevant to health. Although a number of studies have
consistently reported physiological effects of exposure to RF-EMF on the brain’s
electrical activity (see section 1.2 for review), these effects may not necessarily reflect
an adverse health outcome, as many of these (and other) studies assessing various
aspects of cognitive and behavioural functioning have found inconsistent, but mostly
null results. Given the close relationship between the brain’s electrical activity and
cognition, and given that IEI-EMF sufferers often report memory and concentration
difficulties as symptoms which they attribute to EMF exposure, this may offer a
potentially useful avenue for research.
It is possible that a number of methodological issues have limited the ability of previous
studies to detect effects of RF-EMF exposure on cognitive performance. These issues
include the use of poor exposure protocols and experimental designs, inadequate sample
sizes and cognitive performance measures which may not have adequately accounted
for confounding variables. Given these methodological limitations, it remains unclear
whether exposure to RF-EMF can affect cognition. Yet, if clear adverse effects of RF52

EMF exposure on cognitive performance endpoints can be established, then this may
offer a starting point for determining the most sensitive objective endpoints to test IEIEMF participants.
In an attempt to improve methodology and identify possible impairments on measures
of cognitive performance, the study presented in this chapter aimed to determine
whether exposure to mobile phone-like RF-EMF exposure could influence cognitive
performance, and whether it does so in a dose-dependent manner. Although this does
not directly test the claim that IEI-EMF symptoms are associated with EMF exposure, it
is a useful first step for developing a potentially sensitive endpoint that may then be
used to test IEI-EMF participants, while also overcoming criticisms that empirical
studies investigating IEI-EMF need to utilise objective tests of sensitivity. This paper
has been published in the International Journal of Radiation Biology.

Verrender, A., Loughran, S.P., Dalecki, A., McKenzie, R., & Croft, R.J (2016). Pulse
modulated radiofrequency exposure influences cognitive performance. International
Journal of Radiation Biology. 92, 603-610.
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2.2

Abstract

Purpose: To investigate whether exposure to pulse modulated radiofrequency (PM RF)
influences human cognitive performance, and whether it does so in a dose dependent
manner.
Materials and Methods: Thirty six healthy adults participated in a randomised, double
blind, counterbalanced provocation study. Cognitive performance was assessed using a
visual discrimination task and a modified Sternberg working memory task, which were
calibrated to individual performance levels in a preliminary testing session. An sXh920
planar exposure system was used to generate a 920 MHz GSM-like signal, providing
three conditions (peak-spatial SAR averaged over 10g) of 0 W/kg (Sham), 1 W/kg (Low
RF) and 2 W/kg (High RF).
Results: A significant decrease in reaction time (RT) in the Sternberg working memory
task was found during exposure compared to Sham. This effect was not dose dependent.
Conclusions: PM RF exposure was shown to influence cognitive performance in a
working memory task. While the majority of the literature has not found effects of PM
RF exposure on cognitive performance, it is possible that the methodological
improvements employed in the present study increased sensitivity, and thus the ability
to detect potential effects.
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2.3

Introduction

Over the past two decades, the increasingly widespread use of mobile phones has
generated growing concern about potential adverse effects that the radiofrequency
electromagnetic fields (RF-EMF) emitted by these devices could have on human health.
While a number of independent reviews have concluded that there are no substantiated
health effects associated with exposure to mobile phone RF-EMF (Health Canada,
2015; Health Council of the Netherlands, 2009; SCENIHR (Scientific Committee on
Emerging and Newly Identified Health Risks), 2009; World Health Organisation, 2014),
there is evidence which indicates that exposure can influence the brain’s electrical
activity. Specifically, it has been consistently shown that pulse modulated RF (PM RF)
affects spontaneous resting alpha (8-12 Hz) (Croft et al., 2008; Croft et al., 2010; Curcio
et al., 2005; Leung et al., 2011; Perentos, Croft, McKenzie, Cvetkovic, & Cosic, 2007;
Regel, Gottselig, et al., 2007) and sleep spindle activity (approximately 11-15 Hz) in
non-rapid eye movement sleep (Huber et al., 2000; Huber et al., 2002; Loughran et al.,
2005; Regel, Tinguely, et al., 2007; Schmid et al., 2012).
However, the functional consequence of this change in EEG activity remains unclear, as
studies assessing aspects of cognitive and behavioural functioning during and following
exposure to PM RF have produced contradictory, but mostly null results (Barth,
Ponocny, Gnambs, & Winker, 2012; Valentini, Ferrara, Presaghi, De Gennaro, &
Curcio, 2010).
One measure of cognitive performance which has yielded inconsistent results is
working memory performance, which has been primarily assessed using the N-back
task. Three studies have reported decreases in reaction time (Koivisto, Krause,
Revonsuo, Laine, & Hämäläinen, 2000; Regel, Gottselig, et al., 2007; Regel, Tinguely,
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et al., 2007) and one study reported an improvement in accuracy (Regel, Tinguely, et
al., 2007). The majority of studies using this task, however, have not found any effects
of PM RF exposure on performance (Haarala et al., 2003; Haarala et al., 2004; Haarala
et al., 2007; Krause, Pesonen, Bjornberg, & Hamalainen, 2007; Leung et al., 2011).
The difficulty in establishing a firm conclusion as to whether PM RF influences
cognitive performance may be attributed to a number of methodological constraints. For
example, the variation in methods between research groups makes it difficult to
compare or verify previous results, while poor exposure protocols and experimental
designs, inadequate sample sizes and a lack of reliable cognitive performance measures
have limited the potential for finding an effect (Regel & Achermann, 2011). Several
other issues may have also contributed to the mixed findings. For instance individual
differences in cognitive performance have not been adequately accounted for in
previous studies. It is also possible that the N-back task is not sensitive enough to
adequately detect changes in cognitive performance as a result of PM RF exposure
(Regel & Achermann, 2011) as it has been shown that this task can be significantly
influenced by learning effects (Haarala et al., 2005; Haarala et al., 2004; Regel,
Gottselig, et al., 2007; Regel, Tinguely, et al., 2007). Furthermore, as the only known
interaction between RF-EMF exposure and the body is via heating (Adair & Black,
2003), thermally induced variability may have also influenced the results. In addition,
the localised, intermittent exposure protocols utilised by some research groups may not
have been sufficiently powerful to produce an effect (Boutry et al., 2008). These factors
have the potential to introduce large amounts of error variance, which may have masked
any potential real effects.
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In order to overcome these issues, the present study has been designed with several
methodological improvements to examine whether exposure to PM RF influences
cognitive performance in a dose dependent manner. In particular, a visual
discrimination task and a modified Sternberg working memory task (Sternberg, 1966)
were employed, both of which were calibrated to individual performance levels in a
preliminary testing session. The study also utilised a planar patch antenna system to
ensure that there was a consistent, uniform exposure across the target hemisphere.
Thermally induced variability was reduced by clamping skin temperature to a thermoneutral level. In addition to these improvements, the cognitive performance data was
treated using an index of the participants’ response sensitivity and bias, as adapted from
signal detection theory (Stanislaw & Todorov, 1999). This treatment takes into account
how well a participant can discriminate between trials (sensitivity) and the participant’s
general tendency to respond with a ‘yes’ or ‘no’ button press (bias), giving a better
indication of task accuracy and minimising Type I and Type II error. Further to the
double-blind, counterbalanced, sham-controlled design; these improvements were
implemented to increase sensitivity, and thus, the possibility of finding potential effects.
The results of the present study are part of a larger study investigating the effect of PM
RF exposure on the electroencephalogram and thermoregulatory processes.
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2.4

Materials and Methods

2.4.1

Participants

Forty-three participants were recruited through advertisements and word of mouth.
Seven participants failed to attend all testing sessions, leaving thirty-six participants
(half male) aged 18 – 52 years (M = 24.44; SD = 6.27). To be included in the study,
participants were required to be between 18 and 55 years of age, be right handed and
report being of good health. Participants were excluded from the study if they reported
having a current illness or medical condition, or having used illicit substances within the
7-day period prior to the study. Suitable participants were required to attend the
Illawarra Health and Medical Research Institute, University of Wollongong, for four
mutually convenient testing sessions, at the same time of day and separated by a period
of at least 7 days. The study was approved by the Human Research Ethics Committee
(University of Wollongong: HE13/146), and written, informed consent was obtained
from all participants. All participants were instructed to abstain from alcohol for at least
8 hr before the commencement of a testing session, abstain from caffeine for at least 1
hour before a testing session, and to not use their mobile phone for at least 2 hr before
the beginning of a testing session. All participants were compensated a total of $200 for
their involvement in the study.
2.4.2

Radiofrequency exposure

An sXh920 planar exposure system (IT’IS Foundation, Zurich, Switzerland) was used
to generate a 920 MHz GSM-like signal (as emitted by a mobile phone handset in active
mode while transmitting voice). The signal included the basic GSM frequency
components (8.33, 216.6, 1733 Hz, including corresponding harmonics; crest factor =
8.3). Two RF antennas placed on wooden pillars were positioned 42 mm vertically
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above the ear canal at a distance of 115 mm from the head (Huber et al., 2002; Huber et
al., 2005; Loughran et al., 2013). The RF exposure of the sXh920 system has been fully
characterised and was calibrated to provide a peak-spatial SAR averaged over 10g of 0
W/kg, 1 W/kg and 2 W/kg, for the Sham, Low and High exposure conditions
respectively (for full dosimetric data see Murbach, Christopoulou, Crespo-Valero,
Achermann, and Kuster (2012)). These exposures were within the Australian general
public RF exposure limits (ARPANSA RPS3). The system was controlled electronically
using defined participant numbers. The fully randomised and counterbalanced exposure
conditions were assigned to each participant and pre-programmed by a researcher not
involved in the collection of data (RC) to ensure that double-blinding was maintained.
An inbuilt failsafe mechanism ensured RF levels did not exceed RPS3 levels. Only the
left hemisphere was exposed to RF, and brown noise was used to mask any sounds
made by the exposure system in order to ensure that participants were not aware of the
exposure condition. At the completion of each experimental testing session, participants
were asked whether they were aware of the exposure status and the side of exposure via
a pen and paper Likert scale (1 = ‘left’, 2 = ‘right’, 3 = ‘both’, 4 = ‘no’, 5 = ‘don’t
know’) and an open ended question asking for further details about their ability to
perceive the exposure (‘If yes, how did you perceive the field?’).
2.4.3

Design

A double-blind, counterbalanced, cross-over design was employed. Following a
preliminary calibration session, each participant’s cognitive performance was tested
under three conditions (Sham, Low and High RF) during exposure (block 1) and
following exposure (block 2) over three separate sessions separated by at least seven
days. RF exposure was emitted to the left hemisphere only, and participants were not
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made aware of which antenna was emitting. Order of exposure was counterbalanced
across participants and randomly assigned.
2.4.4

Cognitive Performance Tasks

Two tasks were used to assess cognitive performance. These tasks were calibrated to
each participant’s individual level of performance in a preliminary testing session and
sufficiently long practice blocks were utilised prior to each experimental session to
reduce learning, floor and ceiling effects. Behavioural outcomes were measured as the
number of correct hits, correct rejections, false alarms and false rejections, as well as
participant’s reaction time (RT) to correct responses.
2.4.4.1 Visual discrimination task. Visual perception was assessed using a visual
discrimination task. A series of crossed white lines were presented in the centre of a
computer monitor with a black background for 200ms each. Between each stimulus
presentation, a mask appeared for 500ms, followed by a blank screen for 300ms. Figure
2.1 presents an example of the stimuli and mask used in the visual discrimination task.

Figure 2.1: Examples of the stimuli used in the visual discrimination task. (a) Is an
example of an easy target stimulus, (b) is an example of a difficult target stimulus (c) is a
non-target stimulus and (d) is the mask used between stimulus presentations.
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For each stimulus presentation, participants were asked to respond as quickly and
accurately as possible via a ‘yes’ button press with the right thumb if they thought that
the lines differed in thickness (target stimulus), or not to respond if they thought that the
lines did not differ in thickness (non-target stimulus). A total of 180 stimuli were
presented (half targets). The frequency and presentation of the target stimuli were
pseudo-randomised across trials and balanced between blocks.
Task difficulty was manipulated by increasing the magnitude of thickness between the
two lines in target stimuli. The greater the difference between the two lines, the easier
the trial. In target stimuli, one line was kept at a constant thickness of 1.5 mm while the
second line was manipulated in increments of 0.05 mm. In non-target stimuli, both lines
were kept constant at 1.5 mm.
2.4.4.2 Sternberg working memory task. Working memory performance was assessed
using a modified Sternberg working memory task (Sternberg, 1966). The task involved
memorising a stimulus set, maintaining that stimulus set in memory during a 3 second
retention period, and recalling whether a subsequent probe stimulus was in the original
memory set. The memory sets ranged in difficulty level from 6 to 15 letters.
The memory sets were constructed from a pool of 21 consonants (B, C, D, F, G, H, J, K,
L, M, N, P, Q, R, S, T, V, W, X, Y and Z) presented simultaneously in a horizontal
arrangement over two lines. The letters were 66pt, capitalised, black and in bold Calibri
font and presented in a centred 6.24 x 25.40 cm grey box on a black background. Each
letter was spaced 2 cm apart.
Figure 2.2 outlines the Sternberg working memory task design and progression for each
trial. For each trial, participants were asked to respond as quickly and accurately as
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possible with a button press using the right thumb if the probe consonant appeared in
the preceding memory set (target), or to not respond if the probe consonant was not
presented in the memory set (non-target). Maximum response time was set at 2 seconds.
40 memory sets were presented (half targets). The frequency and presentation of the
probe stimuli were pseudo-randomised across trials and balanced between blocks. The
position of the target probe stimuli in the memory set was also pseudo-randomised
across trials.

H
Fixation
Cross

Pause

Memory
Set

Retention

Probe &
Response

Pause

Figure 2.2: The modified Sternberg working memory task design and progression. A
fixation cross (800 ms) was followed by a 1000 ms pause. The memory set was then
presented (4000 ms) and was followed by a blank screen retention period (3000 ms).
Following this, a probe stimulus appeared (2000 ms) during which time participants had to
respond with a button press if the probe was present in the preceding memory set, or not
respond if the probe was not present in the preceding memory set. A blank screen pause
(2000 ms) concluded the trial before the onset of the next trial.
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2.4.4.3 Cognitive Task Calibration. For each participant, the cognitive tasks were
calibrated during a preliminary testing session, to ensure that the tasks were at a level
which was difficult, yet still achievable. In the visual discrimination task, the level of
difficulty was defined as the two most difficult line manipulations that resulted in a
response sensitivity score of 0.8 and 0.6, corresponding to the easy and difficult
versions of the task respectively. In the Sternberg working memory task, this level was
defined as the most difficult stimulus set that resulted in a response sensitivity value of
0.8. To attain this value, participants completed four blocks. A five minute break
separated each of the calibration blocks. In all blocks, the visual discrimination task
preceded the Sternberg working memory task. During the calibration session,
participants were not exposed to RF and no physiological data was recorded.
2.4.5

EEG and thermo-physiological apparatus

A water perfusion garment (Grant Instruments Ltd., Cambridge, U.K.) was used to
clamp body skin temperature to 34 °C to produce a thermo-neutral environment. The
water perfusion suit was made of cotton and enclosed a series of pipes which distributed
water across the skin at a rate of 2.5L/min at a temperature of 34 °C. The garment
covered the torso, arms, waist and legs. Water temperature was controlled using a
digital thermostat (Type: GD120, Grant Instruments Ltd., Cambridge, U.K.) which
could heat or cool water accordingly to 34 °C ± .02°C. A range of physiological
measures, including core body temperature, skin temperature, blood pressure, resting
EEG and cutaneous blood flow to the left hand were also acquired. These measures are
beyond the scope of this paper and will not be discussed.
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2.4.6

Procedure

Participants arrived at the laboratory at either 09:00 or 13:00, with the start time for all
experimental sessions kept constant within-subjects to minimise circadian effects.
Participants then completed a 16-item visual analogue mood scale (VAMS) and a series
of short questionnaires asking about sleep, caffeine and alcohol consumption and
mobile phone usage before being fitted with the water perfusion suit, EEG and
physiological recording apparatus.
Participants were then seated inside a Faraday cage in front of a Dell U2311H LCD
monitor between the two RF antennas and the water perfusion suit was switched on.
Participants were positioned such that their eyes were approximately 90 cm from and at
the same height as the centre of the computer screen. The plane of the monitor was
perpendicular to both the floor and the sagittal plane of the participants. Participants
then completed a practice version of the visual discrimination and modified Sternberg
working memory tasks (2.5 min each).
Once setup was complete, participants completed a 16 min ‘Baseline’ block, during
which they were not exposed to RF. During this block participants completed an EOG
correction task (Croft, Chandler, Barry, Cooper, & Clarke, 2005) and resting EEG and
physiological data were also recorded.
The Baseline block was followed by two 30 min experimental blocks, the first block
being ‘RF-ON’ (Sham, Low or High RF depending on counterbalancing) and the
second ‘RF-OFF’(post-exposure), with a 1 min break between each block. At the
beginning of the experimental blocks, resting EEG and physiological measures were
recorded. Subsequent to this, participants completed the cognitive battery; consisting of
a 6 min visual discrimination task (easy and difficult consecutively) and a 9 min
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Sternberg working memory task, with a 1 min break between tasks. Following the
cognitive tasks, EEG and physiological data were again recorded.
At the completion of testing, all monitoring equipment was disconnected and the
participant completed a 16 item VAMS and an exposure condition questionnaire. This
procedure was repeated for the remaining testing sessions.
2.4.7

Data analyses

Behavioural measures were defined as mean reaction time to correctly identified target
probes (‘RT’) recorded in ms, as well as the number of correct hits, correct rejections,
false alarms and false rejections 100-900 ms post stimulus in the visual discrimination
task and 100-2000 ms post probe stimulus in the Sternberg working memory task.
Response sensitivity (Grier’s A’) and response bias (Grier’s B”) were used to assess
task accuracy. All data points were converted to z scores for analysis.
Where a participant performed at below 55% accuracy in the visual discrimination task
or 50% accuracy in the Sternberg working memory task, data points were interpolated
in order to preserve counterbalancing. This criterion affected 1 participant (3 blocks) in
the difficult version of the visual discrimination task, and 6 participants (12 blocks) in
the Sternberg working memory task.
Data points were missing for a further 2 participants (2 blocks for 1 participant, 1 block
for 1 participant) in the visual discrimination task due to the incorrect difficulty level
being administered. The missing data points were interpolated in order to preserve
counterbalancing.
Statistical analyses were performed with SPSS statistical package 21.0. Paired samples t
tests were performed to assess the effect of exposure on RT, response sensitivity and
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response bias overall (comparing the 0 W/kg condition against the average of the 1
W/kg and 2 W/kg conditions) and whether these effects depended on the dose of
exposure (comparing the 1 W/kg condition against the 2 W/kg condition). Exploratory
paired samples t tests were also conducted on non-interpolated data. To correct
normality, square root transformations were computed for the response sensitivity data
in the easy version of the visual discrimination task.
2.5

Results

2.5.1

RF Status

Overall, there was a greater tendency for participants to rate the exposure as being off
(50.93%) or unsure as to whether it was on or off (37.05%) than on (12.03%). The
participants were unable to detect the RF status better than chance with 18.52%
correctly identified trials. No participant was able to correctly identify all 3 exposure
conditions.
2.5.2

Cognitive Tasks

The mean RTs and standard deviations for each cognitive task and the significance of
each paired samples t test are presented in Table 2.1. As shown in Figure 2.3, there was
significant decrease in RT in the Sternberg working memory task during the exposure
conditions compared to Sham, t (35) = 2.070, p = .046, r2 = .109. This effect, however,
was not significant using non-interpolated data (p = .052). No other RT effects were
detected in either the visual discrimination tasks or the Sternberg working memory task
when comparing Sham against the exposure conditions or the Low against the High RF
condition, either during or following exposure.
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The mean response sensitivity and standard deviations for each cognitive task and the
significance of each paired samples t test are presented in Table 2.2. There were no
significant differences in response sensitivity when comparing Sham against the
exposure conditions or the Low against the High RF condition, either during or
following exposure.
The mean response bias and standard deviations for each cognitive task and the
significance of each paired samples t test are presented in Table 2.3. There were no
significant differences in response bias when comparing Sham against the exposure
conditions or the Low against the High RF condition, either during or following
exposure.
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Table 2.1: Mean reaction times (ms) and standard deviations for each cognitive task in
each exposure condition with p values for Sham vs Exposure and Low vs High
comparisons (values significant at p < .05 are in bold).
Condition

Perceptual Easy
BL1
M (SD)

Sham
Low RF
High RF

BL2
M (SD)

Perceptual Difficult
BL1
M (SD)

BL2
M (SD)

Sternberg
BL1
M (SD)

BL2
M (SD)

358 (42) 359 (45) 368 (39) 362 (63) 877 (136) 367 (148)
360 (42) 350 (37) 377 (63) 364 (45) 833 (138) 872 (140)
359 (42) 356 (37) 374 (42) 367 (36) 833 (130) 873 (138)

p values
Sham vs Exposure .762
Low vs High
.850

.207
.162

.192
.870

.330
.436

.845
.983

.045
.989

Table 2.2: Mean response sensitivity (Grier’s A’) and standard deviations for each
cognitive task in each exposure condition with p values for Sham vs Exposure and Low
vs High comparisons.
Condition

Perceptual Easy
BL1
M (SD)

Sham
Low RF
High RF

BL2
M (SD)

Perceptual Difficult
BL1
M (SD)

BL2
M (SD)

Sternberg
BL1
M (SD)

BL2
M (SD)

.94 (.04) .94 (.05) .91 (.09) .90 (.08) .85 (.10) .86 (.07)
.94 (.06) .94 (.06) .91 (.08) .91 (.08) .85 (.08) .85 (.09)
.93 (.06) .94 (.05) .92 (.07) .91 (.08) .86 (.07) .86 (.07)

p values
Sham vs Exposure .454
Low vs High
.391

.741
.920

.528
.297
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.078
.905

.758
.512

.515
.228

Table 2.3: Mean response bias (Grier’s B’’) and standard deviations for each cognitive
task in each exposure condition with p values for Sham vs Exposure and Low vs High
comparisons.
Condition

Perceptual Easy
BL1
M (SD)

Sham
Low RF
High RF

BL2
M (SD)

Perceptual Difficult
BL1
M (SD)

BL2
M (SD)

Sternberg
BL1
M (SD)

BL2
M (SD)

.10 (50) .08 (.52) .25 (.45) .23 (.46) .28 (.36) .29 (.28)
.14 (.48) .07 (.52) .30 (.41) .28 (.45) .25 (.33) .25 (.29)
.11 (.50) .08 (.41) .22 (.32) .21 (.43) .28 (.32) .30 (.30)

p values
Sham vs Exposure .583
Low vs High
.607

.964
.907

.882
.197

.842
.134

.863
.512

.636
.228

* p = .046

1050
Reaction Time (ms)

1000
950
900
850
800
750
700
650
Sham

1 W/kg

2 W/kg

Sham

BL1

1 W/kg

2 W/kg

BL2

Figure 2.3: Mean reaction times (ms) in the Sternberg working memory task as a
function of condition and block (BL1: during exposure, BL2: post exposure). Paired
samples t tests showed a significant decrease in reaction time during exposure when
compared to sham. Error bars represent standard deviation.
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2.6

Discussion

The results of the present study indicate that exposure to PM RF influences cognitive
performance in the Sternberg working memory task. Specifically, a significant decrease
in RT was revealed during the active exposure conditions compared to Sham. This
suggests that exposure to PM RF may have a positive influence on cognitive
performance. This effect, however, was not found to be dose dependent. While the
exploratory analysis revealed that this effect was not significant using the noninterpolated data, the interpolation was used to preserve the sample size and
counterbalancing. Therefore, because the non-interpolated data set contained fewer
participants, the significance of this effect was expected to be reduced in the noninterpolated dataset.
While the present study’s findings are consistent with early reports that exposure to PM
RF affects working memory performance (Koivisto et al., 2000; Regel, Gottselig, et al.,
2007; Regel, Tinguely, et al., 2007), the majority of the literature has not found such an
influence (Haarala et al., 2003; Haarala et al., 2004; Haarala et al., 2007; Krause et al.,
2007; Leung et al., 2011). Although we cannot be conclusive, a number of reasons
related to the methodological improvements employed by this study may explain the
results.
The working memory task used in the present study differs markedly from the N-back
task, which is the task that has been typically utilised in provocation studies assessing
the effect of PM RF exposure on working memory performance. It seems that the Nback task was used primarily because of its perceived face validity and (in latter studies)
as a means to replicate previously reported effects. The problem, however, is that the Nback task is limited in its ability to control for individual differences in working
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memory performance, as well as learning, floor and ceiling effects. These confounds
have the potential to add large amounts of noise to the data, thereby masking potentially
real effects. The Sternberg working memory task overcomes these confounds by
utilising a greater number of difficulty levels to calibrate the task to each individual’s
cognitive ability. This calibration, alongside sufficiently long practice blocks prior to
each experimental session, increases sensitivity and thus the ability to detect any
potential effect of PM RF exposure on working memory performance.
To date, only one other study has accounted for individual differences in working
memory performance by tailoring cognitive task difficulty to participants’ individual
ability. After calibrating the N-back task to a level which was ‘difficult, but achievable
for each participant,’ Leung et al. (2011) did not find any difference in accuracy or RT
during PM RF exposure compared to Sham. However, in a 3G (W-CDMA) condition,
Leung et al. (2011) found a significant decrease in accuracy in an adolescent group
compared to Sham. The present study was able to control for a greater amount of
variation in individual differences in performance, and thus remove the noise which
may have masked any effects.
As the only known mechanism of interaction between RF and the human body is
thermal (Adair & Black, 2003), it is possible that whole body thermoregulatory
processes play an important role in mediating the changes in the brain’s electrical
activity and any potentially associated functional effects resulting from exposure to PM
RF. To reduce thermally induced variability, the present study clamped skin
temperature to a thermo-neutral state. As this is the first study to attempt to reduce the
influence of this potential confound, this should be further explored in future studies.
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Variation in exposure setups and SAR profiles and a lack of detailed dosimetric data has
made it difficult to compare and replicate previously reported effects (Boutry et al.,
2008; Regel & Achermann, 2011). While it is possible that certain brain regions need to
be adequately exposed to PM RF to produce an effect, it should be noted that because
the SAR distribution produced by the present planar exposure system is more
homogenous than mobile phone hand-set exposure, this present exposure differs
significantly to the more localised exposure produced by a typical mobile phone.
Therefore, the results of this study can only reflect whether RF related bioeffects can
occur at the maximum exposure level anywhere within the exposed hemisphere
(Loughran, McKenzie, Anderson, McIntosh, & Croft, 2008). Thus, the present study
cannot definitively comment on whether cognitive performance is influenced by PM RF
emitted by mobile phones, nor can it comment on the effect of long term exposure or the
effect of exposure on different age groups within the population. Indeed, the World
Health Organisation has identified research investigating acute effects of PM RF
exposure on cognition and EEG with children as a priority. While some studies have not
found effects of PM RF exposure on cognitive performance in children and adolescents
(Haarala et al., 2005; Leung et al., 2011; Preece et al., 2005), the methodology used in
the present study may prove to be more sensitive, and should be considered in future
research with children.
A number of factors may have limited this study. First, while the statistical analysis
controlled for comparison-wise error by restricting the planned contrasts to degrees of
freedom error (without multiple comparison adjustment) (Tabachnick & Fidell, 2013),
this method does not control for experiment-wise error. Second, it is possible that the
exposure levels were affected by the EEG electrodes. However, the potential for this to
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occur has been explored in great detail and is unlikely to have influenced the results.
Generally, EEG electrode leads have been found to produce a shielding effect, reducing
the SAR in head regions close to the antenna and also where the maximum value is
obtained. The reduction in SAR tends to be less than 20% (Hamblin et al., 2007;
Murbach, Neufeld, Christopoulou, Achermann, & Kuster, 2014). These findings
indicate that electrode configurations do not act like an antenna, and therefore do not
enhance SAR. Furthermore, as the reductions have been found to be less than 20%,
electrode configurations are also not thought to greatly attenuate SAR to the point
where results are influenced (Hamblin et al., 2007; Murbach et al., 2014).
Whether small variations in performance on cognitive tasks as a result of exposure to
PM RF constitute any meaningful effects in real life situations remains a valid question.
In a critical review of this field, Regel and Achermann (2011) hypothesise that if such
elementary motor reactions are influenced by exposure to PM RF, effects on higher
cognitive functions may be even stronger. It is also possible, however, that the
significant cognitive performance effects found in some RF-EMF provocation studies
have occurred unpredictably and independent of task type (Regel & Achermann, 2011).
This may explain why the significant differences found in the present study only
occurred in one cognitive task on one variable. But while the results of the present study
indicate that there is a slight change in performance, it is important that the
methodology implemented in this study is replicated before determining whether such
an effect is meaningful.
In conclusion, the present study has shown that PM RF exposure influences cognitive
performance in a working memory task. While the majority of the literature has not
found an effect of PM RF exposure on cognitive performance, it is possible that the
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methodological improvements employed in the present study increased sensitivity, and
thus the ability to detect potential effects. However, as this is the first PM RF
provocation study to implement these improvements, replication is required in order to
determine whether these effects represent more than chance findings.
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3.

CHAPTER 3: IEI-EMF PROVOCATION CASE STUDIES: A
NOVEL APPROACH TO TESTING SENSITIVE
INDIVIDUALS
3.1 Chapter Foreword

Despite accounting for a number of methodological limitations, as no clear evidence of
adverse effects was demonstrated in Study 1, the study failed to identify any sensitive
health-relevant cognitive performance endpoints with which to test IEI-EMF
participants. In light of this outcome, a change of focus for investigating the
determinants of IEI-EMF was required.
While provocation studies offer one of the most powerful methods for testing the claims
of IEI-EMF sufferers, these studies have been heavily criticised by many IEI-EMF
advocacy groups and a minority of researchers. These criticisms are often related to
questions about whether laboratory testing environments adequately reflect the
conditions in which symptoms normally develop, and a failure of previous studies to
account for the heterogeneous nature of the condition. While there is currently no
empirical evidence to suggest that such issues have affected the outcomes of previous
studies, as these criticisms are often used to suggest that provocation studies are
inappropriate for investigating the symptom claims of IEI-EMF sufferers, it is clear that
an improved provocation study design is needed in order to adequately determine the
aetiology of the condition.
The study presented in this chapter (Study 2) incorporated a number of methodological
improvements designed to specifically address the potential methodological issues that
are claimed to render provocation studies inappropriate for assessing the determinants
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of IEI-EMF. The study aimed to determine whether IEI-EMF symptoms are more
closely related to EMF exposure or a nocebo effect. This chapter has been published in
the journal Bioelectromagnetics.
Verrender, A., Loughran, S.P, Anderson, V., Hillert, L., Rubin, G.J, Oftedal, G., &
Croft, R.J (2018). IEI-EMF provocation case studies: A novel approach to testing
sensitive individuals. Bioelectromagnetics, 39,132 – 143
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3.2

Abstract

The aetiology of Idiopathic Environmental Intolerance attributed to Electromagnetic
Fields (IEI-EMF) is controversial. While the majority of studies have indicated that
there is no relationship between EMF exposure and the symptoms reported by IEI-EMF
sufferers, concerns about methodological issues have been raised. Addressing these
concerns, the present experiment was designed as a series of individual case studies to
determine whether there is a relationship between RF-EMF exposure and an IEI-EMF
individual’s self-reported symptoms. Three participants aged 44-64 were tested during a
series of sham and active exposure trials (2 open-label trials; 12 randomised, doubleblind, counterbalanced trials), where symptom severity and exposure detection were
scored using 100mm visual analogue scales. The RF-EMF exposure was a 902-928
MHz spread spectrum digitally modulated signal with an average radiated power output
of 1 W (incident power density at the participant 0.3 W/m2). In the double-blind trials,
no significant difference in symptom severity or exposure detection was found for any
of the participants between the two conditions. Belief of exposure strongly predicted
symptom severity score for all participants. Despite accounting for several possible
limitations, the present experiment failed to show a relationship between RF-EMF
exposure and an IEI-EMF individual’s symptoms.
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3.3

Introduction

A proportion of the population report experiencing a wide range of non-specific
symptoms which they attribute to the electromagnetic fields (EMF) emitted by various
electronic and wireless technologies. Commonly referred to as Electromagnetic
Hypersensitivity (EHS), the condition is characterised by a variety of dermatological,
neurasthenic and/or vegetative symptoms, with headaches, nausea, skin irritations,
fatigue and concentration difficulties amongst the most commonly reported symptoms
(Hagström, Auranen, & Ekman, 2013; Hillert, Berglind, Arnetz, & Bellander, 2002;
Kato & Johansson, 2012; Röösli, Moser, Baldinini, Meier, & Braun-Fahrländer, 2004).
Generally, the reported symptoms are claimed to be triggered by technologies which
emit EMF in the radiofrequency (RF-EMF) and extremely low frequency (ELF-EMF)
domains of the non-ionizing radiation spectrum, at levels well below the thresholds
known to cause adverse health effects in humans (ICNIRP, 1998, 2010). These devices
include mobile phones and their base-stations, Wi-Fi, electricity transmission and
distribution systems, and ‘smart’ meters. The condition can have major implications for
an individual’s quality of life and is often associated with decrements in general health
status, increased levels of distress, increased levels of health service use and serious
impairments in occupational and social functioning (Johansson, Sandström, Heiden, &
Nordin, 2010).
Yet, despite the considerable prevalence of the condition globally (estimated to be
between 1.5 – 13.5%) (Baliatsas et al., 2015; Blettner et al., 2009; Eltiti, Wallace,
Zougkou, et al., 2007; Hillert et al., 2002; Levallois, Neutra, Lee, & Hristova, 2002;
Schreier, Huss, & Röösli, 2006; Schröttner & Leitgeb, 2008; Tseng, Lin, & Cheng,
2011), recent reviews of the scientific literature have concluded that there is no
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relationship between exposure to EMF and the non-specific symptoms reported by EHS
individuals (Health Canada, 2015; Health Council of the Netherlands, 2009; Röösli,
Frei, Mohler, & Hug, 2010; Rubin, Das Munshi, & Wessely, 2005; Rubin, NietoHernandez, & Wessely, 2010; Scientific Committee on Emerging and Newly Idenified
Health Risks, 2015). This discrepancy between the scientific consensus and the
subjective reports of sensitivity to EMF not only limits the treatment options and
support for those who experience EHS, but also leaves some members of the public
feeling uncertain and anxious about potential adverse health effects of EMF exposure.
Due to the lack of evidence for an association between exposure to EMF and EHS, the
World Health Organization recommended that the term Idiopathic Environmental
Intolerance attributed to Electromagnetic Fields (IEI-EMF) be used in place of EHS to
avoid implying a causal role of EMF in producing the reported symptoms (World
Health Organisation, 2004).
Experimental provocation studies have been predominately used as a means of
investigating IEI-EMF. In these studies, a participant is exposed to both active and sham
EMF under controlled, preferably double-blinded protocols, while their symptomatic
response to each condition is monitored. Over the past decade, a number of provocation
studies using a range of EMF and varying methodologies have failed to provide
sufficient evidence to support the view that IEI-EMF is directly associated with
exposure to EMF (Rubin et al., 2010; Scientific Committee on Emerging and Newly
Idenified Health Risks, 2015; World Health Organisation, 2014). Indeed, sham
exposures alone have been found to be sufficient to trigger symptoms in IEI-EMF
participants (Nam et al., 2009; Oftedal, Straume, Johnsson, & Stovner, 2007; Wilén,
Johansson, Sandström, Kalezic, & Lyskov, 2006). Two studies have also reported an
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increase in symptoms in an initial non-blinded active exposure condition, compared to
sham, but have then found no significant differences between active and sham
conditions in subsequent double-blind trials (Eltiti, Wallace, Ridgewell, et al., 2007;
Wallace et al., 2012). Similarly, a recent study reported that IEI-EMF participants were
unable to correctly identify when they were being exposed under double-blind
conditions, despite an initial verification that they could detect active from sham
conditions in an open-label trial (van Moorselaar et al., 2017). These findings have led
many to suggest that IEI-EMF may be the result of a nocebo response, where conscious
or subconscious symptom expectation following a perceived exposure to EMF leads to
the formation or detection of symptoms (Hillert et al., 2008; Landgrebe et al., 2008;
Oftedal et al., 2007; Rubin et al., 2010). Recent findings from a qualitative study,
however, suggest that instead of the condition originating from a nocebo response, IEIEMF individuals may be using the notion of sensitivity to EMF to provide a narrative to
explain their medically unexplained symptoms (MUS) in an effort to make their
condition more practically and emotionally manageable (Dieudonné, 2016).
Although the reviews cited above have failed to support the view that EMF exposure
was related to symptoms in self-diagnosed IEI-EMF participants, it is important to note
that there are a number of studies that have claimed to identify such relations, and which
are often used in support of the claim that there is a causal relation. However, such
studies do not provide the claimed support, but are more easily explicable in terms of
methodological considerations. For example, McCarty et al. (2011) claimed an effect of
on-off electric field transitions, but as the study was later criticised for lacking clear
methodology, and given that it has not been replicated, this cannot be taken as evidence
for a relation (Rubin, Cleare, & Wessely, 2011, 2012). Similarly, Kwon et al.(2008)
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reported that two healthy participants were able to detect EMF at greater than chance
levels, but they could not replicate their results in the same individuals a month later,
which suggests that whatever caused the initial significant results, it is unlikely that it
was due to a bioelectromagnetic phenomenon.
In line with the focus on methodology, both advocacy groups and some researchers
have argued that the null results are due to methodological limitations, such as a failure
to account for the heterogeneous nature of the condition and the way in which
participants have been selected and tested. For example, it is possible that the samples
tested have included a combination of both individuals who are sensitive to EMF and
others who may suffer from unrelated conditions (Rubin et al., 2010). This is
problematic, as the majority of studies have taken a nomothetic approach to testing IEIEMF, and have therefore relied on group means which may have had potentially
reduced statistical power due to the noise added to the analysis from non-responders. In
addition, few studies have tested whether the exposure signal used was relevant in
eliciting symptoms for each individual in the sample, which again may have potentially
made the RF-EMF exposure irrelevant for many of the participants. Furthermore, while
the experience of IEI-EMF is known to vary considerably between individuals in terms
of the type and severity of symptoms experienced and the amount of time required for
symptoms to develop and subside following exposure (Hocking, 1998; Röösli et al.,
2004), the majority of provocation studies have not taken this heterogeneity into
account. Instead, studies have generally used relatively standard exposure and wash-out
periods across all participants, which, without verification of an open-label effect using
the particular study protocol, may again make the protocol irrelevant to the reported
EMF-symptom relation and make interpretation problematic.
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Concerns have also been raised about whether the testing environments of provocation
studies adequately reflect the conditions in which IEI-EMF individuals report
symptoms. It is possible, for instance, that the laboratory setting has caused some
participants to experience anxiety, which may have then affected their symptom
response. It is also possible, on the assumption that there is a relation between EMF and
symptoms, that participants have encountered other EMF exposures on the way to an
experimental session which have then inadvertently triggered symptoms (Rubin et al.,
2010). If symptoms had been triggered by external factors prior to the experimental
manipulation, this would also increase the error variance and potentially mask any real
effects. However, although it is logically possible that these limitations have masked
real effects of EMF on symptoms, it is important to point out that there is no
substantiated evidence that this is the case; such issues need to be determined
empirically.
In light of this, the present experiment was designed as a series of individual case
studies to determine whether there is a relationship between RF-EMF and an IEI-EMF
individual’s self-reported symptoms, employing several important methodological
improvements in order to overcome potential limitations of previous studies. First, the
study utilised a portable exposure device which enabled double-blind testing to take
place in environments where participants generally felt safe and asymptomatic, such as
in their own home. This was implemented in order to reduce the stress and anxiety
which may be experienced by a participant in a laboratory setting, while also reducing
potential confounding effects associated with inadvertent exposures to environmental
EMF emissions on the way to an institutional testing location. Second, the methodology
incorporated a consideration of each participant’s IEI-EMF symptom history. This
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included using a similar RF-EMF exposure to the one which the participant claimed
triggers symptoms, and both the exposure source and reported symptoms were
individually verified in an initial open-label, non-blinded trial. This limits potential
‘non-responder’ data from statistically confounding ‘responder’ data. Further to this, the
study included a consideration of the reported symptom onset and recovery periods,
such that the testing regime, if necessary, could be modified to incorporate these. A
sufficient number of sham and exposure conditions were also used to determine
statistically, within the individual, whether any symptom/exposure relation was
significant. Finally, the design incorporated a fully counter-balanced protocol in order to
reduce time of day and time on task effects. The aim of the study was first to test
whether exposure to RF-EMF from the portable exposure device resulted in an increase
in an IEI-EMF participant’s nominated symptom compared to sham, and second, to
determine whether IEI-EMF participants could detect the active RF-EMF signal at
greater than chance levels, under double-blind conditions.
3.4

Materials and Methods

3.4.1

Participants

In total, twenty-five potential participants contacted the research centre during the
recruitment period. Of these, three participants aged 44-64 (two male) completed the
study. Six participants were excluded from the study in an initial phone screen due to
not meeting the eligibility criteria. The remaining sixteen participants either expressed
that they did not want to continue participation in the study (after receiving a participant
information sheet and speaking with the researchers via telephone) or could not be recontacted by the researchers.
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Participants were recruited through advertisements on the research centre website and
via a press release in the local newspaper and television network. All participants were
first screened via a telephone interview to confirm eligibility for the study. To be
included in the study, participants must have reported one or more acute symptoms
which they attributed to the use of or to their personal proximity to mobile phone or WiFi devices. Acute symptoms were defined as any symptom with an onset time of less
than 30 min and which took less than 2 hr to subside following exposure, and that could
be self-managed without the need of a health professional. Participants must have also
self-diagnosed or labelled themselves as having EHS or IEI-EMF for greater than 1
year. Participants were excluded from the study if they reported any serious medical or
psychological illnesses, or indicated that they used recreational illicit drugs.
A mutually convenient testing time was arranged with suitable participants. The study
was approved by the Human Research Ethics Committee (University of Wollongong:
HE15/160), and informed written consent was obtained from all participants.
3.4.2

Radiofrequency Exposure

RF exposure was generated using a portable, self-contained, battery-operated device
(Two Fields Consulting, St Kilda, Australia). The RF device was placed 30 cm from the
participant (either on the side or to the front depending on what was comfortable for the
participant) on a hard surface. The main exposure from the device was a spread
spectrum RF signal in the 902-928 MHz ISM band which was digitally modulated in a
similar manner to signals from Wi-Fi and 3G and 4G mobile phones. The RF signal was
generated by a commercial RF modem which emitted a frequency hopping spread
spectrum signal with an average radiated power output of 1 W for 30 min, or was
completely EMF silent (RF-OFF, sham trials). The incident RF exposure level from the
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side of the device facing the participant was measured using a calibrated broadband
instrument with an uncertainty of ±2.4 dB for a two-sided coverage interval and a
coverage factor of 2 (Narda EMR 300 meter and Type 9 E-field probe, Narda Safety
Test Solutions, Hauppauge, NY), and was found to be 0.3 W/m². This RF exposure
level is below the power density reference level limit of 4.6 W/m² specified for the
Australian general public (ARPANSA RPS3) and by the ICNIRP (1998). It is important
to note that the maximum localised specific absorption rate (SAR) from the exposure
device used in the present study is less than that which typically results from personal
mobile phone use (held against the ear in the active taking mode) due to the greater
separation distance. Conversely, the whole body averaged SAR and localised SAR of
the device used in the present study is greater than that which normally results from WiFi and mobile phone base station signals. The device was fully enclosed in a thermally
insulated case and coded inputs were used to maintain double-blinding. The device
contained an independent RF monitor to check the status of the RF transmitter and each
use of the device was logged using internal memory. The fields emanating during the
RF-ON exposure and sham conditions were demonstrated to each participant in the
open-label trial using a Nardalert S3 broadband monitor (Narda Safety Test Solutions,
Hauppauge, NY). This monitor was then removed for the subsequent double-blind
testing.
3.4.3

Questionnaires

3.4.3.1 Demographic and health questionnaire
Demographic and health screening questionnaires were used to capture data on the age,
handedness, education level, gender, general medical condition, and caffeine, tobacco,
alcohol, illicit and medically prescribed substance use of each participant.
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3.4.3.2 Symptom history questionnaire
Two open ended questions were used to assess each participant’s symptom history.
These were “What are the two most immediate EMF symptoms you experience?” and
“Do you suffer from any debilitating EMF symptoms?” Participants were asked to
include information on the source perceived to be responsible for triggering the
symptoms, the symptom severity, the time of onset and the time needed for the
symptom to subside, the first time the symptom was experienced and any treatment
methods used to relieve the symptom. Participants were also asked to indicate any other
EMF symptoms which they regularly experienced on a checkbox list of 11 common
IEI-EMF symptoms (Rubin, Hahn, Everitt, Cleare, & Wessely, 2006).
3.4.3.3 WHOQOL-BREF
The WHOQOL-BREF (World Health Organisation, 1998) assesses how disease impairs
the subjective well-being of a person across a range of domains. The questionnaire
comprises 26 items, which measure quality of life in the following broad domains:
physical health, psychological health, social relationships, and environment.
3.4.4

Symptom and Exposure Status Scale (SESS)

During the provocation trials, participants were asked to indicate symptom severity and
exposure status via pen and paper 100mm visual analogue scales. Participants were
asked “how sure are you of the current exposure status right now?” anchored with the
terms ‘Definitely OFF’ and ‘Definitely ON’, and “how strong/unpleasant is your
nominated symptom right now?” anchored with the terms ‘Barely Detectable’ and
‘Maximum Severity’. While a full symptom history was obtained from each participant
prior to testing, the symptom tested in the double-blind trials was defined as the most
immediate symptom triggered during the initial open-label RF-ON trial.
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3.4.5

Design

Each participant’s symptom severity and exposure detection ability was tested under a
series of 14 sham and active provocation trials. On the first day of testing, two openlabel trials (1 RF-OFF, 1 RF-ON) were conducted, where both the participant and the
researcher were aware of the exposure status. This was used to determine whether the
exposure device could trigger individually-relevant symptoms in each participant. If a
participant did not report symptoms or was unable to detect the exposure in the RF-ON
condition in this initial test, their participation in the experiment ceased at this point.
The initial open-label trials were followed by a series of 12 double-blind, randomised,
counterbalanced trials, consisting of 6 sham and 6 RF-ON exposure conditions. This
was achieved using the Excel randomization command, such that a sham and RF-ON
condition were treated as a pair; the conditions of each pair were randomly allocated
before assigning the next pair; where more than two sequential pairs had the same order
the third pair was replaced with the alternate pair order; and no more than three of the
same pair-order were permitted. In total, each trial ran for 105 min (except for the RFOFF open-label trial, where there was no post-trial assessment or rest interval as there
had been no exposure). For each participant, the 14 trials took 24 hr to complete, spread
over a period of 3 consecutive days (the number of RF-ON and sham trials were
matched within each day).
3.4.6

Testing Location

Testing was conducted in a safe, asymptomatic environment (determined by the
participant) in order to reduce stress and to reduce any confounding effects due to
environmental RF emissions. In all three cases, participants chose (and were tested in)
their own home.
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3.4.7

Procedure

Upon arrival at the participant’s home, the researchers set up the exposure device in a
comfortable area and ensured that all known electronic and RF emitting devices were
switched off. All participants were then given a verbal description of the ensuing
session before completing demographic and health screening questionnaires. To begin
the provocation trials, participants were asked to sit comfortably in a chair with the
exposure device placed approximately 30 cm from them (either to the side or in front of
them, depending on what was comfortable for the participant). The progression of each
provocation trial is shown in Figure 3.1. The first day of testing began with two openlabel trials. The first open-label trial was an RF-OFF (sham) trial, which began with a
15 min baseline interval (no exposure; status known to participant and researcher) to
assess the participant’s symptom severity pre-trial. The SESS was completed at the 1and 14-min mark (B1 and B2) of the trial. This was followed by a 30 min exposure
interval, where the exposure device was switched to an RF-OFF (sham) setting
(exposure status known to the participant and researcher) and the SESS was again
completed at the 16-, 30- and 44-min mark of the trial (E1, E2 and E3). The RF-OFF
open-label trial was immediately followed by the RF-ON (active) open-label trial.
Again, a 15 min baseline interval (no exposure; status known to participant and
researcher) was used to assess the participant’s symptom severity pre-trial. The SESS
was completed at the 1- and 14-min mark (B1 and B2) of the trial. This was followed by
a 30 min exposure interval where the exposure device was switched to an RF-ON
setting (exposure status known to the participant and researcher) and the SESS was
completed at 16-, 30- and 44-min mark (E1, E2 and E3) of the trial. The exposure
interval was then followed by a 30-min post-exposure assessment (no exposure; status
known to the participant and researcher), where the SESS were again completed at the
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46-, 60- and 74-min mark (PE1, PE2 and PE3) of the trial. The post-exposure interval
was followed by a 30 min rest interval, where the participant was free to move around,
rest and consume food and water before the onset of the next trial. The subsequent 12
double-blind trials followed the same progression as the open-label RF-ON trial, except
that during the exposure interval, the exposure device was set to either sham or RF-ON
(status unknown to the participant and researcher) depending on randomization and
counterbalancing.

Figure 3.1: Provocation trial design. Each trial begins with a 15 min Baseline (B) interval,
followed by a 30 min Exposure (E) interval, a 30 min Post-Exposure (PE) interval and a 30
min Rest interval, with a total trial time of 105 min. Arrows represent the time points where
the SESS was administered.
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3.4.8

Statistical Analysis

Statistical analyses were performed with SPSS Statistics for Windows 21.0 (IBM,
Armonk, New York). For each individual, a Mann-Whitney U test was used to assess
the difference in symptom severity and exposure detection ability, comparing the 6
sham to the 6 RF-ON double-blind exposure conditions (which are treated as
independent). This provides power (0.80) to detect effect sizes of > 1.6 with an alpha =
0.05, which is consistent with the (anecdotal) reports of effect sizes from IEI-EMF
sufferers (who claim to be able to reliably detect and/or suffer symptoms from EMF). It
is important to note that there are currently no effect sizes related to actual effects of
exposure, which is why one based on anecdotal reports of IEI-EMF has been used. The
primary dependent variable was the difference between the baseline score at 14 min of
the trial (B2) and the exposure score at 44 min of the trial (E3), for both symptom
severity and exposure detection. A difference score was used to minimise the influence
of baseline variability and potential carry-over effects. In order to determine the
magnitude of the effect induced by the open-label exposure for each participant, an
effect size was calculated, based on the difference in symptom severity for the RF-ON
and RF-OFF condition. However, because there is no measure of variability in the openlabel trial, the experimental double-blind data was used to calculate a standard
deviation. To achieve this, the effect of belief of exposure first needed to be removed.
To do this, a simple linear regression was conducted to predict symptom score based on
how confident each participant was that the exposure was on or off in the double-blind
trials (belief of exposure), and unstandardised residuals were calculated. The
unstandardised residuals were then used to calculate the standard deviation, which could
then be used in the effect size calculation of the open-label trials. These linear
regressions also provided important information regarding the potential relation
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between belief and symptom severity for each participant via the resultant r-squared
values.
3.5

Results

3.5.1

General health status

The participants did not report any severe medical or psychological conditions. One
participant reported suffering from tinnitus and one participant was on thyroid hormone
replacement therapy but was clinically euthyroid at the time of the tests.
3.5.2

Effect size in the open-label trials

Confirming that the open-label manipulation had worked in each case, all of the
calculated effect sizes in the open-label trials were extremely large (P01 = 5.97, P02 =
3.66, P03 = 6.98), and much larger than the traditionally used nomenclature of Cohen
(1988), which treats the largest category of effect size as >.5.
3.5.3

Participant 1 (P01):

3.5.3.1 Symptom history
The two most common immediate symptoms the participant reported experiencing in
response to EMF were headache (severity 8/10) and dizziness (severity 8/10), with an
onset time of 10 min and taking up to 2 h to subside. The two most common debilitating
symptoms reported by the participant were Vertigo (with an onset time of 12 to 24 hr
following exposure and taking up to 2 days to subside), and confusing thoughts (onset
time and time needed to subside not known). The participant also reported experiencing
nausea, fatigue, eye pain, skin itching, sensation of burning on the skin, memory loss,
insomnia and immune system deficiency. These symptoms were attributed to mobile
phone base stations, Wi-Fi, mobile phones and wireless phones. The symptoms
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developed 5 years prior to testing. Although the participant reported a number of
symptoms, headache was reported as the immediate symptom in the RF-ON open-label
trial and used as the symptom assessed in the double-blind trials.
3.5.3.2 Exposure Detection and Symptom Provocation
Open-label trial: The results of the open-label trial are shown in Figure 3.2a. In the RFON condition, the participant was confident that the exposure device was emitting RF,
and experienced an increase in symptom severity from baseline throughout the trial. As
shown in Figure 3.2a, the severity of these symptoms gradually decreased during the
post-exposure interval. These results indicate that the participant developed symptoms
and reported detecting the active RF signal. A gradual decrease in symptom severity
post-exposure was also observed. The participant did not detect the presence of RF or
exhibit an increase in symptom severity in the RF-OFF condition.
Double-blind trials: The results of the double-blind trials are shown in Figure 3.2b.
Symptom severity (Median =14.00 versus 34.00, U = 15.00, z = -.481, p = .699, r =
.139) and detection ability (Median = 54.50 versus 86.50, U = 17.50, z = -.087, p =
.930, r = .025) did not differ significantly between the RF-ON and sham trials
respectively. The regression analysis showed that ‘belief of exposure’ significantly
predicts symptom severity (F(1, 10) = 48.799, p < .001; R2 = .830).
3.5.3.3 WHOQOL-BREF
As shown in Table 3.1, the participant’s overall quality of life, physical health,
psychological health and overall health scores are below the mean population norm (but
within one standard deviation). The social relationships and environment scores are
above the population norms.
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3.5.4

Participant 2 (P02):

3.5.4.1 Symptom history
The two most common immediate symptoms the participant reported experiencing in
response to EMF were feelings of ‘induced hangover’ with an onset time of 30 s to 5
min (severity 5/10) and a burning sensation in the throat (severity 5/10) with an onset
time of 4 to 5 min. The participant reported that the time symptoms take to subside can
vary substantially depending on the exposure, but estimated a range of between 30 min
to 4 hr. No debilitating symptoms were reported by the participant. The participant also
reported experiencing eye pain and spots on the face. The reported symptoms were
attributed to mobile phones and developed 16 years prior to testing. Although the
participant reported a number of symptoms, a burning sensation in the throat was
reported as the immediate symptom in the RF-ON open-label trial and was therefore
used as the symptom assessed in the double-blind trials.
3.5.4.2 Exposure Detection and Symptom Provocation
Open-label trial: The results of the open-label trial are shown in Figure 3.2c. In the RFON condition, the participant was confident that the exposure device was emitting RF,
and experienced an increase in symptom severity from baseline throughout the trial. The
severity of this symptom fluctuated during the post-exposure interval. These results
indicate that the participant developed an individually relevant symptom and reported
the presence of the active RF exposure. In the RF-OFF trial, the participant did not
report the presence of RF but a slight increase in symptom severity was also observed.
Double-blind trials: The results of the double-blind trials are shown in Figure 3.2d.
Symptom severity (Median = 6.50 versus 2.50, U = 14.00, z = -.656, p = .512, r = .189)
and detection ability (Median = 49.00 versus 15.50, U = 8.00, z = -1.601, p = .109, r =
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.462) did not differ significantly between the RF-ON and sham trials respectively. The
regression analysis showed that ‘belief of exposure’ significantly predicts symptom
severity (F(1, 10) = 79.290, p < .001; R2 = .888).
3.5.4.3 WHOQOL-BREF
As shown in Table 3.1, the participant’s overall quality of life score is below the
population norm, overall health score above the population norm, and the remaining
domains are within the population norms.
3.5.5

Participant 3 (P03):

3.5.5.1 Symptom history
The two most common immediate symptoms the participant reported experiencing in
response to EMF were feelings of pain and strain in the head and ears with an onset
time of 1 to 5 min (severity 5/10), which they attributed to Wi-Fi. The participant
reported that these symptoms subside within 5 to 15 min. The participant also indicated
that they experience headache, mild dizziness, fatigue, tinnitus, and “sensations which
self-highlight in the knees, elbows, tendons and lower arms” which they attributed to
EMF exposure. The participant also reported experiencing a heavy head and eyelids,
memory loss, pain and strain, and a tingling sensation attributed to EMF from
television, however, the symptomatic response to EMF from television was unable to be
tested in the current protocol. The reported symptoms developed at least 12 years prior
to testing. Although the participant reported a number of symptoms, a feeling of pain
and strain in the head and ears was reported as the immediate symptom in the RF-ON
open-label trial and was therefore used as the symptom assessed in the double-blind
trials.
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3.5.5.2 Exposure Detection and Symptom Provocation
Open-label trial: The results of the open-label trial are shown in Figure 3.2e. In the RFON trial, the participant was confident that the exposure device was emitting RF and
they experienced an increase in symptom severity during the trial. The severity of this
symptom decreased during the post-exposure interval. In the RF-OFF trial, the
participant did not report the presence of RF but there was a decrease in symptom
severity from baseline. These results indicate that the participant developed symptoms
and reported detecting the presence of RF during the RF-ON exposure trial.
Double-blind trials: The results of the double-blind trials are shown in Figure 3.2f.
Symptom severity (Median = 0.50 versus 1, U = 17.50, z = -.082, p = .935, r = .024)
and detection ability (Median = 50.50 versus 47.00, U = 12.00, z = -.966, p = .334, r =
.288) did not differ significantly between the RF-ON and sham conditions respectively.
The regression analysis showed that ‘belief of exposure’ significantly predicts symptom
severity (F(1, 10) = 34.093, p < .001; R2 =.773).
3.5.5.3 WHOQOL-BREF
As shown in Table 3.1, the participant’s overall quality of life is below the population
norm, their psychological health, social relationships, physical health and environment
scores are well below the population norms, and their overall health score is below the
population norm (but within 1 SD).
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Table 3.1: WHOQOL-BREF participant domain scores and mean population norms.
Mean population scores were derived from (World Health Organisation, 1998).
Domain

P01

P02

P03

Population

Domain

Domain

Domain

Norms

Score

Score

Score

(SD)

Overall Quality of Life

4

3

3

4.3 (0.8)

Overall Health

2

5

3

3.6 (0.9)

Physical Health

63

81

88

80.0 (17.1)

Psychological Health

69

63

38

72.6 (14.2)

Social Relationships

81

56

0

72.2 (18.5)

Environment

75

69

94

74.8 (13.7)
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Figure 3.2: Mean exposure detection and symptom severity scores across the Baseline
(B1 – B2), Exposure (E1 – E3) and Post Exposure (PE1 – PE3) intervals for P01, P02 and
P03 are shown, for the open-label (RF-ON and OFF) [left column; a, c, e] and doubleblind provocation trials (RF-ON and sham) [right column;b, d, f] separately.
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3.6

Discussion and Conclusions

A number of methodological issues have been raised by both IEI-EMF advocacy groups
and researchers as possible explanations for why provocation studies have generally
failed to provide evidence of a relationship between EMF exposure and IEI-EMF
symptoms. The present study was designed as a series of individual case studies which
incorporated several methodological improvements to overcome limitations of previous
studies. In order to determine whether these methodological improvements were
adequate in providing the necessary conditions to test IEI-EMF participants, an initial
open-label trial was conducted in each case.
Crucially, the results of these open-label trials show that the limitations of previous
studies were sufficiently dealt with. Specifically, the testing environment and the type
of exposure used were shown to be sufficient to produce the individually relevant
symptoms which each participant self-nominated as being due to exposure to EMF and
for each participant to report that RF exposure was indeed active in the RF-ON trial.
This is important, as it confirms that the environment, RF-EMF exposure device and
emitting EMF strength used in the study was relevant for eliciting symptoms for these
particular IEI-EMF individuals. In addition, the observed increase in symptoms over the
30 min open-label active exposure interval (on average) shows that the exposure
interval was sufficient to evoke relevant symptoms in each participant, while the
reduction in symptoms in the post-exposure interval demonstrates that the time course
of each trial was sufficient to allow symptoms to subside prior to the next trial. The
effect sizes observed in the open-label trials in each case were also extremely large
(greater than 3.6), and much larger than the traditionally used nomenclature of Cohen
(1988), which treats the largest category of effect size as greater than .5. These factors
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verify that the protocol used in the present study was appropriate for testing the sample
of IEI-EMF individuals.
While all three participants displayed an increased symptom severity and were
confident that they could detect the presence of RF-EMF in the RF-ON exposure
condition compared to RF-OFF in the initial open-label trial, no significant differences
in symptom severity or exposure detection between the RF-ON and sham conditions
were found in the double-blind trials. These findings correspond to those reported by
Eltiti, Wallace, Ridgewell, et al. (2007) and Wallace et al. (2012), who found that IEIEMF participants had a greater symptomatic response in an initial open-label active trial
compared to sham, but no difference in subsequent double-blind trials. Likewise, in a
study similar to the present investigation, van Moorselaar et al. (2017) reported that IEIEMF participants were unable to correctly identify when they were being exposed
during double-blind testing, despite participants reacting to the exposure in an initial unblinded test. Generally, the results of the present experiment agree with the majority of
previous studies, which have not found any relationship between IEI-EMF symptoms
and EMF exposure in double-blind provocation paradigms (Rubin et al., 2005; Rubin et
al., 2010).
Interestingly, belief of exposure was found to significantly predict symptom severity,
with belief accounting for 83, 89 and 77 percent of the variance for Participants 1, 2 and
3 respectively. This may explain why a sham exposure is sufficient to trigger symptoms,
as has been reported previously (Nam et al., 2009; Oftedal et al., 2007; Wilén et al.,
2006). The strength of belief was particularly noteworthy in Participant 3, who reported
that the experiment was designed with a deception element. As a result the participant
reported detecting RF exposure in the post-exposure interval of the double-blind trials,
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despite specific instruction from both the participant information sheet and the
researchers throughout the trial that the RF exposure was switched off during the postexposure interval.
Although varied, each participant also scored lower than the general population in terms
of overall quality of life and other measures of health on the WHO-QOL BREF
questionnaire. This is consistent with the conclusions of many cross-sectional survey
studies (Hagström et al., 2013; Johansson et al., 2010; Kato & Johansson, 2012), and
highlights that, in addition to physical impairment, IEI-EMF can significantly impact
daily functioning and quality of life. This emphasises the importance of developing
appropriate treatments and support for these individuals, but given the strong belief
within the IEI-EMF community that EMF is a cause of their symptoms, this will remain
challenging.
The results of the present study are limited by a number of factors. First, the results of
the study cannot be generalised across the entire IEI-EMF population due the relatively
small sample size. Despite intending to recruit a larger sample, it seems that scepticism
of the scientific process and of the results of previous studies, as well as warnings about
the present study from IEI-EMF advocacy groups (Stop Smart Meters Australia, 2015),
may have led to many IEI-EMF sufferers being persuaded not to participate.
Nevertheless, the idiographic nature of the study protocol and the 6 RF-ON and 6 RFOFF comparisons were designed to enable the detection of partial IEI-EMF responses
within each individual case separately. Second, the exposure device used a simulated
RF signal in the 902-928 MHz ISM band which, although digitally modulated like WiFi and 3G and 4G signals, would not be typically reported as being the associated
trigger of symptoms by individuals who experience IEI-EMF as it is a signal band
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reserved for industrial, scientific and medical use. The use of simulated signals in
provocation studies has been criticised (Panagopoulos, Johansson, & Carlo, 2015),
however, as all 3 participants responded to the active signal in the initial non-blind trial,
this does not seem to be an issue. Finally, the present study is unable to comment on
individuals who report more chronic forms of IEI-EMF, as it was unable to assess
individuals who report more-prolonged symptoms that some IEI-EMF individuals
report to result from the build-up of exposure from a variety of EMF sources over time
[Hocking, 1998; Röösli et al., 2004].
Despite accounting for a number of possible limitations of IEI-EMF provocation studies
to date, the results of the case studies presented here fail to demonstrate that the
symptomatic response of self-reported IEI-EMF participants is affected by EMF
exposure, nor that they can detect the presence of RF-EMF emissions at greater than
chance levels. As in other studies, our results also support an alternative hypothesis for
the aetiology of IEI-EMF; that the symptoms experienced are the result of a nocebo
response. Indeed the size of resultant r-squared values shows that symptoms are more
closely related to belief than EMF itself. Given the increasing prevalence of distressing
and debilitating IEI-EMF symptoms in the general public, there is a great need to better
understand the triggers for eliciting a harmful EMF nocebo response. Public messaging
on the EMF topic by scientists and health administrators are no doubt significant
influences (Wiedemann, Boerner, & Repacholi, 2014; Wiedemann et al., 2013). A
nocebo aetiology hypothesis also provides useful direction in developing effective
treatments for people who experience IEI-EMF, whose only current solutions for
minimizing symptoms involve exposure reduction strategies or the complete avoidance
of all perceived exposures of EMF. Often these remedies not only involve considerable
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financial cost, but they can also have major implications for social and occupational
functioning. Unfortunately, the ongoing debate over the aetiology of IEI-EMF continues
to limit the development of appropriate treatments and support of people who
experience IEI-EMF.
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4.

CHAPTER 4: CAN EXPLICIT SUGGESTIONS ABOUT THE
HARMFULNESS OF EMF EXPOSURE EXACERBATE A
NOCEBO RESPONSE IN HEALTHY CONTROLS?
4.1

Chapter Foreword

Despite accounting for a number of potential methodological limitations, the results of
the case studies presented in Study 2 (Chapter 3) failed to demonstrate that the
symptomatic response of self-reported IEI-EMF sufferers is affected by EMF exposure,
nor that IEI-EMF sufferers could detect the presence of RF-EMF emissions at greater
than chance levels. In line with previous research, the results also showed that the
symptoms reported by IEI-EMF sufferers are more closely related to a nocebo response,
as a significant relationship between a participant’s belief that they were being exposed
(irrespective of the actual exposure condition) and their symptomatic response was
observed in each case. As many of the methodological concerns raised by some
researchers and IEI-EMF sufferers were adequately accounted for in Study 2, these
results also suggest that the overall lack of evidence for a relationship between EMF
exposure and symptoms in the extant literature was not a result of potential
methodological issues.
While the results of Study 2 provide further support for the psychogenic theory of IEIEMF, whether the nocebo response exhibited by IEI-EMF sufferers is specific only to
IEI-EMF sufferers has not yet been determined. If healthy people were found to exhibit
a similar response to those who suffer from IEI-EMF during a perceived threatening
exposure to EMF, this would suggest that the nocebo response exhibited by IEI-EMF
sufferers may be a normal human response. In addition to this, the factors which
contribute to such a response have not been adequately clarified. Although there has
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been some suggestion that alarmist media reports and precautionary information can
negatively influence people’s beliefs about EMF exposure, whether the negative beliefs
induced by such information can result in a symptomatic nocebo response following a
perceived exposure to EMF has not been sufficiently determined.
The study presented in this chapter (Study 3) investigates whether symptomatic nocebo
effects can occur in healthy participants, and whether explicit suggestions about the
adverse effects of EMF can exacerbate a nocebo response. This research will not only
clarify the role of the nocebo effect in the development of symptoms attributed to EMF,
but will also examine the factors which may underlie such a response, and will
determine whether alarmist media reports may contribute to such a response. The
findings from this study may have important implications for the development of
effective treatments for IEI-EMF sufferers, as it may help to remove the stigma attached
to the notion that the condition has a psychogenic origin, which may currently be a
barrier to seeking treatment. In addition to this, the findings of the current study may
also help to identify some of the factors which contribute to nocebo responses. This
chapter has been published in the journal Environmental Research.
Verrender, A., Loughran, S.P., Dalecki, A., Freudenstein, F., & Croft, R.J. (2018). Can
explicit suggestions about the harmfulness of EMF exposure exacerbate a nocebo
response in healthy controls? Environmental Research, 166, 409 – 417
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4.2

Abstract

While there has been consistent evidence that symptoms reported by individuals who
suffer from Idiopathic Environmental Intolerance attributed to Electromagnetic Fields
(IEI-EMF) are not caused by EMF and are more closely associated with a nocebo effect,
whether this response is specific to IEI-EMF sufferers and what triggers it, remains
unclear. The present experiment tested whether perceived EMF exposure could elicit
symptoms in healthy participants, and whether viewing an ‘alarmist’ video could
exacerbate a nocebo response. Participants were randomly assigned to watch either an
alarmist (N = 22) or control video (N = 22) before completing a series of sham and
active radiofrequency (RF) EMF exposure provocation trials (2 open-label, followed by
12 randomised, double-blind, counterbalanced trials). Pre- and post-video state anxiety
and risk perception, as well as belief of exposure and symptom ratings during the openlabel and double-blind provocation trials, were assessed. Symptoms were higher in the
open-label RF-ON than RF-OFF trial (p < .001). No difference in either symptoms (p =
.183) or belief of exposure (p = .144) was observed in the double-blind trials.
Participants who viewed the alarmist video had a significant increase in symptoms (p =
.041), state anxiety (p <.01) and risk perception (p < .001) relative to the control group.
These results reveal the crucial role of awareness and belief in the presentation of
symptoms during perceived exposure to EMF, showing that healthy participants exhibit
a nocebo response, and that alarmist media reports emphasizing adverse effects of EMF
also contribute to a nocebo response.
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4.3

Introduction

The public’s perception of the potential health implications associated with the use of
modern technologies has been steadily changing in recent years (Petrie et al., 2001;
Petrie & Wessely, 2002). This is often reflected in the mainstream media, where news
reports consistently suggest that there are dangers of various aspects of modern life
while often neglecting more mundane causes of illness (Frost, Frank, & Maibach, 1997;
Petrie & Wessely, 2002). Generally, these stories do not reflect the current state of
science (Claassen, Smid, Woudenberg, & Timmermans, 2012; Eldridge-Thomas &
Rubin, 2013), but instead focus on reports of members of the community who claim to
experience conditions characterised by a variety of adverse symptoms which they
ascribe to their use of, or proximity to, various environmental stimuli, including
vaccinations, genetically modified food, infrasound from wind turbines and
electromagnetic fields (EMF) emitted by mobile phone and wireless technologies
(Petrie & Wessely, 2002).
One particularly prominent condition is Idiopathic Environmental Intolerance attributed
to Electromagnetic Fields (IEI-EMF). People who suffer from this condition typically
report experiencing a diverse range of non-specific symptoms which they attribute to
their exposure to the EMF emitted by everyday electrical and wireless technologies and
infrastructure (Baliatsas, Van Kamp, Lebret, & Rubin, 2012; Röösli, Moser, Baldinini,
Meier, & Braun-Fahrländer, 2004). Yet, while a considerable proportion of the
population report experiencing IEI-EMF (estimated to be between 1.5 – 13.5%
(Baliatsas et al., 2015; Blettner et al., 2009; Eltiti, Wallace, Zougkou, et al., 2007;
Hillert, Berglind, Arnetz, & Bellander, 2002; Levallois, Neutra, Lee, & Hristova, 2002;
Schreier, Huss, & Röösli, 2006; Schröttner & Leitgeb, 2008; Tseng, Lin, & Cheng,
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2011)), there has been no robust evidence to implicate a bioelectromagnetic mechanism
in producing the reported symptoms (Health Canada, 2015; Health Council of the
Netherlands, 2009; Röösli, Frei, Mohler, & Hug, 2010; Rubin, Das Munshi, & Wessely,
2005; Rubin, Nieto-Hernandez, & Wessely, 2010; Scientific Committee on Emerging
and Newly Idenified Health Risks, 2015; Staudenmayer, Binkley, Leznoff, & Phillips,
2003). For instance, when tested under double-blind protocols, IEI-EMF participants do
not report an increase in symptoms to EMF and are unable to perceive the difference
between active and sham exposures (Röösli et al., 2010; Rubin et al., 2010). Instead, the
evidence suggests that the condition is more closely associated with a nocebo response,
as awareness of the exposure and a belief of being exposed have been shown to play an
important role in the presentation of the condition. For example, a number of studies
have found that participants experience an increase in symptoms when they are aware of
the active exposure condition in an initial non-blinded trial compared to sham, but do
not exhibit more symptoms in active than sham exposures in subsequent double-blind
trials (Eltiti, Wallace, Ridgewell, et al., 2007; van Moorselaar et al., 2017; Verrender et
al., 2018). Furthermore, sham exposures (i.e. with no EMF) have been shown to be
sufficient to trigger symptoms in IEI-EMF participants (Nam et al., 2009; Oftedal,
Straume, Johnsson, & Stovner, 2007; Verrender et al., 2018; Wilén, Johansson,
Sandström, Kalezic, & Lyskov, 2006). The exact role of the nocebo response in the
development of IEI-EMF, however, is not fully understood. For instance, recent
findings from a qualitative study suggest that instead of the condition originating from a
nocebo response, IEI-EMF individuals may be using the notion of sensitivity to EMF to
provide a narrative to explain their pre-existing medically unexplained symptoms, in an
effort to make their condition more practically and emotionally manageable Dieudonné
(2016). Yet, it is important to note that Dieudonné (2016) did not test the cause of the
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participant’s symptoms, but rather, retrospectively asked participants about their beliefs
regarding the cause of their symptoms. As retrospective self-reports are known to suffer
from recall bias (Baliatsas et al., 2015; Vrijheid et al., 2009), these methods are not able
to determine symptom aetiology.
Given the prevalence of distressing and debilitating IEI-EMF symptoms, and in light of
the evidence suggesting that such symptoms may be the result of a nocebo response,
there is a great need to better understand the triggers that elicit such responses.
Generally, a nocebo response occurs when conscious or subconscious negative
expectations trigger or exacerbate adverse symptoms in response to an exposure that is
not known to cause those effects (Bräscher, Kleinböhl, Hölzl, & Becker, 2017; Hahn,
1997). These expectations may be induced by explicit suggestions about the potential
effects of an exposure (Benedetti, Lanotte, Lopiano, & Colloca, 2007; Webster,
Weinman, & Rubin, 2016) or by learning through classical conditioning (Bräscher,
Kleinböhl, et al., 2017).
The communication of information about potential adverse health effects associated
with EMF exposure constitutes an explicit suggestion which may be responsible for the
formation of negative expectations and consequent nocebo response seen in IEI-EMF
individuals (Webster et al., 2016). For example, there has been consistent evidence that
precautionary information can negatively influence beliefs about EMF exposure, despite
this information originally being intended to reassure the public (Barnett, Timotijevic,
Shepherd, & Senior, 2007; Nielsen et al., 2010; Wiedemann, Boerner, & Repacholi,
2014; Wiedemann et al., 2013; Wiedemann & Schütz, 2005; Wiedemann, Thalmann,
Grutsch, & Schütz, 2006). Similarly, viewing mainstream media reports which either
promote the view that EMF exposure is hazardous, or focus on individuals with IEI120

EMF, have been shown to increase worries about EMF exposure (Witthöft et al., 2017),
while viewing an advertisement claiming to protect against the ‘harmful effects of
everyday EMF exposure’ has been shown to increase both heart rate and concern about
EMF (Köteles, Tarján, & Berkes, 2016). Further, recent content analyses have shown
that mainstream media reports about EMF exposure often misrepresent the current state
of scientific evidence by focusing on an electromagnetic cause for IEI-EMF, or
suggesting a relationship between EMF exposure and ill-health (Claassen et al., 2012;
Eldridge-Thomas & Rubin, 2013). If such misinformation is being distributed on a wide
scale and is negatively influencing people’s beliefs about EMF exposure, it is possible
that this may be a contributing factor to the prevalence of IEI-EMF.
Yet, it remains unclear whether the negative beliefs induced by such communications
can result in greater symptom formation following a perceived exposure to EMF.
Although Szemerszky, Köteles, Lihi, and Bárdos (2010) demonstrated that suggestions
about the strength of EMF exposure can lead to increased symptom scores and an
increase in the belief that a sham magnetic field was active, that study did not assess the
effect of explicit suggestions of risk from EMF exposure (which may induce negative
expectations) and was limited by a lack of counterbalancing. Furthermore, while
Witthöft and Rubin (2013) reported that viewing a sensationalist media report about the
adverse effects of Wi-Fi can increase the likelihood of a person experiencing symptoms
following a sham exposure and developing an apparent sensitivity to EMF, the effect
was only found for those with high pre-existing levels of state anxiety. This may be
because the study lacked a verified non-exposure condition, potentially resulting in
insufficient statistical power to detect effects in non-anxious individuals. In support of
this notion, a similar study which included a cued non-exposure condition found that
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those who watched a film focusing on ‘adverse effects of Wi-Fi’ perceived tactile
electrical stimuli as more intense during a cued Wi-Fi exposure (which was actually a
sham exposure) compared to a cued no Wi-Fi condition, and that the effect was not
mediated by anxiety (Bräscher, Raymaekers, Van den Bergh, & Witthöft, 2017). This
suggests that manipulating a participant’s belief of exposure via cues may be important
for influencing symptom perception irrespective of pre-existing state anxiety levels. The
latter study, however, assessed somatosensory perception rather than symptom
perception, and so it remains uncertain as to whether negative beliefs induced by
information about EMF exposure can result in greater symptom formation or belief
regarding exposure status following a perceived exposure to EMF.
To address these limitations, the present study was designed to determine whether
perceived EMF exposure could elicit symptoms in a healthy population, and
additionally, whether messages emphasizing ‘adverse health effects of EMF exposure’
can exacerbate a nocebo response. The study was also designed to explore, withinsubjects, whether there is a relationship between a person’s belief of exposure and
symptoms, and whether there is a difference in symptom response between participants
with low, medium and high pre-existing levels of state anxiety. To this end, an initial
non-blinded open-label trial was employed, where the status of exposures emanating
from the device (during an active and sham condition) were visually demonstrated to
each participant using an EMF meter.
4.4

Materials and Methods

4.4.1 Participants
Forty-four participants aged 18 – 30 years (M = 21.92, SD = 4.88; 50% male) were
recruited through advertisements placed online and around the University of
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Wollongong campus. A power calculation conducted in G*Power 3.0 (Faul, Erdfelder,
& Buchner, 2007) for an independent samples t test based on an effect size of 0.8, an
alpha level of .05 and a power of 0.80 recommended a total sample size of 42.
All participants were first screened via a telephone interview to confirm eligibility for
the study. To be included in the study, participants were required to be over the age of
18 and report being of good health. Participants were excluded from the study if they
reported having a current illness or medical condition, or having used illicit substances
within the 7-day period prior to the study. Suitable participants were required to attend
the Illawarra Health and Medical Research Institute for one mutually convenient testing
session. The study was approved by the Human Research Ethics Committee (HE:
2016/981). All participants were instructed to abstain from alcohol for at least 8 hr,
caffeine for at least 1 hr, and mobile phone use for at least 2 hr before the beginning of
the testing session. Participants were compensated with a monetary gift card for their
involvement in the study.
4.4.2 Radiofrequency exposure
RF exposure was generated using a portable, self-contained, battery-operated device
(Two Fields Consulting, St Kilda, Australia). The RF device was placed 30 cm to the
left side of the participant (at approximately shoulder to head height) on a hard surface.
The main exposure from the device was a spread spectrum RF signal in the 902-928
MHz ISM band which was digitally modulated in a similar manner to signals from WiFi and 3G/4G mobile phones. The RF signal was generated by a commercial RF modem
which emitted a frequency hopping spread spectrum signal with an average radiated
power output of 1 W for 10 min (RF-ON), or was completely EMF silent (RF-OFF,
sham trials). The incident RF exposure level from the side of the device facing the
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participant was measured using a calibrated broadband instrument with an uncertainty
of ± 2.4 dB for a two-sided coverage interval and a coverage factor of 2 (Narda EMR
300 meter and Type 9 E-field probe, Narda Safety Test Solutions, Hauppauge, NY), and
was found to be 0.3 W/m². This RF exposure level is below the power density reference
level limit of 4.6 W/m² specified for the Australian general public (ARPANSA RPS3)
and by the International Commission on Non-Ionizing Radiation Protection (ICNIRP,
1998). It is important to note that the maximum localised specific absorption rate (SAR)
from the exposure device used in the present study is less than that induced from
personal mobile phone use (held against the ear in the active talk mode) due to the
greater separation distance. Conversely, the whole body averaged SAR and localised
SAR of the device are greater than those normally produced by Wi-Fi and mobile phone
base station signals. The device was fully enclosed in a thermally insulated case and
coded inputs were used to maintain double-blinding. The device contained an
independent RF monitor to check the status of the RF transmitter and each use of the
device was logged using internal memory.
4.4.3 Questionnaires
4.4.3.1 Symptoms and exposure status scale (SESS)
During the provocation trials, participants were asked to indicate whether they believed
the exposure was on or off, and to rate whether they were experiencing any symptoms
via pen and paper 100 mm visual analogue scales. To assess belief of exposure,
participants were asked “how sure are you of the current exposure status right now?”
anchored with the terms ‘Definitely OFF’ and ‘Definitely ON’. To assess symptom
experience, a modified state version of the 34 item Checklist for Symptoms in Daily
Life (Wientjes & Grossman, 1994; Witthöft & Rubin, 2013) was used. Participants were
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asked “how strong/unpleasant are the following symptoms right now?” anchored with
the terms ‘Barely Detectable’ and ‘Maximum Severity’. These response categories
differed from the original questionnaire (Wientjes & Grossman, 1994) and were used in
line with our previous study (Verrender et al., 2018). The symptom responses of the 34
items were added to calculate a total symptom score for each of the baseline and
exposure intervals in each trial. The primary dependent variables for belief of exposure
and symptoms in the provocation trials were calculated as difference scores between the
baseline and exposure questionnaires (exposure interval minus preceding baseline)
given during each trial (see procedure below); a difference score was used to minimise
the influence of baseline variability and potential carry-over effects.
4.4.3.2 Risk perception questionnaire (RPQ)
A self-generated risk perception questionnaire comprising 4 questions was used to
assess EMF risk perception. Question 1 assessed concerns about electromagnetic fields
in general and question 2 assessed concerns about electromagnetic fields in relation to
mobile phones and Wi-Fi. Participants were asked “How concerned are you about the
potential health risks of electromagnetic fields in general?” rated on a 7-point Likert
scale (1 = not worried at all, 7 = very worried) and “All in all, how threatened do you
feel by electromagnetic radiation emissions from mobile phones and Wi-Fi?” rated on a
7-point Likert scale (1 = not threatening at all, 7 = very threatening). To enable
standardised measurement of RF-EMF risk perception in relation to mobile phones and
Wi-Fi, questions 3 and 4 used picture-guided scenarios which illustrated everyday
exposure situations (Freudenstein, Wiedemann, & Brown, 2015). Participants were
asked “How dangerous do you think the electromagnetic fields from mobile phones are
while you talk on the phone, as illustrated in this picture?” and “How dangerous do you
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think the electromagnetic fields are from Wi-Fi routers in close proximity, as illustrated
in this picture?” rated on a 7-point Likert scale (1 = not dangerous at all, 7 = very
dangerous). The RPQ score was defined as the mean score from all responses.
4.4.3.3 State and Trait Anxiety Index (STAI)
The 40 item version of the STAI (Spielberger, Gorsuch, & Lushene, 1970) was used to
assess participant’s state and trait anxiety. This comprises two, 20-item forms, assessing
state (STAI-Y1) and trait (STAI-Y2) anxiety separately, with items answered on a 4point Likert scale (1 = not at all, 4 = very much so). Low, medium and high anxiety
were defined as being less than minus 1 standard deviation from the mean, between
minus 1 standard deviation and plus 1 standard deviation from the mean, and greater
than plus 1 standard deviation from the mean, respectively (Witthöft & Rubin, 2013).
4.4.3.4 NEO Five Factor Personality Index (NEO-FFI)
The 60 item NEO-FFI (Costa & McCrae, 1992) was used to assess personality traits:
Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Openness to
Experience. This measure is beyond the scope of this paper and will not be discussed
further.
4.4.4 Design
In an experimental between-groups design, participants were assigned to the alarmist or
control video group by a computerised random allocation process. In the alarmist video
group, participants viewed a 3 min video appeal to the United Nations from a concerned
scientist asking that more precautionary action be taken in regard to EMF exposure
“from our favourite gadgets.” This included statements about the potential health risks
from mobile phone and Wi-Fi signals, as well as sensationalised images of exposure
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scenarios (Blank, 2015). In the control group, participants viewed a 3 min segment of a
documentary on gravity (Cox, 2013). This video contained no health related content. To
minimise the influence of experimenter bias, a researcher not involved in data collection
(AD) was responsible for the randomisation and administration of the videos.
For the provocation trials, a randomised, counterbalanced, cross-over design was
employed. Each participant’s symptoms and belief of exposure was tested under a series
of 14 sham and active provocation trials. The first two trials were non-blinded, openlabel trials (1 RF-OFF, 1 RF-ON), where both the participant and the researcher were
aware of the exposure status. This was verified to the participant using a Nardalert S3
broadband monitor (Narda Safety Test Solutions, Hauppauge, NY). These trials were
followed by a series of 12 double-blind, randomised, counterbalanced trials (6 sham, 6
RF-ON). Randomization and counterbalancing was achieved using Excel
(randomization command), such that a sham and RF-ON condition were treated as a
pair; the conditions for each pair were randomly allocated before assigning the next
pair; and no more than three of the same pair-order were permitted.
4.4.5 Procedure
A participant information sheet was sent to people who responded to recruitment flyers.
This informed participants that a small percentage of the population report being
sensitive to EMF, described some of the symptoms reported by IEI-EMF sufferers and
explained that although the scientific evidence has yet to establish a clear relationship
between exposure and symptoms, news reports about the possible adverse health effects
of RF exposure continue to focus on people who report these symptoms. The general
aims of the study were also listed in the information sheet.
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Following a telephone screening interview, suitable participants were booked in for one
mutually convenient testing session starting at 09:00 am, which lasted approximately
5.5 hr. Upon arrival at the laboratory, participants provided informed written consent
and were given a verbal briefing of the ensuing testing session. After being instructed to
switch off and leave all electronic devices in a general area of the laboratory,
participants were then seated comfortably inside a Faraday cage, where they completed
the baseline (Time 1 (T1)) measures of the STAI and RPQ. After completing the T1
questionnaires, participants then watched one of the two videos (based on their
randomly assigned group). To maximise attention, participants were instructed to pay
attention to the video as they would be required to answer questions about the video as
part of a memory test at the conclusion of the study (although no memory test was
conducted). After watching the video, participants again completed the STAI and RPQ
(Time 2 (T2)). The exposure device was then set up and the provocation trials
commenced, beginning with the initial 2 open-label trials (1 RF-OFF, 1 RF-ON),
followed by the 12 double-blind trials. Each of the provocation trials lasted 20 min,
beginning with a 5 min baseline interval, followed by a 10 min exposure interval (RFON or RF-OFF/sham, depending on randomization and counterbalancing), and
concluded with a 5 min rest interval before the onset of the next trial. In each trial,
participants were required to complete the SESS 2.5 min into the baseline interval and
again 7 min into the exposure interval. At the conclusion of the provocation trials,
participants were led out of the Faraday cage and asked whether they had any questions
or concerns about any aspect of the experiment. No participants reported any concern
about the experiment. A 15 min break was given after the 8th provocation trial.
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4.4.6 Statistical analyses
Statistical analyses were performed with SPSS Statistics for Windows, Version 23.0
(IBM, Armonk, New York). Where normality tests and visual inspection of the data
revealed violations to the assumption of normality, non-parametric tests were employed
and the corresponding effect sizes (ES) were calculated as r, (where 0.1 = small, 0.3 =
medium and 0.5 = large (Cohen, 1988)). Where parametric tests were conducted,
corresponding effect sizes were calculated as Cohen’s d, (where 0.3 = small, 0.5 =
medium and 0.8 = large (Cohen, 1988)).
4.4.6.1 Preliminary Analyses:
Independent samples t tests were used to compare pre-existing (T1) levels of state
anxiety (STAI-Y1), trait anxiety (STAI-Y2) and risk perception (RPQ) between the
control and alarmist video groups. A Wilcoxon Signed-Ranks test was used to
determine whether participants understood the exposure protocol by assessing whether
there was a difference in belief of exposure rating of the SESS between the RF-OFF and
RF-ON open-label trials.
4.4.6.2 Hypothesis Driven Analyses:
A Wilcoxon Signed-Ranks test was used to determine whether there was a main effect
of exposure on the symptom score of the SESS in the open-label trials. To assess
whether there was an interaction between video group and symptom score, a symptom
difference score (RF-ON minus RF-OFF) was calculated and a Mann-Whitney U test
used to compare the difference score between control and alarmist video groups in the
open-label trials.
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4.4.6.3 Exploratory Analyses:
To verify whether there was no effect of RF-EMF exposure, Wilcoxon Signed-Ranks
tests were used to determine whether there was a main effect of exposure on either the
belief of exposure rating or the symptom score of the SESS in the double-blind trials.
To assess whether there was an interaction between video group and either belief of
exposure rating or symptom score, a difference score for each variable was calculated
(RF-ON minus RF-OFF). These difference scores were calculated by averaging the
belief of exposure, and separately the symptom difference scores (already calculated as
the difference between the baseline and exposure intervals) of each variable across the 6
RF-ON and 6 RF-OFF conditions. The averaged RF-ON score was then subtracted from
the averaged RF-OFF score. Mann-Whitney U tests were then used to compare each of
these variables between the control and alarmist video groups.
Spearman’s rho measure of association was used to test whether there was a relationship
between belief of exposure and symptoms in the double-blind trials (irrespective of
actual exposure condition) for each individual participant. The resultant rho values were
then transformed using a Fisher transformation, and a one sample t test was used to
determine whether these transformed correlations differed from 0. An independent
samples t test was used to assess whether there was a difference in the Fisher
transformed Spearman’s rho values between the control and alarmist video groups.
Mann-Whitney U tests were used to assess whether the difference between T1 and T2
STAI-Y1 score, and separately RPQ score, differed between the control and alarmist
video groups.
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A Jonckheere-Terpstra test was used to determine whether there was a linear trend in
the symptom score of the RF-ON open-label trial as a function of pre-existing state
anxiety.
4.5

Results

4.5.1 Preliminary Analyses
The means, standard deviations and test statistics for assessing whether there were
significant differences between the control and alarmist video groups in relation to preexisting levels of state anxiety (STAI Y-1), trait anxiety (STAI – Y2) and risk
perception (RPQ) are displayed in Table 4.1. No significant differences were detected.
Verifying that participants understood the exposure protocol (they believed that they
were being exposed in the open-label RF-ON condition and that they were not being
exposed in the open-label RF-OFF condition), belief of exposure ratings were
significantly higher in the RF-ON (Median = 100) compared to the RF-OFF (Median =
0) condition, T = 0.00, z = - 5.86 (corrected for ties), N – ties = 44, p < .001, ES = 0.88.
All participants correctly reported that they were confident that the exposure was
‘Definitely ON’ in the RF-ON condition and ‘Definitely OFF’ in the RF-OFF condition
of the open-label trials.
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Table 4.1: Descriptive statistics and tests for differences in pre-existing levels of state
anxiety, trait anxiety and risk perception between the two video groups.

Dependent

Control video

Alarmist video

variable

N = 22

N = 22

State Anxiety

M = 29.00, SD = 8.11

Trait Anxiety

Risk Perception

Test statistic for
differences between
groups

M = 30.45, SD =

t(42) = -0.639,

9.96

p = .527, ES = 0.19

M = 38.45, SD =

M = 36.41, SD =

t(42) = -0.624,

11.85

9.79

p = .536, ES = 0.19

M = 2.35, SD = 1.12

M = 2.51, SD = 1.09

t(42) = - 0.477,
p = .636, ES = 0.14

M = mean; SD = standard deviation; ES = effect size.
4.5.2 Hypothesis Driven Analyses:
4.5.2.1 Symptoms in the open-label trials:
Figure 4.1 shows the SESS symptom scores for the RF-OFF and RF-ON open-label
trials. Overall, participants had significantly higher increases in symptom scores in the
RF-ON condition (Median = 17.00) compared to the RF-OFF condition (Median = 0.50), T = 77.00, z = -4.476 (corrected for ties), N - ties = 40, p < .001, ES = 0.71.
4.5.2.2 Effect of video group on symptoms in the open-label trials:
The symptom scores in the RF-OFF condition were equal between the alarmist (Mean =
11.59 Median = -3) and control (Mean = 11.45 Median = 0) video groups, validating the
comparison of symptom difference scores between the two groups. Figure 4.2 shows the
symptom difference score (RF-ON – RF-OFF) for the control and alarmist video groups
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in the open-label trials. The symptom difference score was higher in the alarmist
(Median = 25.50) compared to the control (Median = 5.00) video group, and the
interaction between symptom difference score and video group was significant, U =
159.50, z = -1.738, p = .041 (one-tailed), ES = 0.26 3.

3

One significant outlier was removed from this analysis. The interaction between symptom difference
score and video group only reached trend level when including this outlier, U = 181.50, z = -1.421, p =
.078 (one-tailed), ES = 0.24.
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Figure 4.1 The mean (dot), median (line), interquartile range (box) and range
(whiskers) of the SESS symptom scores are shown for the RF-OFF and RF-ON openlabel trials.
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Figure 4.2: The mean (dot), median (line), interquartile range (box) and range (whiskers) of
the difference in SESS symptom score (RF-ON – RF-OFF) are shown as a function of video
group in the open-label trials3.
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4.5.3 Exploratory Analyses
4.5.3.1 Effect of exposure on belief of exposure and symptoms in the double-blind trials:
The SESS belief of exposure ratings in the RF-ON and sham double-blind trials are
shown in Figure 4.3. Overall, there was no difference in belief of exposure rating
between the RF-ON (Median = 34.58) and sham conditions (Median = 38.33), T =
331.00, z = -1.062 (corrected for ties), N – ties = 40, p = .144 (one-tailed), ES = 0.17,
indicating that there was no main effect of exposure on belief of exposure rating. Three
participants correctly identified at greater than chance levels (within-subjects), when
they were and were not being exposed in the double-blind trials, with 1 participant
getting 75% correct and 2 participants getting 83% correct. No other participants could
correctly identify when they were being exposed. Given a chance level of 5% and that
there were 44 participants, it would be expected that 2.2 participants would correctly
identify the conditions by chance.
The SESS symptom scores in the RF-ON and sham double-blind trials are shown in
Figure 4.4. Overall, there was no difference in symptom score between the RF-ON
(Median = 10.33) and sham conditions (Median = 10.33), T = 398.00, z = -0.906
(corrected for ties), N – ties = 43, p = .183 (one-tailed), ES = 0.14, indicating that there
was no main effect of exposure on symptoms.
Spearman’s rho measure of association showed that the relationships between belief of
exposure and symptoms in the double-blind trials were highly variable between
participants. These values ranged from -.276 to .882 in the control video group and .675 to .852 in the alarmist video group. Following a Fisher transformation, a onesample t test found that the transformed rho values were significantly greater than 0,
t(43) = 6.862, p < .001, ES = 1.03.
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4.5.3.2 Effect of video group on belief of exposure and symptoms in the double-blind
trials:
The belief of exposure difference score (RF-ON – Sham) also not differ between the
control (Median = -0.33) and alarmist (Median = 4.25) video groups, U = 186.50, z = 1.303, p = .096 (one-tailed), ES = 0.20, indicating that there was no interaction between
video group and belief of exposure rating. The symptom difference score (RF-ON –
Sham) also did not differ between the control (Median = -1.25) and alarmist (Median =
1.92) video groups, U = 218.00, z = -0.563, p = .287 (one-tailed), ES = 0.08, indicating
that there was no interaction between video group and symptoms.
4.5.3.3 Effect of video on state anxiety and risk perception:
The difference in state anxiety (STAI-Y1) from T1 to T2 was significantly higher in the
alarmist (Median = 3.50) compared to the control (Median = -.50) video group, U =
135.50, z = -2.505, p <.01 (one-tailed), ES = 0.38. The difference in risk perception
(RPQ) from T1 to T2 was also significantly higher in the alarmist (Median = 1.00)
compared to the control (Median = 0.00) video group, U = 75.50, z = -3.946, p < .001
(one-tailed), ES = 0.60.
4.5.3.4 Relationship between belief of exposure and symptoms in double-blind trials as
a function of video group:
The relationship between belief of exposure and symptoms (Fisher transformed
Spearman’s rho values) did not differ between the control (M = .47, SD = .48) and
alarmist (M = .54, SD = .50) video groups, t(42) = -.443, p = .660, ES = 0.07.
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4.5.3.5 Relationship between pre-existing state anxiety and symptoms in open-label
trials:
Figure 4.5 shows the SESS symptom scores as a function of anxiety group. No
significant trend between symptom scores and higher levels of pre-existing anxiety was
detected, J = 210.00, z = -.838, p = .402, ES = 0.13.
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Figure 4.3: The mean (dot), median (line), interquartile range (box) and range (whiskers) of
the SESS belief of exposure rating are shown for the sham and RF-ON double-blind trials.
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Figure 4.4: The mean (dot), median (line), interquartile range (box) and range
(whiskers) of the SESS symptom score are shown for the sham and RF-ON doubleblind trials.
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Figure 4.5: The mean (dot), median (line), interquartile range (box) and range (whiskers) of
the SESS symptom scores in the RF-ON open-label trial are shown as a function of preexisting state anxiety level.
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4.6

Discussion

While there has been growing evidence that the symptoms reported by IEI-EMF
sufferers are likely the result of a nocebo effect (Eltiti, Wallace, Ridgewell, et al., 2007;
Nam et al., 2009; Oftedal et al., 2007; van Moorselaar et al., 2017; Verrender et al.,
2018; Wilén et al., 2006), there has been limited understanding of the factors which
contribute to such a response. Although a number of studies have shown that explicit
suggestions about the adverse effects of EMF exposure can increase concern and
negatively influence people’s beliefs about EMF exposure (Barnett et al., 2007; Köteles
et al., 2016; Nielsen et al., 2010; Wiedemann et al., 2014; Wiedemann et al., 2013;
Wiedemann & Schütz, 2005; Wiedemann et al., 2006; Witthöft et al., 2017) (factors
which are considered to be key in contributing to a nocebo response (Webster et al.,
2016)), it has remained relatively unclear whether the negative beliefs induced by such
communications can result in greater symptom formation following a perceived
exposure to EMF. The purpose of this experiment was to investigate whether perceived
EMF exposure would elicit symptoms in a healthy population and to assess whether
messages that emphasise ‘adverse health effects of EMF exposure’ can induce a nocebo
response, including for those without high pre-existing levels of state anxiety. In the
provocation trials, both active and sham EMF exposures were first demonstrated to
participants in an initial non-blinded, open-label trial, before a series of double-blind,
randomised, counterbalanced trials were conducted. By demonstrating that the
experiment contained a ‘no exposure’ condition, the present study was able to more
clearly determine whether any observed increases in symptoms were the result of a
nocebo effect.
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A number of preliminary tests were first used to establish whether the experiment was
valid and whether the experimental manipulation had worked. These checks
demonstrated that there were no differences in pre-existing levels of state anxiety, trait
anxiety and EMF risk perception between the alarmist and control video groups.
Further, these tests verified that participants understood the exposure protocol, as they
correctly indicated that they were being exposed in the RF-ON open-label trial and not
being exposed in the RF-OFF open-label trial.
The results of the provocation trials revealed the crucial role of awareness and belief in
the presentation of symptoms during perceived exposure to EMF. In the open-label
trials, participants reported higher symptom scores in the RF-ON trial compared to the
RF-OFF trial. In the subsequent double-blind trials, however, there was no difference in
either belief of exposure or symptom scores between the RF-ON and sham conditions.
These findings demonstrate that knowledge and/or awareness of the exposure condition
was essential for producing an effect on symptoms. In addition to this, belief of
exposure was found to be positively associated with higher symptom scores in the
double-blind trials, giving further indication that a nocebo effect, rather than EMF
exposure itself, was responsible for the increase in symptoms. In regards to the effect of
messages which emphasise the ‘adverse health effects of EMF exposure’, the present
study found that participants who viewed the alarmist video had higher symptom scores
in the open-label trials than participants who viewed the control video. While, in
contrast to Witthöft and Rubin (2013), the present study found that the effect of the
video on symptom score was not moderated by pre-existing levels of state anxiety, it is
important to note that the effect of the video on symptom score in the present study was
only trend level when including an outlier in the sample. This may indicate that the
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effect of the video was strongly influenced by the individuals in the study. This
corresponds to the notion that both situational factors (such as viewing a particular
media report) and dispositional factors (such as personality traits) interact to influence
people’s worries about the potential health hazards of modern life, though further
research is required to clarify the personality traits which may be involved in
moderating this effect (Witthöft et al., 2017). It is important to note, however, that
sample size may also play a considerable role in the interaction between the type of
video viewed and symptom score, and a larger sample size would have increased the
chance of identifying an effect of the video in the present study. In line with previous
research, the present study also found that participants who viewed the alarmist video
had a larger increase in state anxiety and risk perception from baseline relative to those
who viewed the control video (Bräscher, Raymaekers, et al., 2017; Witthöft et al., 2017;
Witthöft & Rubin, 2013). This provides further support to the notion that
sensationalised media reports are capable of increasing people’s concerns and worries
about exposure to EMF. Nonetheless, it is also possible that pre-existing beliefs about
the relative harmfulness of EMF exposure may have influenced the results of this study
via a ceiling effect. Future studies could usefully address this issue by using prescreening to allocate participants into “high” and “low” risk perception groups, within
each of the control and alarmist video groups.
Overall, the results of the present study corroborate those of IEI-EMF provocation
studies, and demonstrate that the belief of being exposed, rather than EMF exposure
itself, is sufficient to trigger symptoms in healthy participants, including those without
high pre-existing levels of anxiety. This is supported by the fact that 77% of participants
reported higher symptoms in the open-label RF-ON trial compared to the RF-OFF trial,
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while no difference in symptom score was detected in the double-blind trials. Although
the size of the effect on symptoms in the open-label trials in the present study was not as
large as the effect observed for IEI-EMF sufferers in a previous study (ES > 3.6)
(Verrender et al., 2018), the effect observed in the present study was still quite large (ES
= 0.71), and is larger than the traditionally used nomenclature of Cohen (1988) (who
treats the largest category of effect size as >.05). This may indicate that the nocebo
response displayed by IEI-EMF sufferers during a perceived exposure situation is a
normal human response. In addition to this, the results of the present study not only
support those of previous studies suggesting that sensationalist media reports about
perceived environmental hazards can raise concerns and negative beliefs about EMF,
but also demonstrate that such reports may be contributing to a symptomatic nocebo
response. This is analogous to the conclusions reached by studies investigating whether
media health warnings can influence symptom expectations after exposure to infrasound
from wind turbines or chemical pollution (Crichton, Dodd, Schmid, Gamble, & Petrie,
2014; Winters et al., 2003) and further emphasises the importance of disseminating
accurate scientific and health information in order to reduce the likelihood of
symptomatic nocebo responses in the community more generally.
A number of potential limitations should be considered when interpreting the results of
the present study. First, as the sample was mainly comprised of a relatively young
healthy population, the present study is unable to comment on whether similar effects of
alarmist media would be observed in a more general population sample. While online
advertisements were used in an attempt to attract greater interest in the study, future
studies could address this issue by using local newspapers and radio stations to recruit
more broadly from the community. Second, as the RF-OFF condition always preceded
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the RF-ON condition in the open-label trials, the possibility that part of the increase in
symptoms in the open-label trials (independent of the media content) was due to the
elapsed study time cannot be completely ruled out. However, it is important to note that
participants in provocation studies generally do not report such large increases in
symptoms as a function of time (Schmidt, Wolfs-Takens, Oosterlaan, & van den Hout,
1994). In addition to this, it is possible that effects on risk perception and symptoms
may be triggered by any message on EMF and health, irrespective of whether it is an
alarmist or positive message. However, Crichton and Petrie (2015a) found that
positively framed health information may reverse or dilute the effect of negative
expectations formed by alarmist media in the context of infrasound exposure, which
suggests that the frame of the message is important for symptom perceptions.
Nevertheless, future studies could include a third ‘positive’ video group to address this
issue. Finally, due to feasibility requirements, the present study was limited to assessing
acute symptom responses to acute exposures and the experiment was conducted in a
laboratory setting using a Faraday cage. It is important that these factors are taken into
consideration when interpreting the results of the present study, as these conditions may
not reflect typical everyday exposure scenarios.
Although the present study has provided further evidence that symptoms attributed to
EMF exposure are likely the result of a nocebo response, one of the major difficulties in
treating IEI-EMF is the stigma attached to the notion that the condition is a
psychological illness. While cognitive-behavioural therapy has been shown to be
efficacious in treating IEI-EMF (Rubin, Das Munshi, & Wessely, 2006), simply telling
sufferers that their symptoms do not have a toxicological cause is not reassuring and is
unlikely to completely alleviate symptoms (Rief, Heitmüller, Reisberg, & Rüddel,
2006). For instance, although van Moorselaar et al. (2017) found that providing
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individual feedback on the results of double-blind provocation studies reduced IEI-EMF
participants certainty about responding to acute EMF exposures, the feedback did not
materially change IEI-EMF sufferers perception of being sensitive to EMF in their
everyday life. Likewise, Nieto-Hernandez, Rubin, Cleare, Weinman, and Wessely
(2008) found that providing feedback to IEI-EMF sufferers about their ability to
discriminate between active and sham exposures had no influence on subsequent
symptom levels or perceived sensitivity to EMF. Explaining the nocebo response may,
however, offer an alternative solution. Recently, Crichton and Petrie (2015b) found that
participants who reported symptomatic experiences during infrasound exposure returned
mood and symptom levels to baseline levels in a subsequent exposure after they had
received an explanation of the nocebo response with supporting scientific evidence.
Whether such an effect could be replicated in people who experience IEI-EMF,
however, remains unclear. Explaining that the nocebo response experienced by IEIEMF sufferers is a normal human response may also offer a useful approach for
addressing the condition in the future. Nonetheless, it is conceivable that explaining
psychological mechanisms to people who claim to experience IEI-EMF may be
interpreted as offensive or lacking credibility. It may thus be more appropriate (and
more accurate) to emphasise that although EMF has not been shown to cause
symptoms, that this does not mean that IEI-EMF symptoms are necessarily due to the
nocebo effect; they may also relate to an undiagnosed medical condition (Dieudonné,
2016) which would require attention from a medical professional. Discussing the
potential aetiology of symptoms with IEI-EMF sufferers is thus a difficult task, and one
that requires further investigation.
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5.

CHAPTER 5: GENERAL DISCUSSION

Despite decades of research, the aetiology of IEI-EMF has remained extremely
controversial. While much of the existing literature has not found convincing evidence
of a relationship between EMF exposure and the symptoms reported by IEI-EMF
sufferers (Röösli, Frei, Mohler, & Hug, 2010; Rubin, Nieto-Hernandez, & Wessely,
2010), it has been estimated that between 1.5 – 13.3% of the population report
experiencing the condition. While disagreement has existed over the cause of IEI-EMF,
it has generally been agreed that sufferers are experiencing real symptoms which
significantly impair their daily functioning and quality of life (Johansson, Nordin,
Heiden, & Sandström, 2010; Rubin, Hillert, Nieto-Hernandez, van Rongen, & Oftedal,
2011). The continuing aetiological debate, however, has limited the development of
effective treatments and support for those who experience the condition, and this has
warranted the need for further investigation.
The overall aim of the present doctoral research was to clarify the determinants of IEIEMF by investigating whether toxicogenic or psychogenic processes can explain the
symptoms reported by IEI-EMF sufferers. Specifically, the research contained in this
thesis encompassed three human provocation studies, each designed with considerable
methodological improvements on the extant literature, to determine whether individuals
can be sensitive to EMF exposure and to further explore the potential role of
psychological processes and alarmist media reports in the presentation of symptoms
attributed to EMF exposure. The following chapter discusses the findings and
contribution of each study to the literature, and outlines the implications of this research
for the development of effective treatments and interventions for IEI-EMF sufferers.
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The potential limitations of this research are also discussed, and directions for future
studies are highlighted.
5.1

Contribution to the Literature

5.1.1

No evidence of an adverse functional consequence of RF-EMF

A number of studies have consistently shown that exposure to RF-EMF, similar to that
emitted by a mobile phone, can influence the brain’s electrical activity, specifically in
the spontaneous resting alpha (Croft et al., 2008; Croft et al., 2010; Curcio et al., 2005;
Leung et al., 2011; Perentos, Croft, McKenzie, Cvetkovic, & Cosic, 2007; Regel,
Gottselig, et al., 2007) and sleep spindle (Huber et al., 2000; Huber et al., 2002;
Loughran et al., 2005; Regel, Tinguely, et al., 2007; Schmid et al., 2012) frequencies of
the electroencephalogram (EEG). Given the close relationship between the EEG and
cognition, and given that IEI-EMF sufferers often report memory and concentration
difficulties as symptoms which they attribute to EMF exposure, Study 1 (Chapter 2,
Verrender, Loughran, Dalecki, McKenzie, & Croft, 2016) was developed as a means of
establishing whether exposure to RF-EMF below the established safety guidelines is
capable of eliciting these effects in humans. While a number studies assessing various
aspects of cognitive and behavioural functioning have found inconsistent, but mostly
null results (Barth, Ponocny, Gnambs, & Winker, 2012; Barth et al., 2008; Valentini,
Ferrara, Presaghi, De Gennaro, & Curcio, 2010), the methodological issues inherent in
previous research may have limited the ability of these studies to detect real effects. If
clear adverse effects on cognitive performance could be demonstrated in healthy
participants, this could offer a starting point for determining the most sensitive
endpoints with which to test IEI-EMF participants. Thus, to address the potential
limitations of previous studies, and as a means of developing a potential sensitive
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objective test for IEI-EMF sufferers, Study 1 was designed with considerable
methodological improvements to determine whether RF-EMF exposure could influence
cognitive performance in a dose-dependent manner.
The first stage of Study 1 required identifying possible methodological constraints in
previous studies and developing appropriate improvements to overcome these issues.
For instance, previous studies have generally relied on cognitive performance measures,
such as the N-back task, because of their perceived face validity or as a means to
replicate previously reported effects. However, these measures have generally been
unable to account for individual variation in cognitive performance (Regel &
Achermann, 2011), or have been found to be affected by learning effects (Haarala et al.,
2005; Haarala et al., 2004; Regel, Gottselig, et al., 2007; Regel, Tinguely, et al., 2007).
This means that the cognitive performance tasks utilised in previous studies have not
been able to reliably measure the potential effects of RF-EMF exposure on cognition
due to large error variance (Regel & Achermann, 2011). To overcome this issue, the
cognitive performance tasks utilised in Study 1 were individually calibrated to each
participant’s cognitive ability, and sufficiently long practice blocks were conducted
before each experimental session to reduce the influence of potential learning effects. In
addition to this, Type I and Type II error was minimised by treating the data using an
index of the participants’ response sensitivity and bias, as adapted from signal detection
theory (Stanislaw & Todorov, 1999). This treatment takes into account how well a
participant can discriminate between trials (sensitivity) and the participant’s general
tendency to respond with a ‘yes’ or ‘no’ button press (bias), giving a better indication of
task performance. Further to these improvements on the cognitive performance tasks,
Study 1 also reduced the influence of thermally induced variability by clamping skin
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temperature to a thermo-neutral state. This is potentially important, because it is
possible that whole body thermoregulatory processes play an integral role in mediating
the changes in the brain’s electrical activity and any functional effects resulting from
exposure to RF-EMF given that the primary mechanism of interaction between RF and
the human body is thermal (Adair & Black, 2003). Together, the improvements
implemented in Study 1 were intended to increase the sensitivity of the experiment, and
thus the ability to detect potential effects.
The results of Study 1 indicated that exposure to pulse modulated RF-EMF, similar to
that emitted by a mobile phone, may influence cognitive performance. Specifically, a
small improvement in reaction time was observed on the Sternberg working memory
task during exposure compared to sham. The improvement in performance, however,
was not found to be dose dependent, and the relatively small effect size means that it
may not be important in relation to normal variation in cognitive performance. While a
number of studies have not found that pulse modulated RF-EMF influences behavioural
measures of cognitive performance (Haarala et al., 2003; Haarala et al., 2004; Haarala et
al., 2007; Krause, Pesonen, Bjornberg, & Hamalainen, 2007; Leung et al., 2011), the
methodological improvements employed in Study 1 may have increased the sensitivity
of the experiment and thus enhanced the ability to detect potential effects. However,
without further replication, it is unclear whether the improvement in performance
observed in Study 1 represents more than a chance finding. Consequently, despite
accounting for a number of methodological limitations, Study 1 did not provide
sufficiently convincing evidence that exposure to RF-EMF can influence cognitive
performance; it thus did not identify any sensitive cognitive performance endpoints with
which to test IEI-EMF participants.
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5.1.2

No evidence of a relationship between IEI-EMF symptoms and EMF

exposure
As Study 1 did not identify an appropriate objective cognitive performance measure
with which to test IEI-EMF participants, and indeed, did not find convincing evidence
that exposure to RF-EMF can elicit adverse functional effects on cognitive performance,
Study 2 (Chapter 3, Verrender, Loughran, Anderson, et al., 2018) was designed as a
series of individual case studies to test whether exposure to RF-EMF results in an
increase in IEI-EMF participants self-nominated symptoms compared to sham, and
additionally, to determine whether IEI-EMF individuals could accurately detect the
presence of EMF emissions under double-blind conditions. Despite much of the existing
literature indicating that the symptoms experienced by IEI-EMF sufferers are the result
of a nocebo effect (Röösli et al., 2010; Rubin et al., 2010), some researchers and many
IEI-EMF sufferers have raised concerns about the way in which IEI-EMF provocation
studies have been conducted and have argued that methodological issues have
influenced the results of previous studies (Leszcynski, 2018; Weller, 2014). These
concerns have often been related to questions about whether laboratory testing
environments adequately reflect the conditions in which symptoms are normally
developed, and worries about whether previous studies have adequately accounted for
the heterogeneous nature of IEI-EMF (including between-subject differences in both
symptoms and EMF triggers).
To address these concerns, Study 2 incorporated a number of important methodological
improvements. First, to reduce the stress and anxiety experienced by participants in a
laboratory experiment, and to minimise potential confounding effects associated with
inadvertent environmental EMF exposures on the way to a laboratory, Study 2 utilised a
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portable exposure device which enabled double-blind testing to take place in
environments where participants generally felt safe and asymptomatic, such as in their
own home. Second, to limit potential statistical confounds, the study took an
idiographic, case-study approach to testing, and used a sufficient number of sham and
active exposure trials to determine statistically, within each participant, whether any
symptom/exposure relationship was significant. Further to this, the study included a
consideration of each participants IEI-EMF history, which involved using a similar RFEMF exposure to the one which the participant claimed triggers symptoms as well as
verifying that the exposure triggered symptoms in an open-label trial. In addition, the
testing protocol could be modified, if necessary, to match the reported symptom onset
and recovery periods for each participant, thus accounting for potential inter-individual
heterogeneity in symptom onset and recovery times. Finally, the design incorporated a
fully counter-balanced protocol in order to reduce time of day and time on task effects.
Yet, despite accounting for a number of potential limitations of previous IEI-EMF
provocation studies, the results of the case studies presented in Study 2 failed to
demonstrate that the symptomatic response of self-reported IEI-EMF sufferers is
affected by EMF exposure, nor that IEI-EMF sufferers could detect the presence of RFEMF emissions at greater than chance levels. While all three case study participants
displayed an increased symptom severity and were confident that they could detect the
presence of RF-EMF in the RF-ON compared to RF-OFF open-label trial, no significant
differences in symptom severity or exposure detection were found between the RF-ON
and sham conditions in the double-blind trials. Notably, in each case, a significant
relationship between a participant’s belief that they were being exposed (irrespective of
the actual exposure condition) and their symptomatic response was observed, giving a
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strong indication the symptoms experienced were more closely related to a nocebo
response. In line with the overall pattern of results of previous provocation studies
investigating IEI-EMF (Rubin et al., 2010), these findings confirm that awareness
and/or belief of exposure status, rather than the EMF exposure itself, is more closely
associated with IEI-EMF symptoms. This not only provides strong support for the
psychogenic theory of IEI-EMF, but also demonstrates that the lack of evidence for a
relationship between symptoms and EMF exposure observed in previous studies was
not due to the methodological concerns raised by some researchers and IEI-EMF
sufferers.
5.1.3

Nocebo responses may reflect a normal human response and may be
exacerbated by alarmist media coverage

As Study 2 provided further evidence to support the psychogenic theory of IEI-EMF, it
became crucial to understand whether the nocebo response exhibited by IEI-EMF
sufferers is a ‘normal’ human response, and to determine the factors which may
contribute to such a response. If healthy participants were found to exhibit a similar
response to those who suffer from IEI-EMF during a perceived threatening exposure to
EMF, then this may remove the stigma attached to the notion that the condition is a
psychological illness and may help to overcome the current reluctance of IEI-EMF
sufferers to seek psychological treatment. In addition, although there has been
consistent evidence that both precautionary and mainstream media messages about the
potential harmful effects of EMF exposure can negatively influence people’s beliefs and
raise concerns about EMF exposure (Barnett, Timotijevic, Shepherd, & Senior, 2007;
Nielsen et al., 2010; Wiedemann, Boerner, & Repacholi, 2014; Wiedemann et al., 2013;
Wiedemann & Schütz, 2005; Wiedemann, Thalmann, Grutsch, & Schütz, 2006;

161

Witthöft et al., 2017), it has been relatively unclear whether these negative beliefs
directly result in greater symptom formation and detection following a perceived
exposure to EMF. This is because previous research has either not assessed the effect of
explicit suggestions of risk from EMF exposure (which may induce negative
expectations) (Szemerszky, Köteles, Lihi, & Bárdos, 2010), has assessed somatosensory
perception and not symptom perception (Bräscher, Raymaekers, Van den Bergh, &
Witthöft, 2017), or has not included a verified non-exposure condition, which may have
resulted in insufficient statistical power to detect effects in non-anxious healthy
participants (Witthöft & Rubin, 2013). Thus, it has remained unclear as to whether the
negative beliefs induced by explicit suggestions about EMF exposure contribute to a
symptomatic nocebo response.
To address these issues, Study 3 (Chapter 4, Verrender, Loughran, Dalecki,
Freudenstein, & Croft, 2018) tested whether perceived EMF exposure could elicit
symptoms in a healthy population sample, and whether viewing an alarmist video
emphasising the ‘adverse effects of EMF exposure’ could exacerbate a nocebo response
in a healthy population. In this study, participants were first randomly assigned to view
either an alarmist video, which emphasised the ‘adverse effects of EMF exposure’, or a
control video completely unrelated to EMF health effects, before completing a series of
2 open-label (RF-ON and RF-OFF) and 12 randomised, double-blind, counterbalanced
provocation trials (6 RF-ON, 6 Sham). Importantly, like Study 2, the open-label trials
were used to verify that the experiment contained both active and sham exposure
conditions. By demonstrating that the experiment contained a ‘no exposure’ condition,
Study 3 was able to more-clearly determine whether any observed increases in
symptoms in healthy participants were the result of a nocebo effect.
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In line with Study 2, the results of Study 3 showed that healthy participants reported
higher symptom scores in the RF-ON compared to the RF-OFF open-label trial.
However, in the subsequent double-blind trials, no difference in either belief of
exposure or symptoms was found between the RF-ON and sham conditions. Belief of
exposure was also found to be positively associated with higher symptom scores in the
double-blind trials, giving further indication that a nocebo effect, rather than EMF
exposure itself, was responsible for the increase in symptoms. These results again
demonstrate that knowledge and/or awareness of the exposure condition is essential for
producing an effect. The large effect sizes observed for the relationship between belief
of exposure and symptoms in the open-label trials of Study 2 (ES = 3.6) and Study 3
(ES = .71) also provide robust support for the notion that a nocebo effect can explain
symptoms attributed to EMF exposure, and suggest that the nocebo response exhibited
by IEI-EMF sufferers may be a normal human response. Participants who viewed the
alarmist media video were also found to report higher symptom scores in the open-label
trials; and a greater increase in state anxiety and risk perception from baseline, than
those who viewed the control video. This indicates that viewing sensationalist media
reports about perceived environmental hazards both raises concerns and negative beliefs
about EMF exposure, and may also contribute to a symptomatic nocebo response.
While these findings provide further support for the psychogenic theory of IEI-EMF,
they are also consistent with a large amount of evidence which has demonstrated that
health warnings can increase concerns about environmental exposures and elicit
symptomatic nocebo responses (Crichton, Chapman, Cundy, & Petrie, 2014). For
instance, Winters et al. (2003) found that participants who had received warnings about
environmental pollution reported more symptoms to a foul smelling (but
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physiologically irrelevant) odour stimulus than participants who had received no prior
information about environmental pollution. Similarly, Crichton, Dodd, Schmid,
Gamble, and Petrie (2014) demonstrated that healthy participants who had received
information about an expected negative physiological effect of wind turbine infrasound
reported symptoms that aligned with that information during exposure to both active
and sham infrasound. In a follow up study, Crichton and Petrie (2015a) found that the
framing of information is important in eliciting an effect. In that study, positively
framed health information about the effects of infrasound exposure was shown to
reverse an initial symptomatic nocebo response that was generated by negatively framed
information. Clearly, the type of information disseminated in public has profound
effects on expectations and the experience of nocebo responses. In a powerful
demonstration of the role of expectations in producing symptoms, Landgrebe et al.
(2008) deceived IEI-EMF participants into thinking that they were being exposed to
EMF. The results showed that the deception not only lead to expectations which
resulted in symptom formation, but was also accompanied by activations of the brain
regions known to be involved in pain perception. This not only demonstrates the role of
expectations in producing a nocebo response, but also provides a psychophysiologically plausible mechanism as to why symptoms develop and are detected
during nocebo responses. Given the strong indications of the determinative role of
nocebo effects and negative expectations in eliciting symptoms attributed to EMF, it is
possible that the consistent misrepresentation of the scientific evidence in the
mainstream media (Claassen, Smid, Woudenberg, & Timmermans, 2012; EldridgeThomas & Rubin, 2013) may contribute to a symptomatic nocebo response.
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5.1.4

Implications for developing effective treatments and interventions for
IEI-EMF sufferers

Given the historical lack of evidence for an association between exposure to low level
EMF and adverse health effects, the development of effective treatments for people who
experience IEI-EMF has remained relatively challenging. While many public health
organisations and governments have recommended exposure reduction strategies to
those who are concerned about their EMF exposure, the current evidence does not
provide any support to the notion that such strategies are effective for treating IEI-EMF.
The difficulty in developing treatments and interventions for those who experience IEIEMF has also been limited by sufferers’ firm belief that the condition is caused by
exposure to EMF and the stigma attached to the notion that the condition is
psychological in origin, with the suggestion that symptoms are more closely related to a
psychosomatic phenomenon often attracting derision from IEI-EMF advocacy groups.
Overall, the results of the present thesis have provided strong support for the
psychogenic theory of IEI-EMF, which has several implications for the development of
effective treatments and support for IEI-EMF sufferers.
For example, exposure reduction strategies are one of the most commonly adopted
interventions employed by IEI-EMF sufferers. Generally, exposure reduction strategies
involve minimising or avoiding the use of EMF emitting technologies. However, many
exposure reduction strategies involve considerable social and/or financial cost without
any tangible benefit. For instance, although rooms and buildings can be shielded from
EMF through the use of metallic paints or the construction of Faraday cages, these
methods are often extremely expensive, and vary greatly in their ability to attenuate RFEMF. Similarly, products typically sold by IEI-EMF advocacy groups which claim to
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reduce EMF exposure from personal devices, such as protective stickers for personal
devices or protective clothing fabrics, are often ineffectual or have not been supported
by empirical tests of their claims (Leitgeb, Cech, Schröttner, & Kerbl, 2008; Rubin, Das
Munshi, & Wessely, 2006). In a recent survey study, Hagström, Auranen, and Ekman
(2013) found that 76% of IEI-EMF respondents reported the reduction or avoidance of
EMF as an action they had taken to manage their condition and that this behaviour
helped in their full or partial recovery. Yet, as the current thesis has found no support
for the toxicogenic explanation of IEI-EMF, exposure reduction strategies are likely to
be ineffective, and may only provide a limited placebo-like solution that would only be
useful in specific and limiting circumstances, such as in an IEI-EMF sufferers’ home.
Moreover, electromagnetic sanitation through exposure reduction or avoidance
behaviour may be counterproductive, as it may reinforce an IEI-EMF sufferers’ belief
that their symptoms are caused by EMF and worsen their condition when they perceive
that they are in an environment with EMF (Rubin et al., 2006). In addition to exposure
reduction, complementary and alternative medicine treatments are also popular amongst
people who suffer from IEI-EMF (Huss & Röösli, 2006). Such treatments, however,
have rarely been evaluated in controlled studies with IEI-EMF participants, and thus
their effectiveness in treating the condition remains to be determined. Of the few studies
that have assessed the use of acupuncture in treating patients with ‘environmental
illnesses’ (Arnetz, Berg, Anderzen, Lundeberg, & Haker, 1995) and antioxidant vitamin
supplements to treat individuals with IEI-EMF (Hillert, Kolmodin-Hedman, Eneroth, &
Arnetz, 2011), no specific therapeutic benefits were found.
In an attempt to find an explanation and solution for their symptoms, many IEI-EMF
sufferers often consult with general practitioners (GPs) and other first-line health
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professionals. Although data concerning the use of health services by IEI-EMF sufferers
in Australia is lacking, survey studies evaluating the use of GP consultations in
European nations have shown that the majority of GPs in these countries have been
consulted at least once by IEI-EMF sufferers (Huss & Röösli, 2006; Kowall,
Breckenkamp, Heyer, & Berg-Beckhoff, 2010; Leitgeb, Schröttner, & Böhm, 2005;
Slottje et al., 2017). For instance, Leitgeb et al. (2005) reported that at least two thirds
of GPs who responded to the survey were frequently consulted by IEI-EMF sufferers in
Austria, while Huss and Röösli (2006) found that 69% of respondent GPs reported
having at least one consultation about symptoms attributed to EMF. Alarmingly, many
of these survey studies have revealed that health professionals generally have a poor
understanding of the current scientific consensus regarding EMF exposure and health
risks and that many consider a causal relationship between EMF and health complaints
to be at least to some degree plausible. For example, Leitgeb et al. (2005) found that
96% of GP respondents either ‘totally’ or ‘to some degree’ believed in the health
relevant role of EMF exposure in producing symptoms or illness. Similarly, Huss and
Röösli (2006) found that respondent GPs judged the relationship between EMF
exposure and symptoms to be plausible in 54% of cases. Although it is concerning that
health professionals may be fostering people’s beliefs that EMF exposure is the cause of
their symptoms, this may be due to the GPs own insufficient knowledge, or a limited
understanding of the scientific evidence. For instance, Leitgeb et al. (2005) reported that
only 25% of medical practitioners had consulted the scientific literature for information
about the potential health risks of EMF, while only 4% reported receiving information
from health agencies or governments. In addition to this, it is also possible that GPs
have evaluated the relationship between EMF exposure and symptoms to be plausible
on the basis that they are taking a precautionary or preventative approach for their
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patients in an area which they themselves perceive to be scientifically uncertain.
Nevertheless, given that the studies presented in the current thesis provide no support
for the role of EMF in producing symptoms, and given the apparent contradiction
between physicians’ opinions and the positions of the researchers and the world’s
leading health authorities on EMF health risks, it is clear that greater effort is needed to
communicate the current position of science to these first-line health professionals so
that they can begin to discuss this issue and develop appropriate alternative
interventions with their patients (Slottje et al., 2017).
Helping patients to consider alternative explanations for their symptoms has been found
to be effective across a range of similar conditions that are characterised by the
presentation of non-specific symptoms without identifiable cause, such as chronic
fatigue syndrome (van Hout, Wekking, Berg, & Deelman, 2003). Yet, the stigma
attached to the notion that IEI-EMF is more closely related to a psychological illness
has proven to be a difficult challenge to overcome, and simply telling IEI-EMF
sufferers that their symptoms do not have a toxicological cause is not an effective way
to alleviate symptoms (Rief, Heitmüller, Reisberg, & Rüddel, 2006). For example,
Nieto-Hernandez, Rubin, Cleare, Weinman, and Wessely (2008) found that providing
feedback to IEI-EMF sufferers about their lack of ability to discriminate between active
and sham exposures had no influence on subsequent symptom levels or perceived
sensitivity to EMF. Likewise, van Moorselaar et al. (2017) found that while feedback on
provocation study results reduced IEI-EMF sufferers’ certainty about their ability to
respond to acute exposure scenarios, the overall feedback did not materially change
their perceptions of being sensitive to EMF. As Study 2 and Study 3 have demonstrated
the crucial role of awareness and belief of exposure in producing symptoms attributed to
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EMF, interventions which focus on these psychological processes, such as Cognitive
Behavioural Therapy (CBT), may offer an alternative avenue for treatment research and
development.
CBT is a form of structured psychotherapy designed to change unhelpful or unhealthy
thoughts and behaviours (Neenan & Dryden, 2014). It is a problem-focused and
individualised approach that focuses on remedying immediate problems, but it also
attempts to develop long-term strategies to replace thoughts and behaviours that
interfere with a person’s happiness and satisfaction with their life (Neenan & Dryden,
2014). CBT has been found to be an effective treatment for a range of psychological
issues, such as depression and anxiety, and it has also been used extensively to reduce
somatic symptoms in somatosensory disorders and to reduce the side-effects of
medications (e.g. nausea associated with chemotherapy for the treatment of cancer)
(Neenan & Dryden, 2014). Given that CBT has also been shown to be efficacious in
treating other conditions characterised by medically unexplained symptoms (Edwards,
Stern, Clarke, Ivbijaro, & Kasney, 2010; Escobar et al., 2007; Sharpe et al., 1996;
Speckens et al., 1995), it may also be an appropriate approach for treating IEI-EMF.
However, as only a limited number of studies have assessed the efficacy of CBT as an
intervention for IEI-EMF sufferers, the potential benefits of this treatment option
remain to be adequately clarified.
To date, only four studies have assessed the efficacy of CBT as an intervention for
suffering from IEI-EMF. After assessing symptoms and quality of life outcomes in IEIEMF sufferers following CBT, three of these studies found reductions in self-ratings of
hypersensitivity (Hillert, Arnetz, Hedman, & Dölling, 1998), disability (Andersson et
al., 1996), symptoms (Andersson et al., 1996; Harlacher, 1998), and overall perception
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and degree of suffering (Harlacher, 1998), while one study did not report any
significantly better outcomes than the control condition (Hillert, Savlin, Levy Berg,
Heidenberg, & Kolmodin-Hedman, 2002). However, while the majority of these studies
generally indicate that CBT may be an effective treatment for those who suffer from
IEI-EMF, a number of possible methodological issues have limited our understanding
of the long term efficacy of CBT as an IEI-EMF treatment (Rubin et al., 2006). For
example, no studies have conducted follow-up assessments of patients for more than 6
months, so it is unclear how long any beneficial effects of CBT last in these cases
(Rubin et al., 2006). Furthermore, it is possible that the beneficial effects reported in
these studies were actually associated with the general non-specific effects of receiving
psychotherapy (Rubin et al., 2006). Although this could be interpreted as a useful
placebo-like effect, and would not be an issue while therapy is ongoing, it is unclear if
or for how long these benefits would continue post-therapy. Future studies, therefore,
could usefully clarify the effectiveness of CBT as an intervention for people suffering
from IEI-EMF by employing longer-term follow-up assessments.
While CBT may prove to be an effective treatment for IEI-EMF sufferers, the results of
Study 2 and Study 3 also indicate that other psychological interventions, which focus on
the underlying factors which drive nocebo responses, may provide another alternative
avenue for treatment research and development. Generally, a nocebo response occurs
when conscious or subconscious negative expectations trigger or exacerbate adverse
symptoms in response to an exposure that is not known to cause those effects (Bräscher,
Kleinböhl, Hölzl, & Becker, 2017; Hahn, 1997). These expectations may be induced by
explicit suggestions about the potential effects of an exposure (Benedetti, Lanotte,
Lopiano, & Colloca, 2007; Webster, Weinman, & Rubin, 2016) or by learning through
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classical conditioning (Bräscher, Kleinböhl, et al., 2017). Consequently, interventions
which focus on modifying conscious or subconscious negative expectations may
provide an effective means for treating people who suffer from IEI-EMF.
For instance, there is some emerging evidence that providing a scientific explanation of
the nocebo response and its mechanisms following a provocation trial may offer an
effective way to change people’s conscious expectations about their IEI symptoms.
Recently, Crichton and Petrie (2015b) found that participants who reported symptoms
during infrasound exposure returned mood and symptom levels to baseline levels in a
subsequent exposure after they had received an explanation of the nocebo response with
supporting scientific evidence. This suggests that providing an explanation of the
nocebo response was able to modify people’s response during a subsequent provocation
trial. Given the results of Study 3, it may also be possible that explaining that the
nocebo response experienced by IEI-EMF sufferers is a normal human response (rather
than an abnormal psychological disorder) may also help in modifying conscious
expectations; however, further investigation is required to determine the efficacy of
such an intervention with IEI-EMF participants. If, however, classical conditioning is
one of the main factors driving a nocebo response (as suggested by some theorists, for
example, Barsky, Saintfort, Rogers, & Borus, 2002; Webster et al., 2016), then
interventions based on systematic desensitization, in which repeated exposure to EMF is
paired with relaxation techniques, may also diminish a possible conditioned response to
environmental stimuli (Rubin et al., 2006). The efficacy of such an intervention with
IEI-EMF patients, however, remains to be empirically tested, and it is unclear whether
this type of treatment would be suitable for people who experience symptoms
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associated with a broad range of EMF sources compared to those who only experience
symptoms associated with specific devices.
The way health information is framed may also modify conscious or subconscious
expectations about environmental exposures. For example, there is evidence that has
shown that framing health information about environmental exposures in a neutral or
benign way can ameliorate IEI symptoms. Crichton and Petrie (2015a) found that
participants who formed negative expectations from media warnings about infrasound
from wind turbines reported increased symptoms and deterioration in mood during
simultaneous exposure to infrasound and audible wind farm noise, yet those who
formed positive expectations derived from information about the therapeutic effects of
infrasound experienced improvements in symptoms and mood. This demonstrates the
malleability of symptomatic responses, and highlights the important role of message
framing on expectations and placebo/nocebo effects. Yet, while these studies indicate
that interventions which focus on modifying conscious or subconscious expectations
can effectively reduce symptoms associated with other IEI conditions, as no similar
studies have been conducted with people who report experiencing IEI-EMF, it remains
unclear as to whether such effects could be replicated in IEI-EMF sufferers.
5.2

Potential Limitations

Although considerable effort was made to address the limitations of previous research
in each of the studies contained within the present thesis, a number of possible issues
need to be taken into consideration when interpreting the results of the present thesis.
Many of these issues relate to potential limitations associated with the ecological
validity of human provocation studies and the methods used to assess IEI-EMF
symptoms more generally.
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The first potential limitation relates to exposure duration. While the majority of people
with IEI-EMF report that their symptoms typically occur within minutes to hours after
exposure, some report that their symptoms are the result of longer exposures or of an
accumulation of exposures over time (Hocking, 1998; Röösli, Moser, Baldinini, Meier,
& Braun-Fahrländer, 2004). Generally, to make them feasible, provocation studies are
limited to using short term, acute exposures. As the exposure intervals implemented in
the studies contained in the present thesis were limited to 30 minutes or less, the
conclusions drawn from these studies cannot be used to comment on possible long term,
chronic effects of EMF exposure. However, while the more chronic forms of IEI-EMF
remain under-investigated using the provocation study paradigm, it is important to note
that there has been no convincing evidence from epidemiological studies that long term
exposures have an adverse effect on human health either (Röösli et al., 2010). Although
many advocates of the toxicogenic theory of IEI-EMF argue that the condition may be a
result of a ‘build up’ of chronic exposures over time (for e.g. over several
days/weeks/months), this could only be determined empirically using a sufficient
amount of active and sham exposure conditions (as per the methodology of Study 2).
While the amount of time it would take to conduct such provocation trials would make
this extremely difficult (and likely not feasible), given the complexities of subjectively
trying to summate average exposure periods over long intervals with a multitude of
potential confounding factors (in daily life), it seems unreasonable that IEI-EMF
sufferers could reliably claim that their symptoms were the result of chronic exposures
to EMF. Therefore, acute exposure trials not only offer the most feasible way of testing
the claims of IEI-EMF sufferers, they also offer the most direct means of testing the
claims made by IEI-EMF sufferers.
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The use of simulated exposure signals may be another possible limitation. As no
consistent pattern in the types of EMF emitting sources that are claimed to trigger IEIEMF symptoms has been identified, provocation studies have generally relied on
exposure systems which simulate the emissions produced by everyday devices. The
studies contained in the present thesis used exposure systems which either simulated
mobile handset-like exposure (Study 1) or generated a signal which was digitally
modulated in similar manner to signals from Wi-Fi routers and 3G/4G mobile phones
(Study 2 and Study 3). While it is often argued that simulated exposure signals can be
used to reliably test whether a well-characterised exposure is associated with an adverse
effect (Boutry et al., 2008; Regel & Achermann, 2011), some researchers have criticised
the use of simulated exposure signals and argue that experimental findings could only
be ecologically valid if relevant commercially available EMF emitting devices were
used (Panagopoulos, Johansson, & Carlo, 2015). Unlike everyday devices (such as
commercially available mobile phones), which produce a relatively localised yet
variable SAR distribution which can be reduced by orders of magnitude with greater
separation from the exposure (Loughran, McKenzie, Anderson, McIntosh, & Croft,
2008), simulated exposure devices produce controlled and precise exposures. Although
it may be possible that the unpredictable and heterogeneous nature of everyday EMF
emissions is an important factor for eliciting an adverse effect (Oftedal, Straume,
Johnsson, & Stovner, 2007; Rubin et al., 2010), it is important to note that there is
currently no evidence to support this notion. Despite this, it may be advantageous for
studies to use simulated exposures if they are attempting to develop an understanding of
whether exposures with a specified dosimetric value can affect health (Loughran et al.,
2008). For instance, in Study 1, a planar exposure system was used to generate a mobile
phone handset-like signal to assess whether EMF exposure could influence cognitive
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performance in a dose dependent manner. Because the SAR distribution produced by
the exposure system was more homogenous than that produced by a typical mobile
phone, the findings cannot be used to definitively comment on whether cognitive
performance is influenced by exposure to EMF emitted by mobile phones, but rather
can only reflect whether RF-related bioeffects occur at the maximum exposure level
within the exposed hemisphere. However, in respect to the endpoints of the present
thesis, the use of a planar exposure system in Study 1 was appropriate, as exposure of
the whole hemisphere maximised the chance of finding any possible effects on
cognitive performance. Similarly, while the portable exposure device used in Study 2
and Study 3 generated a signal that would not typically be emitted by everyday devices
(as the signal band was reserved for industrial, scientific and medical use), initial nonblinded open-label trials were used to verify that participants believed that they were
being exposed and that they responded to the signal, which verified that it was
appropriate for the purposes of the study.
Some IEI-EMF advocates also view the use of subjective measures of symptoms as a
major limitation of provocation studies, and argue that such measures are unreliable and
insufficient to either prove or disprove the existence of a causal link between the
reported symptoms and EMF (Leszcynski, 2018). While both Study 2 and Study 3 used
questionnaires to assess participant’s subjective symptom experiences, it is important to
note that such questionnaires are designed to specifically test the claims of IEI-EMF
sufferers, and that no objective test for symptom experiences has been developed and no
formal diagnostic tests have been established to identify people who experience IEIEMF. Although Leszcynski (2018) argues that physiology based research examining
molecular responses of human tissues and organs will provide the evidence for
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individual sensitivity to EMF, it first needs to be established that the exposures claimed
to elicit a symptom response are actually capable of eliciting a symptom response. As
no toxicogenic relationship between adverse health effects and exposure to EMF has
been established, and due to the extremely heterogeneous nature of IEI-EMF, there is no
reason to expect that empirical tests assessing whether one of a vast number of
physiological endpoints is influenced by EMF exposure would contribute to our
understanding of the condition. In this sense, only double-blind provocation studies with
appropriate verification procedures (as implemented in Study 2) are able to test the
symptom claims of IEI-EMF sufferers.
In addition to the aforementioned issues, a number of other possible limitations apply to
the specific studies contained within this thesis. First, the statistical analyses in Study 1
controlled for comparison-wise error by restricting the planned contrasts to degrees of
freedom error without multiple comparison adjustment (Tabachnick & Fidell, 2013).
However, this method does not control for experiment-wise error, and so it is still
possible that the results of Study 1 were influenced by Type 1 error. Second, despite
using an improved methodology, the results of Study 2 cannot be generalised across the
entire IEI-EMF population, given the relatively small number of participants who
completed the study. Recruitment of sufficient numbers of participants is one of the
most challenging aspects of conducting provocation studies involving IEI-EMF
participants, as reflected by the relatively small sample sizes of previous studies
(median number of IEI-EMF participants in previous studies = 19) (Rubin et al., 2010).
However, given the consistency within the literature, it is unlikely that the low sample
sizes are the reason for the overall failure of provocation studies to detect a toxicogenic
relationship between EMF exposure and symptoms (Rubin et al., 2010). For instance,

176

after pooling the results from five separate provocation studies, Roosli (2008) still failed
to detect a significant effect of exposure. The reluctance to participate in provocation
studies may be due to scepticism of the scientific process, concerns about the possible
adverse effects caused by voluntary exposure, and/or of distrust of the research group
conducting the investigation. Nevertheless, the considerable methodological
improvements employed in Study 2 meant that it was appropriately designed to detect
partial IEI-EMF responses within each case separately. Finally, it is possible that preexisting beliefs about the relative harmfulness of EMF exposure may have influenced
the results of Study 3 via a ceiling effect. While it is impossible to control for the beliefs
formed by situational factors (such as viewing a particular media report before an
experimental session), pre-screening could be used to allocate participants into “high”
and “low” risk perception groups before any experimental manipulation has taken place,
which would allow this issue to be controlled for experimentally in future study designs.
5.3

Future Directions

Given that a considerable amount of research has determined that IEI-EMF is of a
psychogenic origin, it is important that future research is directed towards targeting the
factors that contribute to nocebo responses. This needs to be a multifaceted approach,
which involves not only the communication of the current scientific evidence to
frontline medical professionals, but also the dissemination of accurate information to
the community more broadly. As the present thesis found that the nocebo effect was
exacerbated by alarmist media emphasising the ‘adverse effects of EMF’ in healthy
participants, it is regrettable that some commentators and advocates of the toxicogenic
theory continue to discuss IEI-EMF without sufficient evaluation of the literature (e.g.
BioInitiative Working Group, 2012) as this appears to promote or exacerbate nocebo

177

effects in society more broadly. Evidently, the scientific community need to develop
effective ways to communicate the current state of science (Rubin et al., 2011).
Moreover, further research is needed to clarify how personality traits may interact with
situational factors (such as viewing a particular media report) to influence peoples
worries and expectations regarding EMF exposure in order to identify people who may
be more susceptible to alarmist media reports and resultant nocebo effects.
In addition to this, future research could benefit by focusing on developing effective
interventions and support for those who suffer from IEI-EMF. This could be achieved
by first clarifying the efficacy of psychological approaches to treating IEI-EMF (Rubin
et al., 2006), irrespective of whether these are CBT or non-CBT based interventions.
While some evidence has shown that CBT may be an effective strategy for treating IEIEMF (Andersson et al., 1996; Harlacher, 1998; Hillert et al., 1998), non-CBT related
interventions may also provide a useful direction for future research. In particular, given
that Crichton and Petrie (2015a) found that positively framed health information may
reverse or dilute the effect of negative expectations formed by alarmist media in the
context of infrasound exposure, future studies could profit from exploring whether
positively framed messages about EMF exposure can ameliorate symptoms triggered by
negative expectations. However, as many who experience IEI-EMF firmly believe that
EMF is the cause of their symptoms, caution should be applied when providing
psychological interventions or explanations, as such strategies may be interpreted as
being offensive or lacking credibility. Thus, alongside studies assessing the efficacy of
psychological approaches to treating IEI-EMF, it would be important for future research
to focus on developing effective communication of the research between scientists,
health professionals and IEI-EMF sufferers.
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5.4

Conclusions

Overall, the studies presented in this thesis have found no support for the view that
toxicogenic processes can explain symptoms attributed to EMF exposure. Instead, the
results of the present thesis strongly indicate that psychological factors play an
important role in triggering, maintaining, or exacerbating symptoms in response to
perceived exposure to EMF.
In particular, while the present research found that exposure to mobile phone-like RFEMF may improve cognitive performance on a working memory task, the slight
improvement in performance observed in Study 1 did not provide convincing evidence
that exposure to mobile phone-like RF-EMF can influence cognitive performance in a
dose dependent manner, let alone adversely (Chapter 2, Verrender, Loughran, Dalecki,
McKenzie, & Croft, 2016). This result is significant because it provides further support
to the overall evidence that while exposure to RF-EMF within the established exposure
guidelines (ICNIRP, 1998) can trigger subtle biological and physiological effects (as
has been reported previously in relation to the EEG), these changes do not necessarily
constitute an adverse effect on health or functioning. Given this finding, Study 1 also
did not identify any sensitive cognitive performance endpoints with which to test IEIEMF participants. The present doctoral research also demonstrated that awareness and
belief of exposure, rather than EMF exposure itself, is crucial in eliciting symptoms
attributed to EMF (Chapter 3, Verrender, Loughran, Anderson, et al., 2018; Chapter 4,
Verrender, Loughran, Dalecki, Freudenstein, & Croft, 2018). While this not only
provides further support for the psychogenic theory of IEI-EMF, the fact that healthy
participants were found to exhibit a similar symptomatic nocebo response to IEI-EMF
sufferers suggests that this type of response may be a normal human response (Chapter
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4, Verrender, Loughran, Dalecki, Freudenstein, & Croft, 2018). This has important
implications for developing effective treatments for IEI-EMF sufferers, and may help to
remove the stigma attached to the notion that IEI-EMF is a psychological issue. Finally,
this research also showed that viewing an alarmist media report that emphasised the
‘adverse effects of EMF exposure’, increases anxiety and concerns about EMF exposure
and may also exacerbate nocebo responses in otherwise healthy people (Chapter 4,
Verrender, Loughran, Dalecki, Freudenstein, & Croft, 2018). This demonstrates the
clear role of negative expectations in eliciting symptomatic nocebo responses and
highlights the need for the dissemination of information which accurately reflects the
current state of science.
The research presented in this doctoral thesis has considerable implications for the
development of effective treatments and support for those who suffer from IEI-EMF.
First, it suggests that it is important for interventions to focus on helping IEI-EMF
sufferers to consider alternative explanations for their symptoms, and second, that
interventions attempt to modify the negative expectations which contribute to
symptomatic nocebo responses. In addition to this, given that explicit suggestions,
negative expectations and nocebo responses have been found to play a determinative
role in eliciting symptoms attributed to EMF exposure, the evidence presented in this
thesis clearly indicates that greater effort is needed to communicate the current state of
science, not only to medical professionals, but also to the community more broadly.
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